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ABSTRACT 
Systemic rheumatic diseases have been shown to produce 
antinuclear antibodies in many previous studies. This property has 
proved useful both for diagnostic purposes and for the 
identification and characterisation of novel nuclear antigens. 
In a blind study, a panel of 24 sera from patients with a wide 
range of systemic rheumatic disease was assayed for autoantibodies 
specific for the nucleus by whole cell immunofluorescence and 
Western blotting. Some well characterised clinical conditions were 
identified by the specific immunofluorescence staining patterns 
observed, and by the molecular weights of the polypeptides reacting 
on blots. Apparently novel staining patterns in cells and on blots 
were also observed and two sera in particular were chosen for 
further study. 
The autoantibodies present in these sera and in sera from 
additional patients with the same conditions allowed the 
identification of cDNA clones from a human expression library. A 
group of sera from scleroderma patients which recognised a 
polypeptide of 95kDa led to the isolation of 3 clones which cross - 
hybridised with each other, and when sequenced proved to code for 
DNA topoisomerase I. This protein has been shown to be identical to 
the marker antigen Scl -70 originally estimated to have a molecular 
weight of 70kDa (Shero et al, 1986). The second group of sera from 
MCTD patients recognising a polypeptide of 38kDa on Western blots 
led to the isolation of a single human cDNA showing -75á nucleic 
acid sequence identity and -85% amino acid sequence identity with 
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the m9 transcript of the Drosophila developmental gene Enhancer of 
Split E(spl). E(spl) m9 forms part of a complex locus in Drosophila 
which interacts with other neurogenic genes during the initial 
stages of neurogenesis. Loss or a mutation in any one of those 
genes results in neural hyperplasia due to incorrect determination 
of cell fate. 
However this protein is not the 38kDa antigen detected on 
Western blots, as the cDNA is incorporated in the reverse 
orientation relative to the direction of transcription within the X 
vector. The isolation of the human homologue of E(spl) m9 clone was 
probably due to the selection of a spurious negative clone, which 
had not been eliminated in the rounds of screening and which 
remained on the final plate. 
Further studies to investigate the significance of isolating 
an E(spl) analogue from a human cDNA library were carried out. The 
cDNA cross -hybridised with the Drosophila cDNA and with a genetic 
construct which rescues flies with otherwise lethal mutations within 
the locus. It also hybridises to human genomic DNA. Using this 
cDNA as a probe, three mouse cDNAs have been isolated which appear 
to encode the full length mouse equivalent. This opens many avenues 
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Autoimmunity is defined as a condition in which an immune 
response is directed against a constituent of an organism's own body 
(Blakiston's Pocket Medical Dictionary). Autoimmune diseases affect 
between 5 and 7% of the population and consist of a wide spectrum of 
disorders diverse in terms of symptoms, systems involved and their 
degree of manifestation (Sinha et al., 1990). In spite of this 
complexity, they can be subdivided into three basic categories. 
Firstly, there are those characterised by specific organ damage and 
the production of autoantibodies which react with that particular 
organ alone. An example of this type of disease is Graves disease 
in which the thyroid gland is hyperfunctional and autoantibodies are 
produced to the thyroid stimulating hormone (TSH) receptors 
(Strakosh et al., 1982). The second category consists of diseases 
characterised by specific organ damage but the autoantibodies 
produced are not specific for that organ. Primary biliary cirrhosis 
(PBC) is a disease in which the small bile ducts within the liver 
are destroyed leading ultimately to liver failure (Taal et al., 
1983) but the characteristic autoantibody reacts with the 
mitochondria in all cells (Frazer et al., 1985). The final group of 
diseases are those involving multisystem damage and autoantibodies 
which react with a systemic antigen. The classic disease in this 
group is systemic lupus erythematosus (SLE) in which the joints, 
2 
kidneys, skin, central nervous system (CNS), lungs, heart and 
skeletal muscle in any combination are the target organs. 
Autoantibodies produced are characteristically reactive towards the 
nucleus; the defined antigens being deoxyribonucleic acid (DNA), 
histones, nuclear enzymes and protein and ribonucleic acid (RNA) 
complexes (Tan, 1982). SLE is probably the most severe condition of 
this type. Milder conditions in this category affect fewer systems, 
for example, dermato /polymyositis involves skin and muscle only, but 
all produce the characteristic antinuclear antibodies (ANA). These 
few examples clearly indicate the wide range of autoimmune disease; 
the aetiology is similarly diverse. 
1.1.1 The Aetiology of Autoimmune Diseases. 
Autoimmunity has been described as a "mosaic" (Shoenfeld and 
Isenberg, 1989), implying that the aetiology involves many different 
factors. These factors can be classifed as genetic, immune defects, 
hormonal, environmental, plus other factors which do not seem to 
qualify for the groups listed above. 
Familial studies first indicated the importance of genetic 
factors in autoimmunity. The effects were determined as genetic 
rather than environmental by examining the incidence of disease in 
monozygotic and dizygotic twins. The concordance of SLE in 
monozygotic twins is approximately 70% whereas that of dizygotic 
twins is no more than that of first degree relatives at 
approximately 5% (Block et al., 1976). Symptom free family members 
have often been shown to have an increased incidence of autoantibody 
production (Isenberg et al., 1985; Shoenfeld et al., 1987). 
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Genetic predisposition was also studied by the analysis of 
major histocompatibility complex (MHC) associations. More than 40 
diseases are known or thought to be autoimmune and almost all of 
these are influenced by the genes encoded in the MHC, the human 
leukocyte antigen (HLA) region on the short arm of chromosome 6. 
The first associations reported were with human class I alleles, but 
with methods for typing class II alleles, most diseases have been 
shown to be more strongly associated with class II. The class II 
region, HLA -D, is complex, spans approximately 1.1 Mb and is located 
centromeric to classes I and III. Polymerase chain reaction 
technology (Saiki et al., 1988) has allowed the analysis of the 
nucleotide sequences of class II genes of autoimmune patients and of 
normal individuals. For some diseases short stretches of sequence 
or critical residues were identified as playing a role in 
predisposition. For example, the HLA DR$ chain has been associated with 
the development of pemphigus vulgaris (PV) in DR4 positive 
individuals if it contains negatively charged residues in the third 
of its four hypervariable regions (HVR). Some diseases appear to be 
associated strongly with a particular chromosomal combination of 
alleles. For example, individuals that inherit Al, B8 and DR3 HLA 
alleles together on one chromosome by linkage disequilibrium, have 
an increased risk of developing insulin- dependent diabetes mellitus 
(IDDM), myasthenia gravis (MG), SLE and coeliac disease (Dawkins et 
al., 1982). However most individuals who carry the class II 
epitopes which confer predisposition to certain diseases do not 
develop the condition. This emphasises that although MHC class II 
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antigens are important in the development of some autoimmune 
diseases, other factors are required. 
Immune defects are the second class of factors reported to be 
involved in the induction of autoimmune disease. When stimulated, 
the immune system is capable of enhanced replication of the 
components involved in an immune response. Therefore, it is clear 
that strict and specific control mechanisms must be available to 
minimise the production of autoantibodies. A breakdown in these can 
result in a loss of tolerance to self antigens. The mechanisms by 
which self -tolerance is lost are not known, but possible critical 
steps have been identified (Sinha et al., 1990). Susceptibility is 
conferred by the MHC if its gene products bind self antigen and 
present it to the immune system in such a way as to induce an immune 
response. The activation of T cell subsets is also controlled by 
MHC molecules, as they select epitopes for the induction of antigen - 
specific suppressor T cells. 
T cells with 
anti -self reactivities are also required for autoimmunity to 
develop. In normal individuals this type of T cell is present but 
it is thought that antigen- specific suppressor T cells decrease 
their numbers and "clonal paralysis" of anti -self T cells (Burkly et 
al., 1989) assists in maintaining tolerance. Cytokines are involved 
in controlling the duration and magnitude of an immune response. 
(They include lymphokines, interleukins and 
interferons.) They are produced locally by a wide range of cell 
types but almost all act on B and T cells in picomolar 
concentrations (Balkwill and Burke, 1989). T cells infiltrating 
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lesions in autoimmune disease secrete IL -2 and have the IL -2 cell 
surface receptor. IL -2 is produced after specific or nonspecific 
activation of T cells and enhances the level of stimulation of many 
of the cells involved in the immune response (Smith, 1980). These 
examples demonstrate how a loss of regulation of production of these 
potent proteins could result in the induction of an autoimmune 
disease. 
Hormones, particularly sex hormones, have an established 
effect on the incidence of autoimmune diseases (El -Roeiy and 
Shoenfeld, 1985). MHC class II- associated diseases, which form the 
largest group, are generally suffered by female patients. MHC class 
I- associated types show an association with male patients. Thymic 
hormones (Horowitz et al., 1977), corticosteroids and vitamin D 
(Rigby, 1988) have all been linked with autoimmune disease. It is 
thought that testosterone and thymic hormones enhance, whilst 
oestrogens may inhibit the function of CD8+ T cell clones (Lahita 
and Kunkel, 1983), which act as immune suppressors. (Autoantibodies 
and suppressor T cell defects are common in asymptomatic, first 
degree female relatives of patients with certain types of autoimmune disease 
: Shoenfeld et al., 1987.) Patients suffering from Klinefelter's syndrome 
(males 
with an extra X chromosome) have an increased incidence of 
autoimmune disease when compared to the normal male population 
(Lavalle et al., 1987). Studies in New Zealand Black /White (NZB /W) 
mice have assisted in the determination of the effects of sex 
hormones on autoimmune disease. These mice have been 
bred 
specifically so that the female Fi hybrids spontaneously 
develop an 
autoimmune disease similar to human SLE. Castrated 
male mice 
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develop a disease similar to that suffered by the female mice. 
Administration of androgens to an affected female mouse 
significantly increased its lifespan and little or no evidence of 
the autoimmune disease was found (Theofilopoulous and Dixon, 1985). 
The genetic predisposition, immunological defects and correct 
hormonal background are often present in an individual but the 
disease does not manifest itself until a 'trigger' event occurs. 
(Inbred mice are the exception to this; they have been bred to 
exaggerate a specific weakness in order to provide an animal model 
to assist in the study of autoimmune disease.) In many diseases 
this trigger seems to take the form of some environmental insult. 
The major factors involved in this process are the sun, which may 
alter autoantigens by ultra -violet (UV) irradiation, and certain 
drugs which can induce almost any type of autoimmune disease. 
Penicillamine is known to induce scleroderma, myasthenia gravis, 
SLE, rheumatoid arthritis (RA), pemphigus and myositis and drugs 
such as procainamide and hydralazine used in the therapy of certain 
autoimmune diseases can also induce an autoimmune response. 
Procainamide has been studied more than other types of drugs. After 
one year of treatment, approximately 50% of the patients have 
developed antibodies to denatured DNA and histones. 15 to 20% of 
these patients may develop some lupus like symptoms (Rubin, 1988). 
Infectious agents, (Shoenfeld and Cohen, 1987) such as 
hepatitis B and human immunodeficiency virus (HIV), are the third 
group of factors involved in the initiation of certain autoimmune 
diseases. Mycobacteria are thought to induce autoimmunity by 
'molecular mimicry' between the bacterial antigens and those of the 
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host; antigenic similarities have been shown between a measles virus 
protein, a herpes simplex virus protein and vimentin (despite their 
different molecular weights) (Fujinami et al., 1983) and also 
between Trypanosoma cruzi and mammalian neurone antigens (Wood et 
al., 1982). However, infection by mycobacteria is not sufficient to 
initiate an autoimmune disease unless the appropriate immunogenetic 
background is also present; infection by atypical mycobacteria is 
extremely common in certain environmental areas, but the percentage 
of the population with mycobacterial infection is less than that 
which develops autoimmune disease. 
The last category of factors involved in the induction of 
autoimmunity comprises those which fail to fit into any of the four 
above. 
Cancer and ageing have an effect on the immune system which 
may be responsible for the induction of autoimmune disease. Studies 
in mice have shown that autoantibodies to red blood cells are 
produced after certain types of viral infection. Old T cells can 
lose cell surface receptors and changes in their receptors are also 
observed which may explain the presentation of self antigens to the 
immune system and the mounting of an immune response. (Walford, 1980) 
Autoantibodies are more prevelant in the elderly when compared to a 
young control population; 19 to 42% in the elderly compared to 2% in 
the young control group (Tomer and Shoenfeld, 1988). Malignant 
transformation of cells resulting in membrane changes may provoke 
an 
immune response. Expression of proto- oncogenes associated with 
abnormal growth and differentiation of sub -populations of 
lymphocytes has been observed in autoimmune -prone mice (Mountz et 
al., 1985) . 
The aetiology of autoimmune diseases is clearly complex. The 
range of this type of disease is similarly diverse. There is, 
however, a common link between these diseases; the production of 
autoantibodies. 
1.1.2 The Origin of Autoantibodies 
Is the generation of autoantibodies the cause or the 
consequence of autoimmune disease? Autoantibodies are produced by 
asymptomatic individuals with no apparent harmful effects. However 
the titres of autoantibodies produced by such individuals are much 
lower than those in symptomatic patients. It is suggested that 
these "natural" autoantibodies might even prevent autoimmune disease 
(Cohen and Cooke, 1986). An example of the use of the "blinding" 
effects that antibodies may have, is the administration of preformed 
IgG anti -Rhesus (anti -Rh) antibodies to Rh mothers who have given 
birth to Rh+ babies. These antibodies prevent the mother's immune 
system from developing competent T cells specific for the foreign Rh 
antigens by binding to them. During a second Rh' pregnancy, the 
mother will not produce anti -Rhesus factor antibodies, which would 
cause foetal red cell damage. "Natural" autoantibodies tend to be 
of the IgM class whilst those associated with diseases are of 
the 
IgG class (Clough and Valenzuela, 1980). 
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There are two models proposed to explain the production of 
autoantibodies in disease. The first is that of polyclonal B cell 
activation. Hyperactivity in B cells is observed in mouse models of 
SLE (Theofilopoulos et al., 1983) and in human SLE also. B 
lymphocytes taken from patients or animals with active SLE do not 
respond to further stimulation with polyclonal activators in vitro, 
presumably due to prior stimulation in vivo ( Cohen and Ziff, 1977). 
Polyclonal activation has been shown to increase the number of 
autoantibody secreting cells, as a proportion of all antibody 
secreting cells, which may account for the increase in some types of 
autoantibody (Portanova et al., 1985). However polyclonal 
activation is not thought to initiate the disease alone (Hang et 
al., 1985). The second model is that of selected autoantibody 
induction. This mechanism is driven by the antigens themselves. 
The disproportionate increase in autoantibodies in the sera of 
autoimmune patients and mice suggests the preferential activation of 
autoreactive B cells (Portanova et al., 1985). Ineffective removal 
of cellular breakdown products which are present due to ageing 
effects or as the result of cancer, for example, may stimulate this 
response. Genes coding for anti -DNA antibodies in SLE show many 
somatic mutations which suggest that selection is driven by the 
antigens themselves (Shlomchik et al., 1987). B cell hyper 
- 
responsitivity and the polyclonal activation observed 
in SLE can be 
explained as a secondary effect brought on by circulating 
lymphokines. A recent hypothesis proposed has 
combined the two 
models (Dziarski, 1988). It proposes that 
initial polyclonal 
activators and additional signals stimulate 
the B cell population to 
10 
'undergo polyclonal expansion and differentiation into antibody (IgM) 
secreting cells. Autoantigens exposed and lymphokines produced by 
this initial response then stimulate a further expansion of clones 
causing an immunoglobulin class switch and antigen driven selection 
of auto -reactive clones (Dziarski, 1988). A similar model was 
proposed by Klinman et al. for the hyperproliferation of B cells in 
autoimmune -prone mice (Klinman et al., 1988). 
1.1.3 Anti -Nuclear Antibodies (ANA) and Associated Diseases 
Systemic rheumatic disease is a term used to describe a group 
of autoimmune disorders which affect the connective tissues. A 
common feature of this group of related diseases is the presence of 
anti -nuclear antibodies (ANA) in the sera of a high proportion of 
patients. 
The presence of ANA's in the serum of systemic rheumatic 
patients has been shown by many workers to be a useful diagnostic 
aid, as the antigenic specificities of these antibodies are often 
associated with particular diseases. ANAs carabe detected by 
indirect immunofluoresence. Early studies were performed on 
sections of preserved tissues, but now cell lines tend to be 
used as 
they are more easily prepared and are readily available. Using 
this 
method ANAs were observed to produce different staining patterns 
within the nucleus and it was concluded that this was due 
to their 
differing reactivities towards the nuclear components. 
However some 
nonhistone nuclear antigens are readily solubilised 
by some buffers 
used in the preparatory stages of staining (for 
example, nuclear 
ribonucleoprotein (nRNP); Northway and Tan, 
1972) and this 
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initially caused conflicting reports of the activities present in 
some autoimmune sera. 
There are three broad classes of ANA; those which recognise 
DNA, those which recognise histones and those which recognise 
nonhistone proteins. Antibodies to DNA can themselves be grouped 
according to the form of DNA with which they react. The first group 
react only with double -stranded (ds) DNA and do not cross react with 
single- stranded (ss) DNA (Gilliam et al., 1980). It is not known 
what forms the antigenic site of these antibodies. The second group 
of antibodies react with only ss DNA and do not cross react with ds 
DNA. The antigenic sites of this type of antibody are polymers of 
purine and pyrimidine bases which are accessible in the ss form but 
not in the ds form of DNA (Tan, 1989). The final group of DNA 
antibodies is that which reacts with both ds and ss DNA. These 
antibodies mainly recognise the deoxyribose phosphate backbone but 
are occasionally against the helical structure of ds DNA and react 
with ss DNA where it has folded into a secondary helical structure 
(Tan, 1989). Antibodies to DNA are thought to play a role in the 
pathogenesis of some diseases. In some SLE patients it has been 
demonstrated that the appearance of circulating DNA antigen is 
followed by the occurence of autoantibodies to DNA. The antigen 
then precipitates with the antibody to form circulating immune 
complexes in vivo (Tan et al., 1966). DNA is an intranuclear 
component and in order to form these immune complexes it has to 
become 'exteriorised'. This is probably the result of cellular 
breakdown and is only known to occur in the case of DNA. These 
complexes then become deposited in the vascular organs and this 
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correlates with the decreasing titres of the antibody in the serum 
and with worsening symptoms (Koffler et al., 1967) of the disease. 
Antibodies to native or ds DNA only occur in SLE in readily 
detectable levels. They therefore provide a useful diagnostic test 
for cases of SLE. Antibodies to ss DNA are prevelant in drug 
induced lupus erythematosus. Low titres are observed in SLE, RA and 
some non -rheumatic diseases such as chronic active hepatitis and 
infectious mononucleosis (Koffler et al., 1971). This limits the 
use of anti -ss DNA for diagnostic purposes. 
The second class of ANAs recognise histones. There are 
antibodies to all the classes of histone; H1, H2A, H2B, H3 and H4, 
and they are found in SLE, drug induced autoimmunity, RA and 
undifferentiated forms of connective tissue disease (Aitcheson et 
al., 1980; Rekvig and Hannestad, 1980; Molden et al., 1967). There 
are antibodies in this group which also react specifically with 
dimers of H2A and H2B and with tetramers of H3 and H4 (Rubin and 
Waga, 1987; Thomas et al., 1984; Gohill et al., 1985; Portanova et 
al., 1987). The dimer form H2A -H2B is the antigen with which the 
majority of antibodies in patients with SLE and procainamide- induced 
LE react. In LE induced by hydralazine, H2A -H2B dimers are 
recognised as a target antigen but the tetramer form of H3 -H4 is 
more reactive. 
The final class of antibodies are those which react with the 
nonhistone proteins present within the nucleus. Most of the 
antibodies in this group are specific to a particular disease. 
Those which are specific are useful diagnostically. 
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Following DNA and histones, Sm was the next antigen to be 
identified and characterised using autoimmune sera (Tan and Kunkel, 
1966) and has been shown to be associated with SLE. It has also 
been shown to be present complexed with another autoantigen, nuclear 
RNP (nRNP). Antibodies to nRNP and ribosomal RNP (rRNP) are also 
found in the sera of SLE patients. However nRNP is more frequently 
associated with mixed connective tissue disease (MCTD) patients 
(Mattioli and Reichlin, 1973). This particular condition was not 
defined as a disease in its own right until the discovery of the 
autoantibodies that reacted with nRNP. Antibodies to this 
particular antigen are found in lower frequencies in the sera of 
patients with discoid lupus, scleroderma, RA, and Sjogrens syndrome. 
These autoantigens were shown to be composed of a species of small 
nuclear (sn) RNAs, also known as U RNAs complexed with proteins 
(Lerner and Steitz, 1979). The autoantibodies produced by the 
patients with these diseases proved invaluable in showing that the 
snRNPs were involved in the splicing of precursor messenger RNA 
(mRNA) (Yang et al., 1981; Padgett et al., 1983; Bozzoni et al., 
1984). Although these antigens are complexes of RNA and protein, 
the antigenic sites are exclusively found on the proteins. This was 
demonstrated by the fact that the autoantibodies do not precipitate 
snRNAs when dissociated from protein and by the identification of 
the antigenic polypeptides by Western blotting. Sm has four 
antigenic polypeptides of 29kDa (B'), 28kDa (B), 16kDa (D), and 
13kDa (E). Antibodies to B and B' cross react with D and vice 
versa. The presence of serum antibodies has allowed the isolation 
of a cDNA clone coding for E (Weiben et al., 1985). 
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nRNP has 
antigenic proteins of 70kDa, 33kDa (A), and 22kDa (C). There are 
also rarely occurring antibodies which react with polypeptides of 
31 -32kDa (A') and 28.5kDa (B") (Mimori et al., 1984; Habets et al., 
1985). These autoantibodies have been used to show that the core 
proteins of U1, U2, U5 and the U4 /U6 complex are made up of 
combinations of B, B', D, and E polypeptides, in addition to a 
trimer of E, F and G that all run at approximately 12 -13kDa on 
electrophoresis. U1 also contains A and C, whilst U2 snRNP contains 
A' and B". The 70kDa polypeptide has been shown to be a nuclear 
matrix protein and not an intrinsic component of U1 snRNPs 
(Verheijen et al., 1986). However it appears that for the Ui RNP 
antigen to be recognised by the autoantibodies, it has to be 
associated with the 70kDa protein of the nuclear matrix. 
SS -A /Ro and SS -B /La were the next pair of antigens to be 
isolated. Ro was isolated from extracts of spleen from humans and 
identified using antibodies from SLE patients (Clark et al., 1969). 
La was found by similar studies (Mattioli and Reichlin, 1974). Both 
of these antigens were reported to be cytoplasmic. Subsequently two 
antigens were isolated from soluble extracts of a human lymphocyte 
line using serum antibodies from patients with Sjogren's syndrome 
and called SS -A and SS -B (Asplaugh and Tan, 1975). These antigens 
were localised to the nucleus. In 1979, they were shown to be 
identical; Ro was in fact SS -A and La was SS -B, leaving the 
differing reports of their cellular location to be reconciled. La 
was found to be extremely soluble in physiological saline and could 
therefore be leached out of the nucleus and into the cytoplasm 
during preparation for cell fractionation. However further studies 
15 
have indicated that these antigens may be present in the nucleus or 
in the cytoplasm depending on the functional state of the cell (Tan, 
1989). Autoantibodies to these antigens are frequently present in 
patients with Sjogren's syndrome, and sometimes in SLE and in RA. 
Two proteins of 60kDa and 52kDa associated with four or five 
types of small cytoplasmic RNAs (Y RNAs) are precipitated by anti - 
SS-A/Ro antibody. The Y RNAs range in size from 80 to 112 bases in 
size (Wolin and Steitz, 1984). The precipitation of these two types 
of protein is due to two antibody populations present in the sera. 
This was proved when affinity purified antibodies from the 60kDa 
protein did not cross react and vice versa. There are also sera 
which contain only one species of antibody and therefore precipitate 
only one of the protein antigens. SS -B /La antibodies precipitate a 
48kDa protein complexed with nascent RNA polymerase III transcripts 
but the antigenic site is present on the protein as with Sm and nRNP 
antigens (Rinke and Steitz, 1982; Chan et a1., 1986). This protein 
has two distinct structural domains; a 28kDa methionine rich region 
and a 23kDa domain containing phosphorylated amino acids. These are 
thought to provide two distinct antigenic binding sites on this protein. The 
48kDa protein forms a 43kDa degradation product which is also 
recognised by the antibodies. Anti- SS -A /Ro is often present without 
anti- SS -B /La but not vice versa. Anti- SS -B /La is useful as a 
serological marker for Sjogrens syndrome when associated with sicca 
syndrome; the antibody is present in approximately 60% of such 
patients. Anti- SS -A /Ro has been shown to be a good marker for 
neonatal lupus (Franco et al., 1981). 
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Ku is an antigen associated with 55% of scleroderma/ 
polymyositis overlap, 33% of SLE /polymyositis /scleroderma overlap 
and more rarely in SLE and scleroderma alone (Tan, 1982). It 
consists of a pair of proteins 60 -66kDa and 80 -86kDa also known as 
p70 /p80. These proteins have been shown to be DNA binding (Mimori 
et al., 1986) in vivo and in vitro. They have been localised to 
condensing chromosomes in prophase and telophase (Reeves, 1985). 
However their function is unknown. There is one common antigenic 
site on each protein and one that distinguishes them from each other 
(Francoeur et al., 1986). 
3% of SLE patients have autoantibodies to an antigen which 
shows distinct expression patterns within a single population of 
cells, dependent on whether they are proliferating or not. This 
antigen is hence known as proliferating cell nuclear antigen (PCNA) 
and is at the peak of expression in late G and early S phases of the 
cell cycle. It has been localised to the nucleolus and also to the 
nucleus in general (Takasaki et al., 1981). A protein called cyclin 
isolated independently from this study, was found to have a 
molecular weight of 35 -36kDa and its expression was also related to 
the cell cycle (Bravo et al., 1981). These proteins were 
subsequently shown to be identical (Mathews et al., 1984). It is 
thought that this protein is required for chain elongation during 
DNA synthesis and that it is the auxiliary protein to DNA polymerase 
S (Bravo et al., 1987). 
There are several autoantigens which are specifically 
associated with scleroderma and its many related forms. ANAs have 
been reported to be present in frequencies from 40 to 90% in this 
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group. With the advent of tissue culture and the use of cell line 
material as substrate for immunofluoresence, the higher figure seems 
to be more accurate. This group of diseases produces quite a wide 
range of cell staining patterns and autoantibodies to particular 
antigens have been related to these observations. 
A diffuse granular pattern in the nucleus has been correlated 
with sera containing autoantibodies to Scl -70, the marker antigen 
for scieroderma (Douvas et al., 1979). This antigen was isolated 
from chromatin and found to be a basic protein of 70kDa. Further 
studies found that sera from scieroderma patients with antibodies to 
Scl -70 also recognised DNA topoisomerase I which has a molecular 
weight of approximately 100kDa (Shero et al., 1986; Guldner et al., 
1986). The discrepency in molecular weights was resolved by the 
discovery that the 100kDa protein could be spontaneously degraded if 
protease inhibitors were not used in the extraction procedure. The 
autoantibodies produced by scleroderma patients were shown to 
inhibit the relaxation of supercoiled DNA by DNA topoisomerase I. 
It has been found in the cells of man, rabbit and rat indicating a 
degree of cross species conservation (Tan et al., 1980). 
The presence of large granules within an interphase cell and 
the localisation of these granules to the centromeres of condensed 
mitotic chromosomes, is the characteristic staining pattern observed 
with anti -centromere autoantibodies (ACA) (Moroi et al., 1980). The 
actual antigenic region was initially determined to be the inner and 
outer layers of the trilaminar kinetochore (Brenner et al., 1981). 
There was no reactivity with the centromeric DNA itself. The 
antigens of the kinetochore have been shown to be proteins of 
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molecular weights 17 -19kDa (CENP -A), 80kDa (CENP -B), and 140kDa 
(CENP -C) (Cox et al., 1983; Guldner et al., 1985; Earnshaw et al., 
1986). Recently immunoelectron microscopy has clarified the 
position of some of these antigens (Cooke et al., 1990). 95% of 
CENP -B is distributed along the centromeric heterochromatin beneath 
the kinetochore, indicating that it may be associated with the a- 
satellite heterochromatin. CENP -A and /or CENP -C are thought to 
associate with a "collar" of chromatin encircling the kinetochore 
plates. 95% of CENP -B has been cloned (Earnshaw et al., 1987). 
Autoantibodies to the centromeres of chromosomes are characteristic 
of a particular subset of scleroderma patients with a syndrome known 
as CREST (çalcinosis, Raynaud's phenomenon, oesophageal dysmotility, 
aclerodactyly and telangiectasia). The antibody is highly specific 
to this disease and is found in the sera of 70 to 80% of CREST 
patients. Anticentromere antibodies have been found in 25% of 
patients with Raynaud's phenomenon but no other symptoms of CREST, 
but these individuals may have the condition in an early form and do 
not yet show the other characterisic symptoms. 
Antinucleolar antibodies of varying types are present in the 
serum of 45% of scleroderma patients and these were used to try to 
characterise the structural organisation of the nucleolus itself 
(Hernandez- Verdun et al., 1979). In 4% of patients there are 
antibodies to RNA polymerase I and this type of antibody produces 
punctate staining of interphase nucleoli. In dividing cells the 
nucleolar organising regions (NOR) are stained (Reimer et al., 1986; 
Reimer et al., 1987). Thirteen polypeptides ranging in size from 
210 to 12.5kDa are precipitated by this type of antibody. There 
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were four phosphoproteins of 180kDa, 80kDa, 64kDa and 18kDa present 
in the complex which is thought to contain subunits of RNA 
polymerase I and other factors necessary for transcription. 8% of 
scleroderma sera contain antibodies to fibrillarin and produce a 
clumpy nucleolar staining pattern on immunofluoresence of whole 
cells. This 34kDa antigen is a component of U3 RNP (Parker and 
Steitz, 1987) and the epitope is highly conserved between species 
(Vaughan, 1987). Homogeneous nucleolar staining associated with 
diffuse granular staining of the nucleus itself is the observed 
pattern given by autoantibodies to the Pm -Scl antigen. The antigen 
is recognised by patients with polymyositis /scleroderma overlap 
disease and consists of a complex of eleven proteins with molecular 
weights ranging from 110 to 20kDa. The localisation of the 
antibodies suggests that the antigen is associated with 
preribosomes. The antigenic determinants were found on polypeptides 
of 100 and /or 80kDa (Reimer et al., 1986). Rarely, scleroderma sera 
contains autoantibodies to a 40kDa protein which is complexed to a 
7.2S RNA in the nucleolus (Reddy et al., 1983). This 7.2S RNA has 
been shown to be an RNA polymerase III transcript and is also 
associated with SS -B /La (Hashimoto and Steitz, 1983). A 90kDa 
protein has been localised to the NOR by a previously undetected 
autoantibody found in scleroderma sera (Rodriguez -Sanchez et al., 
1987). The anti -nucleolar antibodies described here are not 
encountered to any significant extent other than in scleroderma and 
its overlap conditions and is therefore specific for this group of 
diseases. 
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Rheumatoid arthritis -associated nuclear antigen (RANA) has 
been detected with autoantibodies in the sera of 90% of patients 
with RA. Normal controls have the antibodies with a frequency of 6 
to 25 %, equivalent to that found in the sera of patients with other 
types of autoimmune disease, such as SLE, scleroderma and MCTD. 
However the antigen and its function have not yet been 
characterised. 
Certain species of transfer RNA (tRNA) synthetases are 
recognised by autoantibodies specific to dermatomyositis and 
polymyositis. The antigen of the first of these autoantibodies was 
found to be the protein part of histidyl -tRNA synthetase with a 
molecular weight of 50kDa (Mathews and Bernstein, 1983). Threonyl- 
tRNA synthetase (PL -7) was detected by a second autoantibody in the 
sera of myositis patients. The antigen was a protein of 80kDa 
(Mathews et al., 1984). Two further autoantibodies recognised naked 
alanyl -tRNA and alanyl -tRNA synthetase (Bunn et al., 1986). The 
epitopes recognised by the autoantibodies appear to be the catalytic 
sites of these enzymes as the autoantibodies can be shown to inhibit 
their function (Dang et al., 1988) 
The Mi antigen was isolated from calf thymus extract and 
consists of two proteins of 61 and 53kDa, however its structure and 
function are as yet uncharacterised (Targoff and Reichlin, 1985). 
This group of diseases can give rise to autoantibodies in the 
sera of its patients which recognise a 54kDa protein which is part 
of the signal recognition particle (SRP). This protein contains the 
antigenic site and has been shown to be involved in polypeptide 
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synthesis and the translocation across the endoplasmic reticulum in 
preparation for secretion (Reeves et al., 1986). 
31% of patients with polymyositis contain antibodies in their 
serum which recognise an antigen of 150kDa, Jo -1. It appears to be 
a protein and is localised to the nucleus (Nishikai and Reichlin, 
1980) . 
There are some autoantibodies which occur very rarely and are 
difficult to associate with specific diseases. Autoantibodies to 
nuclear lamins recognise three proteins of 74kDa (A), 68kDa (B), and 
60kDa (C). The antibodies produce a linear staining pattern of the 
nuclear envelope. The lamins are thought to provide a point of 
anchorage for interphase chromosomes to the nuclear envelope 
(Gerace, 1986). Antibodies to poly(ADP -ribose)polymerase (ADPRP) 
are found in the sera of patients with Sjogren's syndome and 
sometimes in ill- defined autoimmune disease (Yamanaka et al., 1987). 
The antigen is a DNA binding protein and is involved in DNA repair 
in eukaryotes. 
The anti -nuclear antibody diversity is clearly demonstrated by 
the range of antigens and antibodies discussed here. ANAs have 
aided in the sometimes difficult task of diagnosis, but the question 
of why they arise in these diseases remains unresolved. The reasons 
are possibly as diverse as the diseases themselves but answers to 
this question would probably aid in the discovery of more effective 
treatments and, possibly prevention. 
A practical role for ANAs that has emerged more recently is in 
the isolation and characterisation of nuclear antigens at functional 
and structural levels. The use of isolated nuclear antigens as 
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stimulants to raise antibodies in normal animals has had very 
limited success as they appear to be only poorly immunogenic. 
Therefore serum autoantibodies are of particular importance for 
studying this group of diseases. ANAs have proved invaluable as 
probes for components of the nucleus, as shown by the discovery of 
Sm, its association with nRNPs and their functions. The use of ANAs 
combined with other experimental methods have greatly added to our 
knowledge of the structure and function of the nucleus over the past 
decade or so. This knowledge is valuable for basic scientific 
research, but will hopefully be of clinical value by providing 
insights defects involved in the development of autoimmune diseases 
in patients. 
1.2 The Nucleus 
The nucleus is the feature distinguishing eukaryotic cells 
from prokaryotes and akaryotes, with the notable exception of 
mammalian red blood cells. (These specialised cells lose their 
nuclei during maturation in order to increase their haemoglobin 
content and optimise their oxygen carrying capacity.) Fossil 
evidence suggests that eukaryotes evolved between 1500 and 900 
million years ago and so, therefore, did nuclei (Cavalier- Smith, 
1988). 
The nucleus is defined by a nuclear envelope which consists of 
a double membrane, complete with pore complexes allowing active 
transport and passive diffusion to and from the cytoplasm. 
The 
inner and outer membranes perform different functions. The 
nucleus 
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contains two basic classes of components, nucleic acids and 
proteins. The proteins can be further sub -divided into histone and 
non -histone proteins whilst the nucleic acids are present in 
ribosylated and deoxyribosylated forms. The major part of the 
volume of the nucleus is occupied by DNA. Unlike prokaryotes, it is 
not in the form of a single circular chromosome but is contained in 
a much more complex form of packaging called chromatin. The 
structure of chromatin is observed in differing states which vary 
with the cell cycle. A relatively decondensed form of chromatin is 
found in interphase cells, whilst those undergoing mitosis and 
meiosis condense this Structure further to form chromosomes. 
1.2.1 Chromatin, Chromosomes and Associated Proteins 
The somatic mammalian cell passes through two clearly 
identifiable states during its cycle. These are interphase and 
mitosis. Mitosis is the shorter of the two lasting 
approximately 2 hours of a typical 24 hour cycle. During interphase 
the DNA has to be accessible to enzymes and other effector molecules 
so that proteins necessary for the day to day running of the cell 
can be produced. Therefore the active DNA is packaged in the form 
of decondensed chromatin during interphase. 
DNA in the linear double helical form is too bulky to be 
organised inside the nucleus, so packaging it into chromatin solves 
this. Chromatin structure is largely determined by the histones 
present within the nucleus. The primary unit of chromatin is the 
nucleosome. This consists of a well protected core structure which 
takes the form of 146 base pairs (bp) of DNA (Prunell et 
al., 1979) 
coiled 1.75 times around a histone octamer, comprising two 
each of 
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H2A, H2B, H3 and H4 proteins(Weintraub et al., 1976). Under an 
electron microscope, when prepared under low salt conditions, these 
core units can be seen as beads joined together by a variable length 
of linker DNA. 
The next level of chromatin structure is the mononucleosome, 
which is basically the nucleosome core unit with a linking stretch 
of DNA and histone H1 associated with it. The linker piece of DNA 
can be absent or up to approximately 80bp in sea urchin sperm 
(Morris, 1976; Spadafora et al., 1976). A run of 22óp of DNA 
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completes twoAturns around the nuleosome core (Simpson, 1978). The 
remainder joins the mononucleosomes together. Histone H1 is bound 
to one side of this core particle at the point where the DNA strand 
enters and exits its helical turns around the octamer of histones 
(Noll and Kornberg, 1977). It is thought that H1 is crosslinked to 
the core histones. Experiments performed in vitro have indicated 
that H1 can cross link to H2A and H3 (Boulikas et al., 1980; Ring 
and Cole, 1979). A single molecule of H1 is associated with each 
nucleosome core. This lOnm structure is often referred to as beads 
on a string and has a packing ratio of 6 -7:1 relative to naked DNA. 
The structure of the next level of organisation of chromatin 
is still somewhat disputed and there have been three models 
proposed. All models accept that the lOnm nucleosome string is 
arranged into a 30nm fibre. The first of these, the solenoid model, 
was proposed in 1976 and postulates that the nucleosomes are 
arranged face to face (with respect to the disc -like histone 
octamers) and are coiled with 4 - 10 nucleosomes per each turn. The 
H1 is thought to fill the hollow space inside the coil (Finch and 
Klug, 1976). In 1977, Renz, Nehls and Hozier proposed a superbead 
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model in which nucleosomes associate in globular clusters of 
heterogeneous sizes and that H1 crosslinking assisted in the 
maintainence of this type of structure (Renz et al., 1977). The 
third model, the helical ribbon model, proposes that the nucleosomes 
arrange themselves into a zig -zag formation with each nucleosome 
edge to edge with the next. This relaxed form compacts by twisting 
the nucleosomes by 900 so that they lie face to face forming a 
ribbon -like structure and the ribbon then coils into a helix which 
corresponds in size to the accepted 30nm structure (Woodcock et al., 
1984). Further data has suggested that the superbead model has only 
been observed due to artifacts produced by techniques preparing 
chromatin for study in low ionic strength buffers. It has also been 
suggested that the work done on the helical coil models was carried 
out on native chromatin and is therefore more representative of 
chromatin structure in vivo. The number of nucleosomes per turn in 
the solenoid model was later postulated to be 12 (Walker and 
Sikorska, 1979; Walker and Sikorska, 1979) but it is now accepted to 
be in the region of 5.9 per solenoid turn (Butler, 1988). This 
level of packing using either model increases the packing ratio to 
approximately 40:1. 
The 30nm chromatin conformation folded into loops (Benyajati 
and Worcel, 1976; Paulson and Laemmli, 1977) or domains (Igo -Kemenes 
and Zachau, 1977) is associated with the nuclear lamina which 
lines 
the nuclear envelope of interphase nuclei (Aaronson and Blobel, 
1975; Stick and Hausen, 1980). Other terms for the 
supporting 
structure in interphase nuclei have been suggested, such 
as matrix 
(Comings and Wallach, 1978; Long et al., 1979; Capco 
et al., 1982), 
envelope (Murray and Davies, 1979), ghost (Riley 
et al., 1975) and 
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cage (Cook and Brazell, 1980). Most of the DNA is thought to be in 
the looped form of chromatin (Lepault et al., 1980) associated with 
this support structure. It is proposed that the presence of the 
nucleosome packaging and the higher ordering into loops has a role 
in the control of transcription of genes. Active genes are thought 
to be folded into loops more loosely than inactive ones giving rise 
to hetero- and euchromatin forms. It is thought that active genes 
are preferentially positioned within these looped domains such as 
the puffs seen in the Balbiani rings of Chironomus (Daneholt et al., 
1982). The active genes are thought to be able to unravel 
themselves from the polynucleosome formation reversibly without the 
dissocation of histones (McKnight et al., 1978). This reversible 
change may be triggered by varying rates of polymerase initiation 
and transcription or by non histone proteins, such as SV40 virus VP1 
(Moyne et aí.,1982). The transcribing genes for rRNA in amphibian 
oocytes are not compacted into nucleosomes at all (Scheer, 1980). 
Internal enhancer sequences play a role in gene regulation. 
Mouse immunoglobulin genes are known to contain these enhancer 
sequences (Gillies et al., 1982; Mercola et al., 1983). Alone, 
however, they are not sufficient to promote transcription and are 
thought to act in conjunction with the positional effects already 
discussed above. 
Modifications of the DNA itself have been suggested as 
mechanisms for altering the transcriptional activity of genes. 
These modifications may affect only single bases such as 
postsynthetic methylation. Active genes are relatively unmethylated 
whilst inactive genes are usually methylated, but this is not always 
the case and the true role of methylation in gene regulation 
is not 
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clear. Methylation may induce structural changes which are 
specifically recognised by factors involved in transcription. 
However, methylation alone is not capable of transcriptional control 
(Waalwijk and Flavell, 1978). 
Histones, and modified forms of histone proteins, and non - 
histone proteins, are also known to be associated with DNA in 
chromatin, and are thought to be involved in gene regulation. 
Proteins associated with DNA may be recognising specific sequences 
or more general classes of sequence present within the genome. A 
non -histone protein Dl of Drosophila is a component of the 
transcriptionally inactive satellite 1.688 and has a molecular 
weight of 50kDa (Varshaysky et al., 1983). A 37kDa protein, TFIIIA, 
has been isolated from Xenopus oocytes and shown to bind to the 
intragenic regulatory sequence of the 5S DNA (Engelke et al., 1980). 
Examples of proteins which bind to general sequences are RNA 
polymerase II, which binds to nucleosome cores, and a group of 
proteins called the high mobility group (HMG) proteins which 
associate with transcriptionally active chromatin (Johns, 1982). 
All nucleosomes, whether their constituent DNA is active 
or not, 
appear to have two binding sites for HMGs 14 and 17 
at each of the 
DNA entrance and exit points (Mardian et al., 
1980; Sandeen et al., 
1980). HMGs 1 and 2 are thought to bind to the 
linker DNA (Jackson 
et al., 1979). However the exact role of 
HMG proteins is not clear; 
they cannot be directly associated with transcriptionally 
active 
genes, yet they are sometimes found to 
be present in increased 
amounts. Modifications of histones are 
thought to affect the 
nucleosome and chromatin structure. 
Variant forms have been found 
at different stages of development and 
the cell cycle. These forms 
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have been found to make the chromatin more suceptible to thermal 
denaturation and nuclease digestion in sea urchins (Simpson, 1981). 
This may affect rates of transcription simply by producing 
heterogeneous forms of chromatin. Post synthetic modifications of 
histones affect gene activation, such as acetylation of their amino - 
terminal portions. This is thought to destabilise the 30nm 
structure of chromatin and have conformational effects on the 
nucleosome itself (Bode et al., 1980; Bode et al., 1983; Muller et 
al., 1982). Ubiquitination of histones has been suggested to 
prevent the formation of higher order structures, either by 
modifying nucleosome -nucleosome interactions (Levinger and 
Varshaysky, 1982) or by allowing recognition of active genes by 
proteolytic enzymes which subsequently remove the nucleosome cores 
(Varshaysky et al., 1983). 
The alternative state in which the somatic cell can be 
observed is that of mitosis. This is a short stage of the cell 
cycle, as mentioned previously, when the DNA duplicated during S 
phase, is segregated between the two resultant daughter cells. 
Obviously the segregation must be very accurate otherwise one or 
both of the daughter cells would not contain the complete complement 
of genetic information coded for in the genome. In order to do this 
the DNA must be further condensed from the looped 30nm structure and 
detached from the nuclear lamina, as the nuclear envelope breaks 
down during mitosis. This further condensation of the interphase 
chromatin is observed as the production of distinct chromosomes. 
Electron microscopy suggested that the compact chromosomes 
were produced by the looping of the 30nm fibre (Dupraw, 
1970). In 
1976, it was shown that the long continuous strings of 
interphase 
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DNA were organised into looped domains containing, on average, 80kb 
lengths held in place by RNA and proteins (Cook and Brazell, 1975; 
Benyajati and Worcel, 1976). These domains become radially 
positioned within the chromosome to form a structure known as a 
miniband with a packing ratio of 1.2 x 109:1 relative to naked DNA. 
The minibands now stack on top of one another to form the sister 
chromatid of the mitotic chromosome. The loops were found to form 
supercoils thus compacting the DNA even further. The final packing 
ratio is the same as that of the minibands,i.e. 1.2 x 1091. The 
structure of the metaphase chromosome has been shown not to be 
dependent on histones for its morphology. When the histones are 
selectively removed, the DNA remains bound to a central scaffold 
composed of non -histone proteins (Adolph et al., 1977). The binding 
sites of these proteins are located at specific DNA sequences known 
as scaffold- associated regions (SARs) which were first observed in 
interphase cells. These regions appear to have been conserved 
through evolution. Some SARs have been shown to be closely linked 
to enhancer -like regulatory elements and most of those analysed have 
been found to contain sequences homologous to topoisomerase II 
binding sites (Gasser and Laemmli, 1986; Cockerill and Garrard, 
1986). A major protein of scaffolds has subsequently been shown to 
be topoisomerase II (Earnshaw et al., 1985; Gasser et al., 1986). 
Another major protein was found to be ß- tubulin with a molecular 
weight of 53kDa (Adolph, 1977). Later studies by Gooderham and 
Jeppesen (1983) did not detect any ß- tubulin within scaffolds. The 
DNA projects from the scaffold as a series of loops (Stubblefield 
and Wray, 1971; Adolph et al., 1977; Paulson and Laemmli, 1977; 
Marsden and Laemmli, 1979). The loops which are observed in 
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interphase nuclei are essentially similar to those projecting from 
the chromosomal scaffold following dehistonisation. Topoisomerase 
II is found in both these scaffolds and the nuclear matrix of 
interphase cells (Earnshaw et al., 1985; Gasser et al., 1986; 
Mirkovitch et al., 1984). Therefore the structure of chromatin 
observed in these stages of the cell cycle is postulated to be 
virtually the same; the difference being the location of the 
stabilising structures to which the chromatin attaches. The 
scaffold is thought to behave dynamically under the regulation of 
the cell cycle. This would allow the condensation of chromatin into 
chromosomes to be controlled by the self -assembling scaffold alone 
(Earnshaw and Laemmli, 1983). 
Another group of non -histone proteins have been shown to be 
associated with the chromosome; those which form the kinetochore at 
the primary constriction or centromere. The kinetochore is the site 
of initiation and formation of the spindle microtubules which pull 
the sister chromatids apart during mitosis (Pepper and Brinkley, 
1977; Mitchison and Kirschner, 1985). It has been shown to be a 
tri- lamellar structure of two electron dense plates separated by a 
lucent zone, positioned along the surface of the chromosome 
(Commings and Okada, 1971; Roos, 1973; Reider, 1982). The study of 
kinetochores free from the metaphase chromosome has determined that 
the outer plate is composed of 30nm fibres. It is thought that 
these fibres are a subclass of chromatin fibrils extending from the 
chromosome itself (Rattner, 1986). Proteins associated with these 
plate structures are often recognised by the serum antibodies of 
scleroderma /CREST patients (Moroi et al., 1980; Cooke et al., 1990). 
Later it was shown that there is in fact a family of proteins CENP -A 
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(14- 19.5kDa), CENP -B (70- 80kDa), CENP -C (110- 140kDa), CENP -D (20- 
25kDa) and CENP -E (33- 34kDa) (Cox et al., 1983; Valdivia and 
Brinkley, 1985; Earnshaw et al., 1986; Kingwell and Rattner, 1987) 
localised to the kinetochore. Autoimmune sera have assisted in the 
discovery of the functions of some of these proteins. The 17kDa 
CENP -A is present in pre- mitotic and mitotic centromeres and has 
been shown to be associated with mononucleosomes (Palmer et al., 
1987). It is thought that CENP -A may be a modified histone species. 
The 80kDa CENP -B and 140kDa CENP -C are associated with the scaffolds 
of mitotic chromosomes (Earnshaw et al., 1984), whilst a 50kDa 
protein (later included into the class of CENP -E) has been localised 
to the kinetochore of two mammalian species, cells from the Indian 
Muntjac deer and human HeLa cells, indicating the conserved nature 
of this group of proteins (Kingwell and Rattner, 1987). However the 
function of CENP -E is not yet known. The 80kDa protein of class 
CENP -B has been cloned (Earnshaw et al., 1987) and the analysis of 
this protein is the most complete in the group. As the distribution 
of this protein varies from chromosome to chromosome, it is thought 
that its distribution may reflect the presence of alphoid satellite 
sequences (Cooke et al., 1990). A 2.9kb mRNA codes for the protein 
which is characterised by two acidic domains comprised almost 
entirely of glutamic and aspartic acids. It may also contain a 
tubulin binding domain (Balczon and Brinkley, 1987), but its major 
function is thought to be in mediating chromosome and mitotic 
spindle interactions. Inner centromere proteins of 155kDa (INCENP- 
A) and 135kDa (INCENP -B) have also been identified (Cooke et al., 
1987) and they are thought to be responsible for maintaining sister 
chromatid pairing until division at anaphase. During interphase the 
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kinetochores are associated with the inner surface of the nuclear 
membrane (Moroi et al., 1981). 
The ends of the chromosomes, telomeres, have also been shown 
to be associated with the nuclear membrane during interphase (Moens, 
1987). The telomeres are specialised structures found at the end of 
a linear chromosome which are responsible for the stability and 
complete replication of that chromosome. They consist of an array 
of short tandem repeats at the very ends, with longer more complex 
repeats inside these. The sub -telomeric repeats are thought to 
account for the associations with the nuclear membrane and each 
other. These tandem repeats show similarities between the species 
(Allshire et al., 1988) and human telomeres have now been cloned 
(Cross et al., 1989). Telomeres have also been shown to have non - 
histone proteins associated with them. In Oxytricha a 55kDa and a 
43kDa species have been identified (Price and Cech, 1989). Another 
associated protein, telomerase, has been identified in Tetrahymena 
and is responsible for the addition of the repeated sequences of 
nucleotides base by base (Greider and Blackburn, 1987; Greider and 
Blackburn, 1989). This ensures the complete replication of the 
chromosome. 
There is another type of division which cells can undergo, but 
this does not occur in the somatic cell population. Meiosis is a 
type of segregation which is exclusive to the germ line cells within 
an organism. The organisation of the DNA during meiosis is 
essentially similar to that during mitosis. The DNA condenses to 
form chromosomes by the looping of the chromatid and its attachment 
to the meiotic scaffold. This scaffold is thought to be unique to 
meiosis in its protein composition, although it contains some of the 
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structural proteins found within the scaffold formed by mitotic 
cells. The folding of the loops onto the core is very precise and 
they are positioned within the chromosome so that recombination can 
occur during meiosis I when the homologous chromosomes align in 
parallel by the formation of synaptonemal complexes (SC) (Moens and 
Pearlman, 1988). The structure and sequences of the DNA involved in 
forming these complexes is as yet undetermined. Recombination is 
correlated with the occurrence of a recombination nodule (RN) on the 
SC (Carpenter, 1979) and therefore positions at which chiasma are 
formed are dependent on the position of the SC. As stated this type 
of cellular division occurs in the germ line cells and relative to 
the rest of the body is a rare event. For the purposes of this 
introduction, structure of chromosomes and their associated proteins 
within somatic cells is more important. 
The other form of nucleic acids present within the nucleus are 
those in the ribosylated form, the RNAs. They also have proteins 
specifically associated with them or involved in their functions. 
RNA is associated with chromatin at specific times during the cell 
cycle as a result of transcription of the genetic code of the DNA. 
Unlike prokaryotes, this process is isolated inside the nucleus by 
the nuclear envelope, so transcription is not accompanied by 
simultaneous translation. Therefore the RNA initially transcribed 
can be modified prior to translation and so the structure of the 
translated product is very different from the initial transcript. 
The processing it undergoes will be described below. 
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1.2.2 RNA and Associated Proteins 
RNA is the intermediate which carries the information coded 
for by the DNA into the cytoplasm so that it can be translated 
giving rise to a functional protein. There are three RNA 
polymerases (I, II and III) involved in the process of transcribing 
the code of the DNA into RNA: RNA polymerase I is responsible for 
synthesising the large ribosomal RNAs. The primary transcript is 
known as the 45S RNA and this gives rise to the 28S RNA, 18S RNA and 
the 5.8S RNA. RNA polymerase III is responsible for the 
transcription of the tRNAs, the small ribosomal 5S subunit and the 
small nuclear RNAs, whilst polymerase II is involved in the 
transcription of the genes which give rise to the proteins required 
by the cell. Polymerases all begin and end transcription at 
specific places which are specified by a group of proteins known as 
transcription factors (Bogenhagen, 1985; Bieker et al., 1985). RNA 
polymerase II produces precursor mRNA, also known as heterogeneous 
nuclear (hn) RNA, which is variable in size according to the genes 
from which they were transcribed. Most of these transcripts will be 
translated into protein in the cytoplasm, but before this they are 
packaged by specific nuclear proteins into a form known as hnRNP 
(Martin et al., 1980; Dreyfuss et al., 1984). It is in this form 
that the transcripts undergo a series of modifications within the 
nucleus. The first modification is the capping of the 5' end of the 
molecule with an additional guanine nucleotide (Adams and Cory, 
1975; Perry and Kelly, 1976). The second modification involves the 
addition of 100 -200 adenylic acid residues to the 3' end of the 
transcript by poly -A polymerase. However the 3' end is not that 
specified by the actual transcription termination site but one is 
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produced by the cleaving of the mRNA 11 -30 nucleotide bases after a 
signal sequence AAUAAA, by a specific endonuclease (McLaughlin et 
al., 1973; Zaret and Sherman, 1982; Wickens, 1990). The mRNA is now 
further processed and long stretches of RNA are removed from the 
middle of the molecules (Crick, 1979). This process is known as 
splicing and in most eukaryotic cells, it is mediated by a group of 
particles known as snRNPs (Lerner and Steitz, 1981; Lerner et al., 
1980). The 5' end of the RNA sequence to be removed is bound by U1 
snRNP and the 3' end is possibly bound by U5 snRNP at this point. 
The presence of ATP allows U2 to complex to the intron at its 3' end 
which precipitates the formation of a spliceosome by the addition of 
U4 /U6 and US snRNPs. Another energy dependent step releases the 
intron RNA as a lariat structure and the two exons become bound 
together (from a review by Sharp, 1987). The snRNPs form a major 
group of autoimmune antigens as previously discussed and this 
property was of great use in establishing which snRNPs were required 
for splicing. The mRNA is transported out of the nucleus in this 
processed form to be translated into protein. The RNA polymerase I 
product is a 45S RNA and this too is modified post - 
transcriptionally. It is broken down into its component 28S, 18S 
and 5.8S structures by nucleolar ribonuclease activities (Denoya et 
al., 1981) and U3, which is only found in the nucleolus, is thought 
to be involved (Crouch et al., 1983; Bachellerie et al., 1983). New 
ribosomes are assembled in the nucleolus from precursor molecules 
which have been packaged as RNP particles. 5S RNA, which is 
transcribed by RNA polymerase III does not undergo post - 
transcriptional modification (Birkenmeier et al., 1978). The tRNAs 
which are also a product of polymerase III are modified after 
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transcription. The primary transcripts of the tRNAs are produced 
with extra sequences at their 5' and 3' ends and these sequences are 
"trimmed" by RNase type activities. The 5' end is trimmed first. 
The 3' end then has a CCA terminus added by an energy dependent 
reaction. The enzyme catalysing this reaction is tRNA 
nucleotidyltransferase (Deutscher, 1982). The tRNAs also contain 
introns which are spliced out by cleaving the precursor tRNA at the 
boundaries of the intron and then ligating the two halves of the 
tRNA molecule together again (Peebles et al., 1979). The final 
post -transcriptional proccessing of tRNA is that of base 
modification or transposition which is thought to be necessary for 
stabilising the tRNA in preparation for translation. 
This concludes the discussion of the nucleic acids, their 
structure and their associations with proteins, the other major 
class of molecule present within the nucleus. These proteins 
perform both structural and catalytic functions in association with 
the DNA and RNA of the cell. The final characteristic of the 
nucleus is the envelope which isolates the contents and their 
functions from the cytoplasm. I have mentioned it briefly but will 
now discuss its properties and structure in more detail. 
1.2.3 The Nuclear Envelope 
The nuclear envelope is a double membrane formed by a 
specialised region of the endoplasmic reticulum (ER). However these 
membranes do not entirely isolate the nucleus from the surrounding 
cytoplasm, due to the presence of pore complexes. These provide a 
diffusion channel for ions and small molecules and are able to 
actively select and transport larger proteins and RNP particles into 
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the cytoplasm (Schroder et al., 1988). The nuclear pores are large 
complex structures composed of proteins of sizes ranging from 45- 
210kDa. However the arrangement and function of the individual 
proteins is not known. The inner and outer membranes differ 
functionally; the outer membrane is involved in membrane bound 
protein synthesis and has been shown to be continuous with the 
cellular ER. The inner membrane is lined by a fibrillar mesh known 
as the nuclear lamina. This is believed to function in the 
attachment and spatial organisation of the interphase chromatin and 
rearrangements of the nuclear membrane structure during the cell 
cycle. The nuclear lamina consists of intermediate filament (IF) - 
like proteins comprised of a central helical rod flanked by non - 
helical head and tail domains. they also contain a signal which 
localises them to the nucleus (Loewinger and McKeon, 1988). There 
are three types of lamins in vertebrates: A, which is completely 
solubilised during mitosis and B, which remain attached to the 
nuclear membrane throughout the cell cycle and lamin C(Burke and 
Gerace, 1986). The lamina is associated with the inner membrane due 
to its interaction with the integral membrane proteins (Senior and 
Gerace, 1988). Three proteins of 75kDa, 68kDa and 55kDa have been 
identified and shown to be exclusively located at the inner membrane 
and tightly associated with the insoluble lamina. A 58kDa membrane 
protein from avian nuclear envelope has been postulated to be a 
lamin B receptor (Worman et al., 1988). The association of the 
lamina to the inner membrane has also been suggested to be due to 
post -translational modifications of the lamins (Wolda and Glomset, 
1988; Beck et al., 1988). The nuclear membrane breaks down during 
mitosis and reassembles when division is complete. The mechanisms 
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are poorly understood but the process of reassembly is thought to be 
related to the phosphorylation of the lamin proteins. The 
reformation of the nuclear membrane has been suggested to control 
DNA replication itself (Blow and Laskey, 1988). 
This section has discussed the major components of the nucleus 
and their structures. The nucleus is a very complex organelle and 
the processes that occur within it are essential for the existence 
of the eukaryotic cell. It is not possible to discuss all the minor 
nuclear components due to lack of space in this introduction and, 
indeed, due to the lack of knowledge. The areas that I have 
discussed show how the complexity of the structure correlates with 
the vast range of anti- nuclear autoantibodies which have been 
isolated to date (from the sera of patients). Hopefully these, and 
further autoantibodies yet to be identified, will continue to aid 
our research into the structure of the nucleus, and at the same 
time, our expanding knowledge of the antigenic targets may help our 
understanding of autoimmune disease. 
1.3 The Aims of the Project 
Many previous studies have established the use of autoimmune 
anti -nuclear antibodies for the identification and characterisation 
of nuclear antigens. A previous observation by Jeppesen and Nicol 
showed that serum from a scleroderma /CREST patient contained 
autoantibodies to an antigen which was localised to the non -histone 
scaffold region of the metaphase chromosome (Jeppesen and Nicol, 
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1986). This clearly demonstrates the use of autoimmune sera for 
research purposes. Therefore, in the light of this discovery, the 
aim of my project was to use the sera from patients with a range of 
autoimmune diseases, to identify further antigens, hopefully playing 
structural roles within the nucleus. 
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CHAPTER TWO 
MATERIALS AND METHODS 
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Table 2.1 giving details of the sera used in the course of this 
project. 
Batch No Patient No Initials Disease 
1 #1 MJ SLE 
1 #2 MN SLE 
1 #3 JM MCTD 
1 #4 JM dermatomyositis 
1 #5 JP SLE 
1 #6 AG SLE 
1 #7 ML scleroderma 
i #8 LH Sicca syndrome 
1 #9 MM (ideopathic thrombocytopaenic) 
1 #10 KM ( purpura (ITP) 
1 #11 JaL polymyositis 
1 #12 JG Raynaud's phenomenon only 
1 #13 H scleroderma 
1 #14 R MCTD 
1 #15 FF MCTD 
1 #16 LS SLE 
1 #17 SS MCTD 
1 #18 CL ITP 
1 #19 M osteoarthritis 
1 #20 B Osteoarthritis 
1 #21 EP CREST 
1 #22 SC CREST 
i #23 BB SLE 
i #24 NF SLE 
2 1 -12 scleroderma 
2 13 -24 MCTD 
2 MATERIALS AND METHODS 
2.1 Patients and Sera 
Autoimmune sera used in the course of this project were 
obtained from patients attending the Northern General Hospital, 
Edinburgh and gifted to me by Professor G. Nuki. The control serum 
JL was obtained from an apparently healthy female volunteer who 
worked in this unit. 
Antibody IC2 
This antibody was given to me by D. Hartley. It is a mouse 
polyclonal serum antibody which had been precipitated with ammonium 
sulphate. The antibody was raised against a fusion protein of 
glutathione S- transferase and a 1.2kb Eco RI fragment from the C- 
terminal end of the Drosophila melanogaster E(spl) clone, NB5. The 
fusion protein was produced by the vector pGEX -1N in the host cell 
XL -1 blue. 
the cells were frozen in 10% glycerol, the culture medium was 
changed 24 hours (hrs) after thawing. 
2.2.2 Maintenance of Cell Lines in Culture 
Three types of cell line were used in this project and each 
required different conditions. 
Don K2 
This is a Chinese hamster lung fibroblast cell line. These 
cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) 
(Gibco Biocult) supplemented with 7.5% foetal calf serum (FCS) 
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(Gibco Biocult) which had been heat inactivated for 30 minutes (mins), 
and grown as an attached culture at 37 °C on 9cm Petri dishes (Nunc) 
in a 10% CO2 atmosphere. 
L cells 
This is a mouse fibroblast cell line (Flow Laboratories; NCTC 
L929, passage number 564). They were cultured in DMEM supplemented 
with 10% FCS and lx non -essential amino acids from a 100x stock 
(Gibco Biocult). As before these cells were grown as an attached 
culture on 9cm Petri dishes at 37 °C in a 10% CO2 atmosphere. 
Both of these cell lines were passaged routinely once a week 
and were detached from the dishes by 0.25% trypsin solution from a 
10x stock (Gibco Biocult) in 0.02% ethylenediaminetetraacetic acid 
(EDTA). The cells were split at 1:10 and 1:100 before replating, 
and were also fed once a week between passages. 
PARIT 
This is a human lymphoblastoid cell line and is cultured in 
RPMI 1640 (Gibco Bio -cult) supplemented with 10% FCS as a suspension 
culture in 9cm Petri dishes (Sterilin) again at 37 °C in a 10% CO2 
atmosphere. 
These cells were passaged twice a week, split at a ratio of 
1 :3. 
2.2.3 Preparation of Whole Cells for Indirect Immunofluorescence 
Cell lines which were growing as attached cultures (ie. Don K2 
and Mouse L fibroblasts) were plated out onto Petri dishes 
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containing glass coverslips and grown up for 24 hrs. The coverslips 
were then rinsed in cold Dulbecco's A phosphate buffered saline 
(PBS) (Oxoid) and fixed for 6 mins in 100% methanol at -20 °C (Aubin 
et al., 1980). They were then rinsed in either PBS or "KCM" 
(chromosome isolation medium as described in Gooderham and Jeppesen, 
1983; 120mM KC1, 20mM NaC1, 10mM Tris pH 8.0, 0.1% Triton X -100, 
0.5mM EDTA pH 8.0) and were then taken through the indirect 
immunofluorescence procedure which will be described later in this 
chapter. 
The PARIT cell line which grows in suspension was resuspended 
at 1 x 105 cells /ml in RPMI and 500111 was spun onto slides using a 
Cytotek centrifuge (Miles Laboratories) at 2K for 10mins and then 
fixed as before in methanol. Metaphase spreads were prepared using 
this cell line by incubating a culture passaged the previous day, 
for 3 - 4 hrs in 0.11.1g colcemid (Fluka) per ml of RPMI (in order to 
arrest the cell cycle in metaphase). The cells were resuspended in 
RPMI at 3 x 105cells /ml and swollen by the addition of 2 vols of 
water and incubation at 37 °C for 15mins. 500111 of cells, again at 1 
x 105 cells /ml, were spun onto slides, but in this case, they were 
not fixed at all. 
The slides are washed for 10mins in PBS /KCM prior to staining 
by indirect immunofluorescence. 
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2.3 Preparation of Denatured Nuclear Protein from Cells Grown in 
Culture 
Cells from 5 - 10 plates were counted, harvested by pelleting 
at 1,000 rpm at RT and then gently resuspended in 10m1 of freshly 
prepared 75mM KC1. The cells were swollen at 37 °C for 15mins and 
then cooled on ice for 5mins. The cells were repelleted at 4 °C and 
resuspended in 10m1 KCM pH 7 plus 2mM CaCl2. Triton X -100 was added 
to 0.1% and the cells incubated on ice for 5mins to lyse. Lysis was 
completed by passing the cells several times through a 20G long 
needle, using a syringe, and the released nuclei were pelleted at 
4 °C. The nuclei were then resuspended in 2m1 of KCM pH 7 plus 2mM 
CaC12, 0.1% Triton X -100 and 1mM phenylmethyl -sulphonylfluoride 
(PMSF). The nuclei were incubated on ice for 30mins to allow the 
PMSF to deactivate any proteases and then repelleted. They were 
washed in KCM pH 7 plus 2mM CaC12, 0.1% Triton X -100 and 0.1mM PMSF 
and then resuspended in TBS plus 2mM CaCl2, 0.1% Triton X -100 and 
0.1mM PMSF. The nuclei were pelleted and then resuspended in a 
volume of TBS (as above) such that there are 2.5 x 108 cells /ml. 
104l 0.5M EDTA pH 7.4 is added, then l0041 of 10% SDS, 5% ß- 
mercaptoethanol (Pate) per 40041 of TBS and this is then boiled in a 
waterbath for 3mins and allowed to cool. 10041 (per 40041 TBS) of 
50% glycerol, 0.1% bromophenol blue (BPB) is added and the 
preparation is stored at -20 °C. 
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2.4 Preparation of Fusion Proteins 
Recombinant clones of host cells (BL21 DE3 or XL -1 blue) were 
grown up o/n at 37 °C in 10m1 LB plus 5011g /ml Amp. The next day 1- 
2m1 of this o/n culture was used to inoculate fresh LB plus Amp, and 
this was incubated at 37 °C for 4 hrs. IPTG was added to a final 
concentration of 0.5mM and a Time 0 sample taken. After 1 or 2hrs 
an induced sample was also taken. 
1ml of the uninduced and induced sample was spun down in a 
microcentrifuge, and the supernatant discarded. The bacterial 
pellet was resuspended in l00µ1 of TE and 100µl of 1% SDS. The 
sample was then made up to a final concentration of 10% glycerol and 
0.01% BPB. It is now ready to be run on a polyacrylamide gel. 
2.5 Separation of Proteins by Electrophoresis 
The method used in this project was discontinuous sodium 
dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE), 
which was originally described by Laemmli, 1970. The following 
modifications were also applied. 
A 20cm x20cm slab gel was used. The stacking gel was 3% 
acrylamide and the running gel was 15% acrylamide. The running 
buffer was 192mM glycine, 25mM tris (hydroxymethyl) aminomethan 
(Tris) and 0.1% SDS. The samples were run at 20mA until they 
reached the stacking /running gel front and then at 10Watts until the 
bromophenol blue (BPB) dye was approximately 0.5cm from the bottom 
of the gel. 
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The gel was stained overnight in Coomassie Brilliant Blue R250 
(Gurrs) at 0.5% w/v in 50% methanol, 10% acetic acid. It was then 
destained in 10% methanol, 7% acetic acid. 
2.6 Transfer of Proteins onto Nitrocellulose Membrane 
2.6.1 Western Blotting 
This procedure was first described by Towbin et al., 1979 as 
transfer blotting. The procedure for the purpose of this project 
was carried out as follows. 
The SDS polyacrylamide gel was first equilibrated in transfer 
buffer (192mM glycine, 25mM Tris, 20% (v /v) methanol) plus 0.1% SDS 
(w /v) to facilitate the movement of the proteins out of the gel 
matrix. The proteins were then electrophoretically transferred onto 
the nitrocellulose membrane (0.451m pore) (Schleicher and Schuell) 
at 0.5A for 2 - 3hrs. To check that the transfer has been 
successful a portion of the nitrocellulose was cut off and stained 
in Amido black at 0.1% w/v (Hopkin and Williams) in 20% ethanol, 7% 
acetic acid. It was then destained in 20% ethanol, 7% acetic acid. 
2.6.2 Immobilisation of Protein Produced by Expression Vectors 
Nitrocellulose discs were soaked in 10mM isopropyl -ß -D -thio- 
galactopyranoside (IPTG) for a few minutes and then dried thoroughly 
at 42 °C. They were then overlaid onto the culture plates, keyed to 
them with a needle and incubated for 1.5 - 2hrs at 42 °C. The 
filters were then rinsed in TBS pH 8.2. 
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2,7 Staining Techniques 
2.7.1 Indirect Immunofluorescence of Whole Cells and Metaphase 
Spreads 
The fixed (excluding the metaphase spreads) and rinsed cells 
on slides or coverslips were incubated for 1 hr at room temperature 
(RT) in a damp environment in the first antibody solution. The 
serum antibody was diluted to 1% (v /v) in 10% (v /v) whole normal 
rabbit serum in PBS /KCM. The cells were washed twice in PBS /KCM and 
incubated under the same conditions for 30mins in the second 
antibody solution. The second antibody was a fluorescein conjugated 
rabbit anti -human IgG y antibody (DAKO) and was diluted to 5% 
(v /v) in 10% (v /v) whole rabbit serum in PBS /KCM as before. The 
cells were washed again and fixed in 4% (w /v) paraformaldehyde in 
PBS /KCM for 30mins. They were then washed in water and air dried. 
2.7.2 Counterstaining of Whole Cells and Metaphase Spreads 
In order to visualise the nucleus and chromosomes easily the 
immunofluorescently stained cells were counterstained with a stain 
which is specific for DNA. 
Coverslips were stained with dichlorophenol- indophenol (DAPI) 
at 0.511g /ml for 10mins under damp conditions at RT. The coverslips 
were washed, dried and mounted in glycerol (Merck) and PBS 
(Citifluor) at 1:1. 
Slides were stained with Hoechst 33258 at 0.5µg /ml in lx 
sodium saline citrate (SSC). They were washed in lx SSC for 10mins 
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then stained for 10mins and then washed in lx SSC then water for 
10mins each. After air drying they were mounted as above. 
2.7.3 Immuno Staining of Nitrocellulose Membranes 
Nitrocellulose membranes were first blocked in 10% horse serum 
(HS), 0.05ó Tween -20 in TBS pH8.2 (HS /TBS /Tw) for approximately 
15mins to reduce any non -specific binding of the serum antibody. 
The first antibody was diluted 1/300 in HS /TBS /Tw and the 
nitrocellulose incubated in this for 3hrs at RT. The membrane was 
washed twice in 0.05% Tween -20 in TBS pH8.2 (TBS /Tw) and then 
incubated in the second antibody solution overnight (o /n). The 
second antibody was a peroxidase conjugated rabbit anti -human IgG y 
antibody (DAKO) and was diluted 1/200 in HS /TBS /Tw. The membrane 
was washed as before and then rinsed in 50mM Tris pH 7 to remove the 
salts deposited by the other washes. The antibody binding sites 
were visualised using 3mg /m1 4- chloro -l- naphthol in methanol diluted 
1:5 in 50mM Tris pH 7 plus hydrogen peroxide (30ó w /v) at a 1/3000 
dilution and then washed in water and air dried. 
2.8 Affinity Purification of Serum Autoantibodies 
The method used during the course of this project is that of 
Olmsted, 1981. The antibody of interest was bound to the protein 
band on a preparative Western blot for which it showed affinity. Two strips 
were incubated with the second antibody and stained by the method 
described earlier. These strips were aligned with the remainder of 
the blot and the protein band with the bound antibody was excised. 
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The antibody was eluted from the blot by first washing with Buffer 1 
(0.25á gelatin, 0.05M Tris.HC1 pH 7.5, 5mM EDTA, 0.15M NaC1, 0.05 
Nonidet P -40) minus the the Nonidet P -40 and gelatin. The strips 
were then cut into small pieces and put into a syringe and washed 
again with Buffer 1 minus the Nonidet P -40 and gelatin. Then 0.2M 
glycine.HC1 pH 2.8 was added and incubated for 2mins before being 
forced through the filter twice. It was then neutralised with NaOH 
and stabilised by the addition of 0.1% BSA. This can be used neat 
on Western blots and with 10% rabbit serum added for cells instead 
of first antibody as previously described. 
2.9 Bacterial Cell Culture 
2.9.1 Media and Additives 
All media were sterilised by autoclaving. 
L -Broth and Agar 
Per litre : 10g tryptone (Difco), 5g yeast extract (Difco), 
10g NaC1, 2.46g MgSO4 pH 7.2. The agar contains 15g agar in 
addition. 
SOC Broth 
Basic medium per litre : 20g tryptone, 5g yeast extract, 0.59g 
NaC1, 1.86g KC1. Before use filter sterilised MgC12 and MgSO4 were 
added to a final concentration of 10mM and filter sterilised glucose 
(kept frozen) was added to a final concentration of 20mM. 
Top Agar 
Per litre : L -broth plus 0.7% agarose (w /v) and re- autoclaved 
to dissolve. 
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Bacteriophage Diluting Solution - SM 
Per litre : 5.844g NaC1, 6.055g Tris, 2.465g MgSO4, 0.2g 
gelatin at pH 7.5. 
Media Additives 
When appropriate, antibiotics were added to the media. 
Ampicillin was used at 25 - 5011g /ml; tetracycline at 12 - 1511g /ml. 
5- bromo -4- chloro -3- indoyl -(3- galactopyranoside (X -gal) was stored as 
a 2% stock solution in dimethylformamide at -20 °C. IPTG was also 
stored as 100mM stock. 
2.9.2 Bacterial Strains Used 
All strains used are E. colí. 
XL1 -Blue 
recAl, endAl, gyrA96, thi, hsdR17, (rk -, mk +), supE44, relAl, 
X -, (lac), (F', proAB, lacIgZDM15, Tn10(tetR)} (Bullock et a1., 
1987). This strain is a suitable host for pUC based plasmids. 
Y1090 
rk, lac, bon, hsdR, supF, clac, filon, pMC9. Permissive for 
the growth of Xgtll (Young and Davis, 1983; Jendrisak et al., 1987). 
BL21 DE3 
hsdS, gal (XcIts857indl Sam7 nin5 lac UV5 -T7 gene 1), ion. 
This strain was used as a host cell for the production of fusion 
proteins from the vectors pGEX -3X and pGEMEX -1. 
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2.10 Vectors 
2.10.1 Plasmid Vectors 
pBluescribe 
This is a plasmid /'phage vector of 3.2kb derived from pUC19. 
It is ampicillin resistant and contains T7 and T3 promoters either 
side of the pUC19 polylinker and the lac Z promoter. It contains a 
polylinker inserted into the 0- galactosidase gene (lac Z). Non - 
recombinant plasmids are able to synthesise this enzyme which breaks 
down X -gal to release a blue indolyl derivative. In recombinant 
plasmids the lac Z gene is interrupted by foreign DNA, thus the 
colonies remain colourless. 
pBluescript KS( + / -) 
This is a phagemid vector of 2,964óp derived from pUC19. It 
has fl 'phage and colE1 origins and T7 and T3 promoters flanking the 
polylinker. It contains the lac Z promoter and has ampicillin 
resistance. 
zGEX -3X 
This is a vector of 4,952bp derived from pBR322 which is used 
to produce fusion proteins. It is ampicillin resistant and contains 
the glutathione S- transferase gene which is used to select 
recombinants on a column. 
OGEMEX -1 
This expression system is based on the pGEM vector. Sequences 
cloned into the vector are expressed as T7 gene 10 fusion proteins. 
It is ampicillin resistant and contains three RNA polymerase 
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promotors, a T7 termination sequence down stream from the multiple 
cloning region and fl origin of replication. 
2.10.2 Bacteriophage Vectors 
Xlac5, shndIIIl2-3, srIñ3°, cIts857, srIñ,4°, nin5, srlñ.5°, 
Sam100. 
2gt10 
ñ,srlÀ,l°, b527, srIñ.3°, imm434, (srI434+) , srIñ,4°, srIñ,5°. 
2.11 Screening of Libraries Constructed in Bacteriophage X. Vectors 
2.11.1 Screening of Expression Libraries with Antibodies 
For details of all solutions and media used in this protocol 
refer to 2.9.1. 
Bacteriophage X were grown on lawns of E. coli (strain Y1090). 
(A plating stock of these cells was prepared from an o/n culture of 
a single colony in 25ml L -broth plus 0.2% maltose.) For the primary 
round of screening approximately 2 x 105 'phage were plated on a 9cm 
Sterilin dish. 100111 of an appropriate dilution of the library in 
SM was added to 200111 of plating cells and incubated at 37 °C for 15 
- 30mins. 3 - 4m1 of top agar was added to this, mixed and poured 
onto an L -agar plate and allowed to set. The plate was inverted and 
incubated at 42 °C for 4hrs after which the plaques should be just 
about visible on the lawn of bacteria. The plates were overlaid 
with the nitrocellulose filters soaked in IPTG and incubated for a 
further period as described earlier. After washing in TBS the 
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filters were probed using the serum antibodies. After staining the 
positive plaques were marked and the filters re- aligned with the 
plate. A plug of agar around the positive signal was taken up with 
the wide end of a Pasteur pipette and blown into lml of SM plus a 
few drops of chloroform, to lyse the bacterial cells, and incubated 
at RT for lhr. This stock should contain approximately 1 x 106 pfu 
(plaque forming units i.e. bacteriophage) and was used for the 
second round of screening. Approximately 1 x 10' pfu per plate were 
plated and screened as before. A noticeable amplification of 
positive plaques will be observed if the primary plaques were true 
positives. Again a plug of agar corresponding to a positive signal 
was blown into SM from the thick end of a Pasteur pipette. A third 
round of screening was performed with approximately 1,000 pfu per 
plate. Again a large plug of agar was picked and the final round of 
screening was performed with only 100 pfu on each plate. Every 
plaque formed on these plates should give a positive signal with the 
antibody. This time a single positive plaque was picked with the 
thin end of the Pasteur pipette into lml of SM. This is a 
suspension of purified bacteriophage which contain the DNA sequence 
which codes for the protein recognised by the antibody. 
2.11.2 Screening of Non -Expression and Expression Libraries with 
DNA 
The principle of this type of screening is the same as above. 
Again the bacteriophage were grown on lawns of E. coli (Y1090) but 
the 2m1 of plating cells infected with lml of an appropriate 
dilution of bacteriophage were plated on large 20 x 20cm plates in 
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20m1 of top agar at 2 x 10' pfu per plate. The plates were inverted 
and incubated at 42 °C o /n. Duplicate filters were overlaid and 
keyed to the plate. The plated bacteriophage were screened by 
hybridising radiolabelled sequences of DNA to the filters and 
visualising any binding by autoradiography. Plaques which gave 
positive signals on both autoradiographs were selected as before and 
rescreened with approximately 1,000 pfu per plate. If the signal 
was particularly strong a single plaque may be isolated from the 
secondary plates. If not a third round at 200 pfu per plate is 
necessary to ensure that the plaque picked was definitely giving a 
positive signal. 
2.12 Manipulation of Plasmid DNA 
2.12.1 Preparation of Frozen Cells for Electroporation 
A litre of L -broth was inoculated with 1 /100 volume of a fresh 
o/n culture and the cells grown up with vigorous shaking at 37 °C 
until they reached a density of 0.5 to 1 (0D600). The flask was then 
chilled for 15 - 30mins and the cells harvested by pelleting in a 
cold rotor at 4,000 x gmax for 15 mins. The cells were resuspended 
in 1 litre of cold water and then repelleted as before. They were 
again resuspended, this time in 0.5 litre of water and pelleted. 
The cells were now resuspended in approximately 20m1 of 10% glycerol 
and centrifuged again. The final resuspension was in a final volume 
of 2 - 3m1 in 10% glycerol which gave a cell concentration of 3 x 
101° cells /ml. Aliquots of 40µ1 were frozen on dry ice and stored at 
-70 °C. 
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2.12.2 Electroporation of XL1 -Blue 
An aliquot of prepared cells was thawed at RT and put on ice. 
1 - 24l (10 -50ng) of DNA in a low ionic strength buffer was mixed 
in and left on ice for 1min. The Gene Pulser apparatus is set to 
254F and 2.5kV with the Controller at 200W. The cells and DNA were 
transferred to a 0.2cm cuvette which is placed in the chilled safety 
chamber between the contacts. A single pulse was applied and the 
cells immediately resuspended in lml SOC. The suspension was 
incubated at 37 °C for ihr and then plated on L -agar supplemented 
with 254g /ml ampicillin, 24g /ml X -Gal and 404l of 100mM stock of 
IPTG per plate. The plates were incubated at 37 °C o /n. The 
recombinant colonies are white. 
2.12.3 Preparation of Frozen Cells for Heat Shock Transformation 
40041 of an o/n culture of cells (one colony from a plate 
inoculated into 10m1 of L -broth and grown up o/n at 37 °C) was 
diluted 1/50 into 20m1 of L -broth Mgt* and grown up at 37 °C to OD560 
0.3 - 0.6. 6ml of this culture was then diluted at 1/50 in 294m1 
L -broth Mgt ., plus 60041 5M NaCl and 7.5ml 1M KC1 (i.e. 10mM NaC1 and 
25mM KC1). The cells were grown up to OD560 0.48 and then chilled on 
ice for 15mins. The cells were then pelleted in bottles rinsed in 
ethanol and DEPC water, for 5mins at 4K at 4 °C. The cells were 
taken up in 100m1 of TFB I (1.43g NaOAc, 1.1g CaC12, 75g glycerol, 
6g RbC1 and 4.95g MnC12 per 500m1) at pH 5.8 and stored on ice for a 
further 10 - 15mins. The cells were repelleted by spinning at 5K 
for 5mins at 4 °C and then resuspended in 12ml of TFB II (0.209g 
MOPS, 0.12g RbCl, 1.64g CaC12 and 15g glycerol per 100m1) at pH 6.8. 
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The suspension was chilled on ice for 20mins before aliquotting into 
20041 and snap freezing in liquid N2. The competent cells are now 
stored at -70 °C. 
2.12.4 Heat Shock Transformation of XL1 -Blue 
1041 (10 - 50ng)of DNA was added to 954l of XL1 -blue cells 
thawed from -70 °C on ice. The two were mixed and incubated on ice 
for a further 15mins before incubation at 42 °C for 75secs. This was 
then chilled on ice for a further 2mins. 5254l of L -broth was added 
and the cells grown up for 50mins before plating onto selection 
plates. 
2.12.5 Preparation of Fresh Cells for Heat Shock Transformation 
One colony from a streaked plate was grown up o/n in LB. lml 
of this culture was inoculated into fresh LB and grown to an ODs6o 
0.3 - 0.5. The cells were then spun down and resuspended in 0.5 vol 
of ice cold 50mM CaC12. The cells were then incubated on ice for 
15mins before being spun down again. They were then resuspended in 
0.1 vol of ice cold 50mM CaCl2 and are now ready for transformation. 
2.12.6 Heat Shock Transformation of BL21 DE3 
204l (10 - 50ng) of DNA was added to 20041 of cells and mixed. 
The cells were now incubated on ice for 45mins, before heat shocking 
at 42 °C for 80secs. The cells were cooled on ice for 2mins and then 
grown at 37 °C for 45mins in LB, before plating on the appropriate 
selection media. 
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2.12.7 Small Scale Plasmid Preparations 
The Alkaline Lysis Method 
The method used for the purpose of this project was a 
modification of the methods of Birnboim and Doly, 1979 and Ish- 
Horowitz and Burke, 1981, as described in Sambrook, Fritsch and 
Maniatis (2nd edition) Volume 1, p.1.25 - 1.28. 
A method involving a further modification of the above method 
was found to be particularly useful as the preparations could be 
directly sequenced. lmg /ml of lysozyme was added to Solution I, 3M 
CH3COONa is used instead of Solution III and the DNA precipitated by 
the addition of 0.7 volumes of isopropanol. The remainder of the 
method with the omission of the RNase treatment was essentially the 
same. 
2.12.8 Large Scale Plasmid Preparation 
The Alkaline Lysis Method 
This method is a modification of that of Birnboim and Doly, 
1979 and Ish- Horowitz and Burke, 1981, in Sambrook, Fritsch and 
Maniatis (2nd edition) Volume 1, p. 1.38 - 1.39. The purification 
procedure was that of equilibrium centrifugation in CsCl- ethidium 
bromide gradients also in Volume 1, p. 1.42 - 1.43 and the 
extraction by organic solvent (p. 1.46). 
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2.13 Manipulation of Bacteriophage ? DNA 
2.13.1 Small Scale Bacteriophage % DNA Preparation 
The first step was the production of a plate lysate which is 
done according to Protocol II in Sambrook, Fritsch and Maniatis (2nd 
edition) Volume 1, p. 2.66. The DNA was purified by a method 
involving the use of LambdaSorb (Promega). l0041 of the adsorbent 
was added per 10m1 of lysate and incubated on ice for 30mins. This 
was centrifuged at 7,500 rpm for 10mins and the supernatant 
discarded. The pellet was resuspended in 1ml of SM and 
recentrifuged. This step was repeated and then the pellet 
resuspended in 50041 of 10mM Tris HCL pH 7.8, 10mM EDTA and heated 
to 70 °C for 5 mins to release the 'phage DNA. The adsorbent was 
pelleted and the DNA extracted from the supernatant with buffered 
phenol /chloroform twice and once with chloroform only. The DNA was 
then precipitated with 1 /10 volume 3M CH3COONa and an equal volume 
of iso- propanol on dry ice for 20mins, and then pelleted. The DNA 
was washed in 70% ethanol, dried and resuspended in 10mM Tris HC1 pH 
7.8, 0.1mM EDTA (TE). 
2.13.2 Large Scale Bacteriophage % DNA Preparation 
A 500m1 flask of L -Broth was inoculated with lml of a X 
infected host suspension and incubated o/n at 37 °C with vigorous 
shaking. 10m1 of chloroform was added to the o/n culture which was 
shaken at 37 °C for a further 30mins to ensure complete lysis. The 
'phage DNA was purified according to the protocol in Sambrook, 
Fritsch and Maniatis (2nd edition) Volume 1, p. 2.73 - 2.76 up to 
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step 11. The protocol was then changed and the next step was 
equilibrium centrifugation in CsC1 at 35,000 rpm at 15 °C o /n. The 
DNA was then dialysed for 2x lhr in 1OmM NaC1, 50mM Tris - HC1 pH 8, 
1OmM MgC12 to remove the CsCl. EDTA at pH 8 was added to a 20mM 
final concentration, proteinase K at 504g /ml and SDS to 0.5% and 
this was incubated at 65 °C for lhr. The DNA was extracted once each 
with phenol, phenol /chloroform and chloroform and then precipitated 
as for the small scale preparation above. It was pelleted, washed 
and resuspended in TE. 
2.14 Manipulation of DNA by Enzymes 
2.14.1 Restriction Endonuclease Digestion 
Digests were carried out according to the protocols issued by 
the manufacturers using buffers A, B, L, M and H supplied by 
Boehringer Mannheim. Genomic DNA was digested o/n with 
approximately 5 - 10 units of enzyme per µg of DNA. The reactions 
were stopped by the addition of lx stop mix from a 10x stock (0.2M 
EDTA pH 8, 15% Ficoll and Orange G dye). 
2.14.2 Ligation of DNA Molecules 
Ligase is isolated from E. coli infected with bacteriophage T4 
and is available commercially from Boehringer Mannheim. It 
catalyses the formation of a phosphodiester bond between 3' -OH and 
5' phosphate groups of DNA (Weiss et al., 1968). It is used to join 
complementary cohesive ends of ds DNA. These reactions were carried 
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out o/n at 4 °C in 50mM Tris HC1, 10mM MgC12, 1mM spermidine, 1001.1g /m1 
bovine serum albumin (BSA), 1mM ATP, 10mM dithiothreitol (DTT) at pH 
7.4. 
2.14.3 Nested Deletions of Recombinant Plasmids 
Deletions of dsDNA in one direction only are possible due to 
the observation that blunt ends and 5' overhangs (generated by the 
reaction of restriction enzymes) are susceptible to exonuclease III, 
whereas 3' overhangs are not (Henikoff, 1984). The progressive 
removal of nucleotides from one of the strands by exonuclease III 
leaves a single strand of DNA which is cleaved off by S1 nuclease. 
Nested deletions are created by removing aliquots of reaction mix 
from an ongoing exonuclease III digestion. The molecules of DNA 
with their progressively longer deletions are recircularised by the 
ligation protocol above and transformed into XL1 -Blues by 
electroporation. The deletions were performed using a double 
stranded nested deletion kit from Pharmacia. 
2.14.4 In Vitro Amplification of Specific Sequences of DNA 
This is achieved by means of the polymerase chain reaction 
using a thermostable DNA polymerase isolated from Thermus aquaticus 
(Taq) described by Saiki et al., 1988. The oligonucleotide primers 
required were prepared in this unit by Doreen Chambers. 
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2.15 Separation of DNA by Electrophoresis 
2.15.1 Agarose Gel Electrophoresis 
Conventional horizontal agarose gel electrophoresis was used 
for the separation of DNA fragments of up to 50kb. The 
concentration of agarose used was between 0.5 and 2% made up in lx 
TAE buffer (per litre of 50x stock : 242g Tris base, 57.1m1 glacial 
acetic acid and 100m1 0.5M EDTA pH 8). The gels were also run in lx 
TAE. To prestain the gels, 0.54g /ml of ethidium bromide was added 
to the TAE buffer. 
Specific fragments of DNA used for cloning or radiolabelling 
were also isolated by electrophoresis. However the agarose used was 
of low gelling temperature (LGT) in order that the DNA fragment 
required (cut out of the main body of the gel under long wave UV 
light) could be purified using the method of Burnmeister and 
Lehrach, 1989. This involves melting the gel slice at 65 °C and then 
adding EDTA at pH 8 to 5mM and NaCl to 100mM. The gel was cooled to 
37 °C and 2 units of agarase added per l0041 of gel. This was 
incubated for >lhr and then the DNA was phenol /chloroform extracted, 
precipitated and then resuspended in TE before use. 
2.15.2 Polyacrylamide Gel Electrophoresis 
Sequencing reactions performed as described in 2.21 were run 
on 5% polyacrylamide gels cast and run on Bio -rad apparatus. The 
plates used were 21 x 50cm and were separated by wedged spacers 
which graduated from 0.25mm at the top to 0.75mm at the bottom. 
Casting solutions from Sequagel were used (as described by the 
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suppliers) and set using 10% ammonium persulphate and NNN'N'- 
tetramethylethyl ethylenediamine (TEMED). The gel was pre -run to 
warm it in lx TBE (per litre of 5x stock : 54g Tris base, 27.5g 
boric acid and 20m1 of 0.5M EDTA pH 8) for approximately ihr at 60 
watts. After the samples were loaded the gel was run for 
approximately 2.5hrs at 55 watts. It was then cooled, fixed (to 
remove the urea) in 10% methanol, 10% acetic acid made fresh every 
time for >30mins and dried under vacuum onto Whatman 3MM paper in 
preparation for autoradiography. 
2.16 Transfer of DNA to Nylon and Nitrocellulose Membranes 
2.16.1 Southern Transfer of DNA to Nylon Membranes 
DNA separated on agarose gels was transferred onto reusable 
nylon membrane (Hybond -N) using the method of Southern, 1975. Prior 
to the transfer the gel was photographed under UV light with a ruler 
so that the DNA transferred to the membrane could be sized at a 
later date. The UV illumination introduces thymidine dimers into 
the DNA which makes the transfer of large DNA molecules easier. The 
gels were denatured in 1.5M NaC1, 0.5M NaOH for two 30 mins periods 
at RT, washed in water and then neutralised in 3M NaC1, 0.5M Tris at 
pH 5 for two further periods of 30mins. The actual transfer of the 
DNA was achieved by capilliary blotting the DNA with 20x SSC. The 
gel was placed onto Whatman 3MM wetted with 20x SSC and Hybond -N 
wetted in 2x SSC was placed on top with no air bubbles trapped in 
between it and the gel. Two pieces of 3MM wetted in 2x SSC were 
placed on top of the membrane and then a stack of paper towels put 
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on top of them. A glass plate is rested on the top and the gel 
allowed to blot o /n. When the transfer was complete, the membrane 
was washed in 2x SSC and air dried. The DNA was covalently bound by 
exposing the membrane DNA -side down to UV light for 5mins. 
To reuse the membrane any hybridised probe was removed by 
washing at 45 °C for 30mins in 0.4M NaOH. It is then neutralised by 
incubation in 0.2M Tris, O.lx SSC, 0.1% SDS for 30mins at 45 °C also. 
2.16.2 Immobilisation of DNA from Bacteriophage Colonies onto 
Nitrocellulose 
A piece of nitrocellulose was carefully placed onto the plate 
from the middle outwards ensuring it was thoroughly wetted by the 
agar and left for 30 secs whilst it was keyed to the plate with a 
wide gauge needle. It was then lifted carefully off using Millipore 
forceps and placed into denaturing solution for 5mins DNA -side 
uppermost. It was transferred into neutralising solution for a 
further 5mins and then washed in 2x SSC. A second piece of 
nitrocellulose was overlaid onto the same plate and left for 2mins 
whilst it was keyed to the plate using the holes made when keying 
the first filter. This too was denatured, neutralised and washed. 
The filters were air dried on 3MM and then baked at 68 °C for 2 hrs 
to bind the DNA to the filter. This was the method used for 
screening libraries by DNA hybridisation. 
2.16.3 Immobilisation of Bacterial Colonies on Nitrocellulose 
The method is essentially the same as that of the 
immobilisation of bacteriophage colonies. An additional incubation 
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step of 5mins in 1% SDS before denaturation and neutralisation of 
the DNA ensured that the bacterial cells were broken open to allow 
the DNA to be released. 
2.17 Separation of RNA by Electrophoresis 
Horizontal gel electrophoresis was used to separate the RNA 
samples. The gel was made by melting lg of agarose in 87ml of DEPC 
dH2O. This was then cooled and 10m1 of 10x MOPS (0.2M 3 -(N- 
morpholino)propanesulphonic acid, 0.05M CH3COONa, 10mM EDTA) and 
5.1m1 of 37% formaldehyde were added, the gel mixed, poured and left 
to cool. The RNA sample was made up to 1041 with DEPC dH2O and then 
154l of sample buffer (consisting of 1041 formamide, 2.54l 
formaldehyde, 1.254l 10x MOPS and 1.2541 dH2O) is added and this is 
then incubated at 55 °C for 20mins. 1/10 volume of loading buffer 
(50% glycerol, 1mM EDTA, 0.4% bromophenol blue and 0.4% xylene 
cyanol) is then added. In order to prestain the RNA lµl of 14g /ml 
stock of ethidium bromide is added to each sample. The gel is run 
in lx MOPS buffer at 20V o /n. 
2.18 Transfer of RNA to Nylon Membrane 
RNA was blotted o/n onto Hybond -N in 10x SSC using the same 
method as for the Southern blotting of DNA. The Northern blot was 
then washed in 2x SSC, air dried and UV crosslinked to the membrane, 
as described previously. 
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To reuse the filter after hybridisation, any bound probe was 
removed by incubating the membrane in 0.2% SDS for 1 hour at 80 °C. 
It was then washed in 2x SSC as before. 
2.19 Radiolabelling of DNA 
2.19.1 Random Priming 
DNA probes were labelled by random priming using the method of 
Feinberg and Vogelstein, 1983 and 1984. DNA prepared for random 
priming was in LGT agarose after having been purified by running 
through a gel. It was boiled for 5mins to denature the DNA before 
storage at -20 °C. Random hexanucleotides anneal to the denatured 
DNA and act as primers for complementary strand synthesis. This is 
catalysed by Klenow enzyme from the 3' -OH ends of the primers in the 
presence of 32P- labelled dCTP and unlabelled dATP, dGTP and dTTP. A 
commercially available random priming kit from Boehringer Mannheim 
was used. 
25ng of denatured DNA was added to a reaction mixture 
containing dATP, dGTP and dTTP each at 254M /litre, random 
hexanucleotides and buffer. 2 units of Klenow enzyme and 30jCi n -32P 
dCTP (3,000Ci /mmol, 10mM /m1) were also added. The reaction (in a 
volume of 204l) was incubated at 37 °C for >lhr. The percentage 
incorporation of the label into the DNA was estimated by TCA 
precipitation of counts on a Whatman GF /A filter. (10% TCA 
quantitavely precipitates oligonucleotides of <20 bases.) Proteins 
and unincorporated nucleotides were removed from the probe by 
centrifugation through a Sephadex G -50 column. The DNA is excluded 
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from the column and passes through first. The probe has to be 
denatured once more, immediately before use. 
2.19.2 End Labelling 
T4 polynucleotide kinase (PNK) catalyses the transfer of the 
y- phosphate of ATP to a 5' -OH group of DNA or RNA (Sambrook et al., 
1989). 20 - 30ng of oligonucleotide was added to a reaction mix 
containing lx PNK buffer (50mM Tris.HC1 pH 7.6, 10mM MgCl2, 5mM DTT, 
0.1mM spermidine, 0.1mM EDTA pH 8) , lOOp.Ci 7-32P ATP and 20 units of 
PNK in a total volume of 2411. This was incubated at 37 °C for 
30mins and then incorporation was checked by TCA precipitation as 
before. 
2.20 Nucleic Acid Hybridisation 
2.20.1 Solutions Used For Hybridisation 
Church and Gilbert Buffer 
7% SDS, 0.5M NaPO42 -at pH 7.2. This hybridisation solution is 
described by Church and Gilbert, 1984. It was used for most random 
primed DNA probes. 
Denhardt's Buffer 
0.5% SDS, 0.1% sodium pyrophosphate, 5x SET /Denhardt's 
solution (Stock solution is 20x : 0.4M Tris pH 7.8, 3M NaCl, 
20mMEDTA, 0.4% Ficoll, 0.4% polyvinylpyrolidine (PVP), 0.4% BSA.) 
Denatured sonicated salmon sperm DNA was added as a competitor at 
1004g /ml. This solution was used with certain random primed DNA 
probes and always when using nitrocellulose membrane. 
67 
"Quick Hyb" 
0.1% SDS, 0.1% sodium pyrophosphate, 0.05% BSA, 0.05% PVP, 
0.05% Ficoll, 5x SSC. This solution was used for hybridisations 
using end labelled oligonucleotides. 
2.20.2 Hybridisation Protocol for Random Primed Probes 
All filters were double sealed into plastic bags and pre - 
hybridised for >30mins at 68 °C. All hybridisation incubations were 
o/n at 68 °C in the appropriate solution containing the radiolabelled 
probe. 
After hybridisation, the filters were rinsed twice in 2x SSC, 
0.1% SDS at 68 °C for 10 mins each and then more stringently washed 
twice with i - 0.1x SSC, 0.1% SDS at 68 °C for 30mins each. The 
filters were then placed in plastic bags in preparation for 
autoradiography. 
2.20.3 Hybridisation Protocol Used for Oligonucleotide Probes 
All filters are rinsed in 2x SSC, sealed into plastic bags and 
prehybridised in Quick Hyb at 68 °C for >30mins. The probe is 
diluted with an aliquot of the solution from the sealed bag before 
addition and hybridisation o/n at 48 °C. After hybridisation the 
filters are washed 4x for 5mins each with 4x SSC, 0.1% SDS, 0.1% 
sodium pyrophosphate at 50 °C. The filters are then sealed into 
plastic bags in preparation for autoradiography. 
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2.21 Sequencing 
2.21.1 Sequencing Protocol 
The sequencing performed during this project was on denatured 
double stranded DNA by the dideoxy chain termination method of 
Sanger et al., 1977. The DNA is denatured by the addition of 141 2M 
NaOH per 441 DNA (approximately 24g) in TE. This is incubated at RT 
for 10mins and then 1.541 of 3M sodium acetate pH 4.5 and 3.541 of 
distilled water are added. 3041 of 100% ethanol is also added and 
the DNA precipitated on dry ice for 10mins before pelleting. The 
DNA is then washed in 70% ethanol, dried under vacuum and then 
resuspended in 741 of distilled water. 
The primer is annealed next. 241 of Sequenase sequencing 
buffer and 141 of primer are added and incubated at 65 °C for 2mins. 
This is then allowed to cool before proceeding. 
The sequencing is then carried out using the commercially 
available Sequenase Version 2.0 kit (USB) according to the protocol 
supplied with it. This method involves two basic steps; a 
polymerisation reaction in which limited concentrations of 
nucleotides (including 35S -dATP) are used to extend the primer 
previously annealed. The second step is a chain termination 
reaction in which the radiolabelled chains are rapidly extended and 
then terminated by the incorporation of a dideoxy nucleotide. These 
reactions are specific to one particular nucleotide and so are 
conducted in sets of four, one for each of the bases G, A, T and C. 
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The samples contain a series of different sized fragments which can 
be resolved on a polyacylamide gel (Sanger and Coulson, 1978) and as 
they are radiolabelled, detected by autoradiography. 
2.21.2 Sequence Analysis 
The sequences were manipulated using the UWGCG programs and 
homology searches were carried out using the University of Wisconsin 
Genetics Computer Group's software package. Both of these 
facilities are available on the Daresbury computer. 
2.22 Photography 
2.22.1 Photography of Whole Cells and Metaphase Spreads on Slides 
and Coverslips 
Whole cells and metaphase spreads were photographed by epi- 
illumination on a Leitz Ortholux II fluorescence microscope on black 
and white Kodak Tri -X and T -Max film. 
2.22.2 Photography of Agarose Gels 
Agarose gels were placed on a UV transilluminator and 
photographed using a Polaroid MP4 camera fitted with a red filter 
using Kodak T -MAX Professional film 4052 with an exposure time of 15 




2.23.1 Autoradiography of Filters and Gels 
The autoradiography in this project was carried out using X- 
ray film (Fuji Medical or Kodak X -OMAT) in light tight cassettes 
containing intensifying screens, with the exception of sequencing 
gel exposures. Filters were first exposed o/n at -70 °C and then 
they were further exposed for different lengths of time and /or 
temperatures. Sequencing gels were exposed o/n at RT. The X -ray 
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3 ANALYSIS OF THE HUMAN AUTOIMMUNE SERA 
3.1 Introduction 
Antibodies present in the sera of patients suffering from 
autoimmune conditions have been shown to bind to specific antigens 
present in both the nucleus and cytoplasm of cells cultured in vitro 
(as discussed in Chapter 1). 
The aim of this project was, if possible to identify and 
characterise novel nuclear autoantigens recognised by the sera of 
autoimmune patients. As a first step 24 samples of whole human 
serum, covering a wide range of systemic rheumatic diseases, were 
routinely screened in order to analyse the antigenic specificities 
of the autoantibodies present. 
Two methods were employed; first, the antigenic site was 
localised by the immunocytological staining of whole cells and 
metaphase spreads of both human lymphoblastoid and Chinese hamster 
fibroblast cell lines (PARIT and Don K2 respectively). Whole human 
cells were used in order to localise the antigen to the nucleus 
and /or the cytoplasm of the cell. Human metaphase spreads were used 
as an effective method of displaying any chromosomal associations, 
whilst the whole hamster cells were used to demonstrate the cross - 
species conservation of most (if not all) known autoimmune antigens. 
The cells and serum antibodies were prepared in both PBS and KCM 
(Chapter 2). As KCM contains a mild non -ionic detergent, soluble 
antigens within the cell may leach out through the cell membranes 
during preparation. The nucleoli however are resistant. PBS 
preparation is less likely to remove soluble antigens from the cell 
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and hence both methods are employed. However the results obtained 
by immunocytology are not always easy to interpret thus an 
additional technique was also employed to obtain further 
clarification. 
The method used was Western blotting. Proteins from the 
nuclei of the human lymphoblastoid cell line only were isolated and 
separated according to their size by SDS -PAGE (Chapter 2). The 
polypeptides are inaccessible to antibodies within the 
polyacrylamide gel matrix and are therefore electroblotted (Western 
blotted) onto a nitrocellulose membrane allowing the antibody to 
bind to its antigen(s). Polyacrylamide gel electrophoresis involves 
the denaturation of protein samples by treatment with SDS and ßme. 
This may reduce or even abolish the antigenicity of the protein by 
breaking down tertiary structure and removing disulphide bonds. 
Any antigenicity dependent upon this will be lost. Serum antibodies 
which show high levels of activity on immunocytochemistry do so upon 
antigens present in a more physiological environment, so a negative 
result on a Western blot does not mean that there are no antigens 
present, merely that their antigenicity has been lost due to 
denaturation. In this way known diagnostic antigens can be 
identified by means of their molecular weights, thus aiding 
diagnosis of the condition suffered by the patient. Novel nuclear 
proteins recognised by the serum autoantibodies can also be 
identified in this way. 
The serum autoantibodies were also affinity purified from 
Western blots. The eluate can be used to check whether the 
antibodies have single or multiple specificities for nuclear proteins. 
Whole cells can also be stained and the polypeptide identified on 
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the blot can be specifically localised within the cell without the 
presence of other antibodies which produce the characteristically 
complicated staining pattern. 
The information provided by these techniques is essential in 
order to begin the further characterisation of the serum 
autoantibodies and their antigens. 
3.2 Results 
3.2.1 Indirect Immunofluorescence of Whole Cells and Metaphase 
Spreads Using Sera #1(MJ) to #24(NF) 
This method allows the site of the antigen(s) recognised by 
the serum antibodies to be cytologically localised. 
A control serum, JL (obtained from a healthy female 
volunteer), was used to stain the cells in addition to the test 
sera, in order to determine the level of background staining 
achieved with a normal serum. 
Figures 3.1, 3.2 and 3.3 show the patterns observed in whole 
PARIT cells, whole Don K2 cells and metaphase spreads of PARIT cells 
respectively. The level of staining in the nuclei of the whole 
PARIT cells is fairly low and of a granular appearance in both the 
KCM and PBS preparations. In (a) one cell shows a more intense 
level of staining in both the nucleus and cytoplasm. This effect 
was observed in several cells in every preparation of whole PARIT 
cells prepared in KCM and stained with the serum JL. Don K2 cells 
again show a generally low level of staining in their nuclei in both 
preparations. The staining is not quite as granular as that shown 
in Figure 3.1 but a occasional cell in the KCM preparations shows 
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Figure 3.1 Whole PARIT cells stained with the control serum, JL, as 
the first antibody and fluorescein conjugated rabbit anti -human IgGy 
as the second antibody. 
(a) and (b) show cells prepared in KCM stained with JL and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with JL and 
counterstained with DAPI to localise the nucleus, respectively. 
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Figure 3.2 Whole Don K2 cells stained with the control serum, JL, 
as the first antibody and fluorescein conjugated rabbit anti -human 
IgGy as the second antibody. 
(a) and (b) show cells prepared in KCM stained with JL and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with JL and 
counterstained with DAPI to localise the nucleus, respectively. 
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Figure 3.3 Metaphase spreads of PARIT cells stained with the 
control serum, JL, as the first antibody and fluorescein conjugated 
rabbit anti -human IgGy as the second antibody. 
(a) and (b) show cells prepared in KCM stained with JL and 
counterstained with DAPI to localise the chromosomes. 
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the atypical stronger level of staining observed previously. The 
metaphase spreads of PARIT show fluorescence localised around the 
area of the chromosomes themselves, but there is no particularly 
striking pattern observed. 
Figures 3.4, 3.5 and 3.6 show the staining pattern observed 
when using Serum #7(ML) as the first antibody. PBS and KCM 
preparations of both the whole PARIT cells and Don K2 cells show a 
granular staining pattern with very bright discrete speckles present 
within the nucleus alone. (Unfortunately the photograph of the PBS 
preparation of whole PARIT cells is a little underexposed and out of 
focus to show this as clearly as the photograph of the KCM 
preparation.) The metaphase spreads show these discrete speckles 
localised as a doublet at the kinetochore of each chromosome in 
Figure 3.6(a). This staining pattern is characterisic of the CREST 
subset of scleroderma patients (as discussed in Chapter 1). Western 
blotting should show stained bands at the positions of one or more 
of the centromere antigens (CENP -A at approximately 19kDa, CENP -B at 
approximately 80kDa, or CENP -C at approximately 140kDa). 
Figures 3.7, 3.8 and 3.9 show the staining pattern observed 
when using Serum #23(BB) as the first antibody. In the KCM 
preparations of whole PARIT and Don K2 cells, the staining appears 
to be localised around the nuclear membrane, whilst the PBS 
preparations show very strong fluorescence of the whole nucleus, 
not 
dissimilar to the DAPI staining pattern. Metaphase spreads 
of PARIT 
cells show a high level of fluorescent staining 
localised to the 
actual chromosomes themselves. The staining patterns 
observed when 
using this serum are characteristic of those 
given by serum with DNA 
and /or histone antibodies present. These types 
of serum are usually 
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Figure 3.4 Whole PARIT cells stained with serum #7(ML), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG 7 as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #7(ML) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #7(ML) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.5 Whole Don K2 cells stained with serum #7(ML), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG y as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #7(ML) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #7(ML) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.6 Metaphase spreads of PARIT cells stained with serum 
#7(ML), as the first antibody and fluorescein conjugated rabbit 
anti -human IgG Y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with #7(ML) and 
counterstained with DAPI to localise the chromosomes. 
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Figure 3.7 Whole PARIT cells stained with serum #23(BB), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG y as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #23(BB) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #23(33) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.8 Whole Don K2 cells stained with serum #23(BB), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG 7 as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #23(BB) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #23(BB) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.9 Metaphase spreads of PARIT cells stained with serum 
#23(BB), as the first antibody and fluorescein conjugated rabbit 
anti -human IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with #23(BB) and 
counterstained with DAPI to localise the chromosomes. 
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from patients with SLE. The Western blotting will identify whether 
the antigen is in fact DNA alone or whether histone is also 
recognised. 
Figures 3.10, 3.11 and 3.12 show the staining patterns 
observed when using Serum #24(NF) as the first antibody. 
Both types of preparation of the whole cells show a high level 
of fluorescence throughout the nucleus, again similar to the DAPI 
staining in (b) and (d). The PARIT metaphase spread shown in Figure 
3.12 again has the staining localised to the chromosomes indicating 
that the antibodies are recognising DNA and /or histone as with 
#23(BB). There also appears to be some kinetochore recognition with 
this serum. Most of the chromosomes show brighter fluorescent 
speckles at their centromeres. Western blotting will shed further 
light on the actual identity of the antigen(s). 
Figures 3.13, 3.14 and 3.15 show the staining patterns 
observed when #13(H) is used as the first antibody. 
Whole PARIT and Don K2 cells show coarse granular staining of 
the nucleus with some nucleolar localisation, particularly in the 
PBS preparation of the Don K2 cells. The cell in anaphase in 
Figure 
3.14(c) shows staining localised to the condensed chromosomes 
at 
either end of the newly forming daughter cells. The 
metaphase 
spreads show staining localised throughout the chromosome, 
therefore 
the antigen must again be a component of the chromosome 
or its 
scaffold. The whole cell staining pattern is 
not like that shown in 
Figures 3.7, 3.8, 3.10 and 3.11 (which is typical 
of DNA and /or 
histone antibodies), so the antigen(s) in 
the case of serum #13(H) 
is(are) unlikely to be the same. 
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Figure 3.10 Whole PARIT cells stained with serum #24(NF), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG y as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #24(NF) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #24(NF) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.11 Whole Don K2 cells stained with serum #24(NF), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG 7 as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #24(NF) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #24(NF) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.13 Whole PARIT cells stained with serum #13(H), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG y as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #13(H) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #13(H) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.14 Whole Don K2 cells stained with serum #13(H), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG Y as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #13(H) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #13(H) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.15 Metaphase spreads of PARIT cells stained with serum 
#13(H), as the first antibody and fluorescein conjugated rabbit 
anti -human IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with #13(H) and 
counterstained with DAPI to localise the chromosomes. 
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Figures 3.16, 3.17 and 3.18 show the staining patterns 
observed when #14(R) is used as the first antibody. 
The cytospin preparations of whole PARIT cells show coarse 
granular staining of the nucleus. The cells prepared in KCM show a 
high level of staining at the nuclear membrane also. The Don K2 
cells show very different staining patterns depending on the buffer 
used in preparation. The cells prepared in KCM show a high level of 
granular staining within the nucleus, whereas the cells prepared in 
PBS show a very low level of staining of the nucleus, with one or 
two more densely stained areas within, which are probably nucleoli. 
The metaphase spreads show the periphery of the chromosomes lit up 
with a lower level of staining within. The patterns do not 
correspond to any disease in particular, but the Western blots may 
indicate particular antigens which are markers for some types of 
disease. 
The other sera screened also gave nuclear staining patterns 
(some showed additional cytoplasmic staining), but the level of 
staining was not appreciably greater than the background level shown 
by the control serum, JL, with the notable exception of #21(EP) and 
#22(SC). These serum samples were taken from CREST patients and 
included in the trial batch as positive controls. They showed 
staining patterns like those shown in Figures 3.4, 3.5 and 3.6, when 
#7(ML) was used as the first antibody. 
The observations described here show that although 
some 
staining patterns, such as kinetochore recognition, provide 
valuable 
information as to the identity of some diseases such 
as CREST, most 
of the observations do not provide much aid alone. 
However with the 
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Figure 3.16 Whole PARIT cells stained with serum #14(R), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG ¡ as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #14(R) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #14(R) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.17 Whole Don K2 cells stained with serum #14(R), as the 
first antibody and fluorescein conjugated rabbit anti -human IgG y as 
the second antibody. 
(a) and (b) show cells prepared in KCM stained with #14(R) and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with #14(R) and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.18 Metaphase spreads of PARIT cells stained with serum 
#14(R), as the first antibody and fluorescein conjugated rabbit 
anti -human IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with #14(R) and 
counterstained with DAPI to localise the chromosomes. 
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additional information provided by Western blotting, the situation 
can be further clarified. 
3.2.2 Imamunoblotting Using Sera #1(MJ) to #24(NF) 
This method allows the polypeptide specificity of the 
autoantibodies present in the sera to be investigated. 
Figure 3.19 shows the banding patterns produced by sera #1(MJ) 
to #12(JG) plus the normal control serum, JL, whilst Figure 3.21 
shows those produced by sera #13(H) to #24(NF). From the number of 
bands present on each strip it can be seen that this method is 
indeed sensitive. Many of the bands appear to be present in two or 
more of the sera. These may be proteins of a particularly "sticky" 
nature to which the antibodies bind in a non -specific manner. 
However if that were the case these bands would be observed on all 
the stained strips. It is also possible that the bands may 
represent diagnostic antigens. In order to determine whether these 
are antigens which have been previously identified as diagnostic for 
the disease, their molecular weights must be calculated. 
This is achieved by using the calibration curves displayed 
in 
Figures 3.20 and 3.22. Calibration curves are created by running 
markers of a known molecular weight on the gel with the 
sample to be 
studied. The distance of migration of each marker band 
from the 
origin is measured and expressed as a proportion of 
the distance 
from the origin to the solvent front, known as the 
Rf, which 
corresponds to a particular molecular weight. Calibration 
curves 
result from plotting the molecular weights of 
the markers against 
their Rf values. By measuring the distance of 
migration of the 
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Figure 3.19 Banding patterns produced by sera #1(MJ) to #12(JG), 
plus the control serum, JL, on PARIT nuclear protein extracts, when 
used as the first antibodies. The second antibody was peroxidase 
conjugated rabbit anti -human IgG y, visualised with chloronaphthol 
plus hydrogen peroxide. 
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Figure 3.20 Calibration curve for the Western blot shown in Figure 
3 19 
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Figure 3.21 Banding patterns produced by sera #13(H) to #24(NF), 
plus the control serum, JL, on PARIT nuclear protein extracts, when 
used as the first antibodies. The second antibody was peroxidase 
conjugated rabbit anti -human IgG y, visualised with chloronaphthol 
plus hydrogen peroxide. 
A indicates the total nuclear extract stained with amido black. 
Molecular weight is indicated in kDa. 
kDa 




Figure 3.22 Calibration curve for the Western blot shown in Figure 
3 21 
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bands of interest, their Rf values can also be calculated and hence 
their molecular weights read off the graph. 
The common bands observed on many of the blot strips are shown 
in Table 3.1 with their molecular weights. 
SnRNP has been shown to have antigenic proteins of sizes 33kDa 
(A) and 22kDa (C). U1 RNP is associated with A and C but to be 
antigenic it has to be associated with a nuclear matrix protein of 
70kDa. However RNP is not a specific disease marker as 
autoantibodies to it are found in the sera of patients with SLE, 
discoid lupus, scleroderma, RA and Sjogrens syndrome at low 
frequencies and at a high frequency in the sera from MCTD patients 
(Mattioli and Reichlin, 1973). A band of 70kDa appears on the 
immunoblot of serum #14(R) which, upon consultation with Professor 
Nuki, I discovered was indeed taken from a patient with MCTD. 
Sm is considered to be a specific disease marker for SLE (Tan 
and Kunkel, 1966) and consists of four antigenic polypeptides as 
discussed in Chapter 1. Antigen D has a molecular weight of 16kDa 
and may correspond to the 18kDa common band observed. However D 
cross - reacts with polypeptides B and B' (28kDa and 29kDa 
respectively) so if it is a true Sm polypeptide it would have to be 
present with the common band at approximately 30kDa also (which may 
represent B and B'). This does in fact occur in sera #2, #7, #9 and 
#23, but on consultation with Professor Nuki I discovered that only 
#23(BB) was in fact a SLE patient. This indicates that blind 
immunoblotting may not be particularly useful alone for diagnostic 
purposes. (However if the indirect immunofluorescence information 
and the presence of the more specific histone bands is taken 
into 
account then the correct diagnosis would be made.) 
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Table 3.1 To show the presence of common bands on the Western blots 
stained with each of the 24 sample sera, #1(MJ) to #24(NF) plus JL. 
+ indicates the presence of the band. 
Molecular weights 
1Test SeFum1110 1 89 186 1 66 
in kDa 
1 47 143 I 36 130 1 18 I 
1 
# 1 (MJ) 
I I I 1 + 1 I 
I I 1 
#2 (MN) + I 1 + 1 1 + 1 + 1 + 1 + 1 + 
#3 (JM) 
1 + 1 + 1 I I I I I 
#4 (JM) 1+ 1 + I I I I I I 
#5 (JP) + 1 + 1 + 1 + 1 + 1 + 1 + I + 
#6(AG) I 
I I I 
#7 (ML) I + I + + + 1 + 1 + + 
#8 (LH) + + + + + + 
#9(MM) + + I + + 
#10(KM) + + I 
#11(JaL) 
1 
#12 (JG) + + + 
1 
+ 
#13(H) + 1 
#14(R) + + + + 
#15(FF) + 
1 
#16(LS) + 1 + 
#17 (SS) + + I + 
#18 (CL) + + + + 
1 
#19(M) + + + I + 
#20(E) + + I + 
#21(EP) + + + I 
#22 (SC) I 
#23(BB) + + 1 + + 
#24 (NF) + + 1 + 
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Ro(SS -A) is in fact two antigens with the molecular weights of 
52kDa and 60kDa but these have been shown to be associated with 
cytoplasmic RNAs (Wolin and Steitz, 1984). As the blots only have 
nuclear material present the Ro antigens are not likely to be 
present. La(SS -B) has a molecular weight of 48kDa and there is a 
band present of 47kDa. However La is never observed without Ro 
accompanying it, therefore neither will be present on these 
immunoblots. Cytoplasmic material would be required if 
immunoblotting were to be used as a diagnostic method for Ro and La 
associated diseases. 
Ku antigen consists of a pair of antigens 60 -66kDa and 80- 
86kDa which are DNA binding. These weights correspond to the common 
bands of 66kDa and 86kDa which are observed to be present together 
in sera #5, #8, #9, #10, #12 and #14. This antigen is associated 
with 55% of scleroderma /polymyositis cases and 33% of SLE/ 
scleroderma /polymyositis cases. However these are overlap 
conditions so a specific diagnosis would not be possible. 
Scleroderma is a disease of which small percentages of 
patients' sera have been shown to bind to extremely wide ranges of 
antigens with molecular weights from 12.5kDa up to 210kDa (as 
discussed in Chapter 1). This range includes all the common bands 
observed; a phosphoprotein recognised by 4% of scleroderma patients 
of 18kDa is one of these which may be the common band at 18kDa. 
(However this band may also be the D antigen of Sm). Again this is 
a demonstration of the complexity of autoimmunity and the difficulty 
of diagnosis. 8% of patients recognise fibrillarin which has a 
molecular weight of 34kDa (Parker and Steitz, 1987). This 
corresponds to the 36kDa common band. Scleroderma does however have 
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a specific marker, Scl -70, originally claimed to have a weight of 
70kDa (Douvas et al., 1979) but subsequently discovered to be DNA 
topoisomerase I with a molecular weight nearer 100kDa (Shero et al., 
1986; Guldner et al., 1986). It can be easily degraded accounting 
for the documented weight range. However there does not appear to 
be a common band within this range of weights. 
PCNA has been shown to have a molecular weight of 35 -36kDa 
which corresponds with the 36kDa common band as does fibrillarin. 
PCNA is associated with 3% of SLE patients but is also found in other 
conditions and thus is not useful as a disease marker. 
The common bands are not the only bands observed on the 
immunoblots. More specific bands occurring in only one or two of 
the sera may be more useful for the diagnosis of particular 
diseases. 
Serum #7(ML) has autoantibodies which recognise a band of 
19kDa, which is one of the kinetochore antigens (CENP -A) (Earnshaw 
et al., 1986). These antibodies indicate that the serum is from a 
patient with CREST, a subset of scleroderma. (This band is much 
more clearly visible in Figure 3.23.) Serum #8(LH) also shows this 
19kDa band and therefore may also be a CREST patient, although the 
immunofluorescent staining pattern did not give any indication that 
this might be the case. The band may be that of a co- migrating 
protein which is not specific for any particular disease. Sera 
#21(EP) and #22(SC) are from CREST patients provided as a positive 
controls. However only #21(EP) recognises the 19kDa band. 
None of 
these sera appear to have antibodies to any of the other classes 
of 
kinetochore antigens (CENP -B and CENP -C). 
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Serum #23(BB) shows a very strong reactivity towards histones, 
particularly class Hl. This is characteristic of SLE patients. 
Sera #23(BB) and #24(NF) are from SLE patients which were provided 
as positive controls also. However only #23(BB) shows anti -histone 
activity. 
Two sera show bands which are specific to that serum only. 
Serum #13(H), from a scleroderma patient has a band at 95kDa and 
serum #14(R), from a MCTD patient has a band at 38kDa (in addition 
to the band at approximately 70kDa), both of which do not appear to 
correspond to any of the antigens previously discussed. (As 
mentioned earlier, the 70kDa band most probably corresponds to the 
U1 -RNP antigen. The discovery of this antigen caused the 
identification of MCTD as a disease in its own right and although it 
is not a specific disease marker, its presence is easily accounted 
for with the knowledge of the identity of the disease from which the 
patient is suffering.) 
In order to confirm that the bands observed on the immunoblots of 
these 24 sera are due to the autoantibodies in the sera and not to 
the second antibody binding to the human nuclear proteins, the 
concentration of the second antibody was increased from 1/300 to 
1 /150 and 1/75. If the bands were an effect of the second antibody, 
more bands and /or the same bands at a higher intensity would be 
observed. Figure 3.23 shows the results of that experiment. The 
three immunoblots of JL and #14(R) show the same bands at the same 
intensity with all three concentrations of second antibody. Serum 
#7(ML) shows the same bands at the same intensity with the higher 
two concentrations, but the immunoblot with the 1/300 dilution of 
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Figure 3.23 Western blotted PARIT nuclear extracts stained with 
#7(ML), #14(R) and the control serum, JL, as first antibodies. The 
second antibody was peroxidase conjugated rabbit anti -human IgG y, 
visualised with chloronaphthol and hydrogen peroxide, at differing 
concentrations in HS /TBS /Tw. The concentration is indicated below 
each individual strip. 
A indicates the total nuclear extract stained with amido black. 
Molecular weight is indicated in kDa. 
°Ó 0Ó Ç ° Ó C C ír Lc N- Cr) r Cr) r T 
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second antibody applied shows no bands at all. This strip of 
nitrocellulose may have been allowed to dry out, or the first or 
second antibody may not have been added to the HS /TBS /Tw in error. 
This would give the observed result. The other two panels prove 
that the bands are not an effect of the second antibody or its 
concentration. 
The two sera #13(H) and #14(R) which display reactivity 
towards the two previously unidentified polypeptides were chosen for 
further study. In order to determine whether the autoantibodies 
binding to these bands were disease specific, 24 further sera were 
supplied. 12 of these came from scleroderma patients and the other 
12 were from MCTD patients. These sera were immunoblotted on 
nuclear proteins also. 
3.2.3 Further Immunoblotting and Immunofluorescence With The Second 
Batch of Sera From Scleroderma and MCTD Patients 
First, the sera were immunoblotted in order to determine 
whether these sera also contained antibodies recognising the same 
antigens. 
Figure 3.24 shows the immunoblots of the scleroderma sera I to 
12 and Figure 3.25 shows the MCTD sera 13 to 24. 
Serum 11 shows an extremely strong band at 95kDa with several 
minor bands beneath it. These are likely to be breakdown products 
of the first band. This is the only serum in the second batch which 
recognises the 95kDa band but it proves that this band may be 
related to the disease. Sera taken from patients with auto 
disease do not all contain the same autoantibodies as discussed in 
Chapter 1. 
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Figure 3.24 Western blots of PARIT nuclear protein extracts stained 
with sera from additional scleroderma patients 2 to 12, plus the 
control serum JL, as first antibodies. The second antibody was 
peroxidase conjugated rabbit anti -human IgG y visualised with 
chloronaphthol plus hydrogen peroxide. 
O NJ 








Figure 3.25 Western blots of PARIT nuclear protein extracts stained 
with sera from additional MCTD patients 13 to 24, plus the control 
serum JL, as first antibodies. The second antibody was peroxidase 
conjugated rabbit anti -human IgG y visualised with chloronaphthol 
plus hydrogen peroxide. 
A indicates the total nuclear extract stained with amido black. 
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The immunoblots of the second batch of MCTD sera show two sera 
with activity to the same band, serum 14, at approximately the same 
level as #14(R) and serum 17, which shows a much stronger reaction. 
Many of the common bands are present on these blots as with the 
first 24 sera, some being stained particularly strongly. However, 
as with the scleroderma immunoblots, the presence of autoantibodies 
in the second batch of sera which show activity to the 38kDa band 
suggests that this band is linked to the disease. Serum 11 with 
activity towards the 95kDa protein will now be referred to as 13A 
and the sera 14 and 17 with 38kDa peptide activity will be referred 
to as 14B and 14A respectively. 
The sera #13(H) and #14(R) were used for indirect 
immunofluorescence as part of the routine screening procedure of the 
sera. The sera 13A and 14A may give an indication of the actual 
locality of the antigen within the cell if they are used for the 
same experiment. 
Figures 3.26, 3.27 and 3.28 show the results of 13A on PARIT 
cytospins, Don K2 monolayers and metaphase spreads, whilst Figures 
3.29, 3.30 and 3.31 show the results for 14A. 
PARIT cytospin preparations stained with 13A show coarse 
granular staining with brighter,dense patches of fluorescence 
indicating the nucleoli within the nucleus. The Don K2 cells show 
the same pattern in those cells prepared in KCM, but the PBS 
preparation shows denser, uniform staining throughout the nucleus. 
The metaphase spread again shows the localisation of staining to the 
chromosomes as with #13(H). 
Whole cells stained with 14A show bright granular fluorescence 
throughout the nucleus. PARIT cells prepared in KCM again show 
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Figure 3.26 Whole PARIT cells stained with serum 13A, as the first 
antibody and fluorescein conjugated rabbit anti -human IgG y as the 
second antibody. 
(a) and (b) show cells prepared in KCM stained with 13A and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with 13A and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.27 Whole Don K2 cells stained with serum 13A, as the first 
antibody and fluorescein conjugated rabbit anti -human IgG 7 as the 
second antibody. 
(a) and (b) show cells prepared in KCM stained with 13A and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with 13A and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.28 Metaphase spreads of PARIT cells stained with serum 
13A, as the first antibody and fluorescein conjugated rabbit anti- 
human IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with 13A and 
counterstained with DAPI to localise the chromosomes. 
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Figure 3.29 Whole PARIT cells stained with serum 14A, as the first 
antibody and fluorescein conjugated rabbit anti -human IgG 7 as the 
second antibody. 
(a) and (b) show cells prepared in KCM stained with 14A and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with 14A and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.30 Whole Don K2 cells stained with serum 14A, as the first 
antibody and fluorescein conjugated rabbit anti -human IgG 7 as the 
second antibody. 
(a) and (b) show cells prepared in KCM stained with 14A and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with 14A and 
counterstained with DAPI to localise the nucleus. 
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Figure 3.31 Metaphase spreads of PARIT cells stained with serum 
14A, as the first antibody and fluorescein conjugated rabbit anti- 
human IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with 14A and 
counterstained with DAPI to localise the chromosomes. 
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localisation of staining to the nuclear membrane, as with #14(R). 
Metaphase spreads show staining of the whole chromosome to a 
moderate level of intensity without the recognition of the periphery 
as before. 
Essentially the staining patterns of #13(H) and 13A, and 
#14(R) and 14A are the same, with minor variations. As 13A and 14A 
only show single peptide reactivity it is quite possible that the 
variation seen is due to the absence of the antibodies which bound 
to the other bands on the immunoblots, particularly in the case of 
#14 (R) . 
The sera 13A and 14A have strongly reacting, high affinity 
antibodies for the bands of 95kDa and 38kDa respectively and 
therefore could be affinity purified quite easily. In this way the 
affinity of the antibodies can be checked and the purified 
antibodies used for further cell staining procedures. 
3.2.4 Affinity Purified Antibodies From Sera 13A and 14A 
The purification was carried out according to the protocol of 
Olmsted as explained in Chapter 2. Figures 3.32 and 3.33 show the 
visualisation of the 95kDa and 38kDa bands in X, Y and Z. The 
eluted antibody is then reapplied neat (in its elution buffer) to a 
Western blot in order to check the specificity ((a) and (b)). The 
strips (c) and (d) have had only second antibody applied. This 
shows that the bands other than the 95kDa or 38kDa ones are due to 
second antibody and not to any cross -reactivity of the purified 
antibody with other nuclear proteins. 
118 
Figure 3.32 To show 13A before and after affinity purification. 
A indicates the total nuclear extract stained with amido black. 
X, Y and Z show the strips, from either side and the middle of a 
Western blot, stained with 13A (as the first antibody) in order to 
visualise the position of the protein band bound. 
a and b show affinity purified 13A used as the first antibody on 
Western blots of PARIT nuclear extracts. 
c and d show strips from the same Western blot stained with the 
second antibody only.(The second antibody was peroxidase conjugated 
rabbit anti -human IgG y.) 
Molecular weight is indicated in kDa. 












Figure 3.33 To show 14A before and after affinity purification. 
A indicates the total nuclear extract stained with amido black. 
X, Y and Z show the strips, from either side and the middle of a 
Western blot, stained with 14A (as the first antibody) in order to 
visualise the position of the protein band bound. 
a and b show affinity purified 14A used as the first antibody on 
Western blots of PARIT nuclear extracts. 
c and d show strips from the same Western blot stained with the 
second antibody only.(The second antibody was peroxidase conjugated 
rabbit anti -human IgG Y.) 
Molecular weight is indicated in kDa. 
kDa X Y Z kDaAab c 
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Figure 3.34 Whole PARIT cells stained with affinity purified 13A, 
as the first antibody and fluorescein conjugated rabbit anti -human 
IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with affinity 
purified 13A and counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with affinity 
purified 13A and counterstained with DAPI to localise the nucleus. 
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Figure 3.35 Whole Don K2 cells stained with affinity purified 13A, 
as the first antibody and fluorescein conjugated rabbit anti -human 
IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with affinity 
purified 13A and counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with affinity 
purified 13A and counterstained with DAPI to localise the nucleus. 
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Figure 3.36 Metaphase spreads of PARIT cells stained with affinity 
purified 13A, as the first antibody and fluorescein conjugated 
rabbit anti -human IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with affinity 
purified 13A and counterstained with DAPI to localise the 
chromosomes. 
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The eluted antibody supplemented with 10% rabbit serum was 
also applied undiluted to cells and spreads to localise the antigen. 
Any staining pattern observed will be due to the purified antibody. 
Figures 3.34, 3.35 and 3.36 show the staining patterns 
observed when using affinity purified 13A and Figures 3.37, 3.38 and 
3.39 show those when 14A was used as the first antibody. 
Affinity purified 13A shows nuclear staining in whole cells 
and chromosomal staining on metaphase spreads. Whole PARIT cells 
show some degree of cytoplasmic staining also whilst the Don K2 
cells have a patchy appearance which may indicate some nucleolar 
recognition. 
Affinity purified 14A shows granular staining of whole PARIT 
cells, with the nuclear membrane also stained. Whole Don K2 cells 
show uniform nuclear staining, and metaphase spreads show a moderate 
level of staining localised to the chromosomes. 
These staining patterns are less well defined than those 
observed with the unpurified sera. This may be due to the 
purification procedure itself and /or the storage of the eluted 
antibodies in neutralised HC1, despite having been dialysed and the 
antibodies stabilised by the addition of 1% bovine serum albumin 
(BSA). In this instance the use of affinity purified antibodies 
does not appear to have added to the information deduced from using 
whole sera. 
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Figure 3.37 Whole PARIT cells stained with affinity purified 14A, 
as the first antibody and fluorescein conjugated rabbit anti -human 
IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with affinity 
purified 14A and counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with affinity 
purified 14A and counterstained with DAPI to localise the nucleus. 
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Figure 3.38 Whole Don K2 cells stained with affinity purified 14A, 
as the first antibody and fluorescein conjugated rabbit anti -human 
IgG y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with affinity 
purified 14A and counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with affinity 
purified 14A and counterstained with DAPI to localise the nucleus. 
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Figure 3.39 Metaphase spreads of PARIT cells stained with affinity 
purified 14A, as the first antibody and fluorescein conjugated 
rabbit anti -human IgG Y as the second antibody. 
(a) and (b) show cells prepared in KCM stained with affinity 





Both the immunocytochemistry and immunoblotting techniques 
employed for the purpose of initial characterisation of the 
antigenic specificities of the serum samples provided are extremely 
sensitive. 
The preparation of samples for immunocytochemical analysis 
employed two different buffers, PBS and KCM. KCM contains detergent 
and this causes some of the soluble antigens within the nucleus to 
leach out, whereas PBS does not and therefore provides a more 
natural representation of the cells. (The nucleoli are resistant to 
this phenomenon.) This accounts for the differing staining patterns 
which are sometimes observed. 
In addition to the differing preparation procedures used, 
different cell types were also employed. The use of whole cells 
from a human cell line and a hamster one demonstrates the cross 
species specificity of many of the autoantibodies in the serum 
samples screened. Although many of the sera discussed do not show 
identical staining patterns in both cell types, similarities are 
easily observed. This justifies the use of mouse models of 
autoimmunity as one avenue for the study of this type of disease in 
humans. 
The use of metaphase spreads, as well as whole cell 
preparations ensures that any striking chromosomal associations of 
the autoantibodies present within the sera are clearly demonstrated. 
JL, the normal control serum, shows quite a high 
level of 
activity on some preparations, which may not necessarily 
have been 
expected. However as discussed in Chapter 1, autoantibodies 
are 
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present in apparently healthy individuals in increasing titres with 
the advancing age of the individual (Tomer and Shoenfeld, 1988). 
Serum JL was taken from a middle aged female and the staining 
patterns show very clearly that autoimmune activity can and does 
occur in normal individuals with no adverse consequences. The 
application of serum antibodies using immunocytochemistry revealed 
the identity of two SLE patients and one CREST patient, due to the 
distinctive staining patterns observed. In the case of the CREST 
patient, the individual concerned was recalled to the clinic and was 
rediagnosed after further clinical tests. These results were 
confirmed in two cases by Western blotting information which 
demonstrated the antigenic specificities of #7(ML) and #23(BB) to be 
CENP -A and histone (in particular Hl). Serum #24(NF) showed no 
peptide recognition on Western blotting, so it is highly likely that 
the antigen recognised on immunocytochemistry was DNA, also a 
characteristic antigen of SLE. In addition to demonstrating, in a 
blind study, that these techniques can be gainfully employed to aid 
diagnosis, they provide positive controls to prove that the 
technique is giving reliable results, due to the antigenic 
specificities of the serum antibodies used in the staining 
procedures. 
The 95kDa peptide initially identified by #13(H) has been 
shown to be scleroderma related by the Western blotting of more 
serum samples from different patients with the same disease. The 
discovery of a serum with an increased level of activity as shown by 
13A has allowed the staining pattern to be clarified a little 
further; it is nuclear, with a higher specificity for nucleoli in 
whole cells, and is associated chromosomally upon condensation at 
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metaphase. The affinity purification of the antibody(ies) which 
recognises that particular polypeptide has allowed me to prove that 
the serum is specific for that polypeptide, but unfortunately has 
not provided any further information as to the identity of the 
antigen(s) by immunocytochemistry. The affinity of this serum 
antibody for its antigen will prove invaluable when screening an 
expression library in order to determine the antigen. 
The 38kDa antigen, initially identified by serum #14(R) has 
also been shown to be disease related, in this case to MCTD, by the 
identification of two other sera from MCTD patients which show the 
same polypeptide reactivity. Western blotting also enabled me to 
identify serum #14(R) as that from a patient with MCTD due to the 
presence of antibodies to the marker antigen U1 -RNP. As found 
previously, one of the additional sera screened showed a much 
increased level of activity to the 38kDa peptide on Western blots 
and this was used to stain whole cells and metaphase spreads in 
order to try to clarify the cellular localisation of the antigen. 
It appears to be nuclear, sometimes present at or in the nuclear 
membrane in whole cells, whilst the staining of metaphase spreads 
indicates an association to some degree with condensed chromosomes. 
Affinity purification again proved the single antigenic specificity 
of the serum antibodies, but provided no further information on the 
cellular nature of the antigen. As with 13A, 14A will also be used 
to screen an expression library in order to determine the true 
identity of the antigen. 
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CHAPTER FOUR 
THE CLONING OF DNA TOPOISOMERASE I 
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4 THE CLONING OF DNA TOPOISOMERASE I 
4.1 Introduction 
Sera #13(H) and 13A display reactivity with the 95kDa band on 
immunoblots, appear to stain the nucleoli in whole cells and 
immunofluorescence is localised to chromosomes in metaphase spreads as 
discussed in Chapter 3. These observations provide us with much useful 
information about the antigen, but in order to determine its actual 
identity serum 13A was used to screen a ñ.gtl1 expression library. 13A 
was chosen as it shows much higher reactivity to the antigen than 
#13 (H) . 
The library used in this case was a gift from the ICRF unit of 
Edinburgh University and was commercially prepared by Clontech. It was 
a human testis cDNA library and the cDNAs were cloned into a Xgtll 
vector at the Eco RI site. Figure 4.1 briefly explains the principles 
of screening an expression library. The mRNA source was a normal human 
testis biopsy from a healthy 50 year old. The insert sizes ranged from 
0.7kb to 3.3kb, with an average of 1.2kb. 
4.2 Results 
4.2.1 Isolation of Positive Clones Using Serum 13A 
The library was first titred to ensure that the correct number of 
plaques were plated for the primary round of screening. Five plates 
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Figure 4.1 Schematic representation of the construction and screening 
of a Xgtll expression library. 
A cDNA copy of mRNA isolated from the testis biopsy is 
synthesised enzymatically. The first strand is produced from an oligo- 
dT primer annealed to the poly -A tail of the 3' end of the mRNA. The 
RNA template is removed and the second strand is synthesised using the 
hairpin structures formed at the end of the first strand, as primers. 
The hairpin is removed with S1 nuclease and the double stranded cDNA 
has linker sequences added, which contain restriction enzyme sites. 
The linkers are cut using the restriction enzyme and the cDNA ligated 
into the lac Z gene of the bacteriophage vector ñgtll. 
The library is amplified in E. coli Y1088 cells. 
The library is plated out by infection of E. coli Y1090 cells and 
grown up until plaques are formed. The plate is overlaid with a 
nitrocellulose filter soaked in IPTG, which stimulates the 
bacteriophage vector to produce the ß- galactosidase gene (encoded by 
lac Z) fused to a peptide encoded by the inserted piece of synthesised 
cDNA, by reading through the restriction site, in this case Eco RI. 
The filter is removed and the first antibody is applied. This 
will bind to a fusion protein containing the correct epitope. The 
position of any bound first antibody is localised with a peroxidase 
conjugated second antibody, which gives a colour reaction with 
chloronaphthol and hydrogen peroxide. The position of plaques 
containing bacteriophage expressing a fusion protein with the first 
antibody epitope is marked on the filter by a small, dark blue circle 
or doughnut -like stain. 







RI + RI 






Amplify library: E.coli: Y1088 (hsdR supF lacl+ ) 
1 
Plate library: E. coli: Y1090 (long supF lacl+ ) 
1. Transfer antigen to IPTG- soaked nitrocellulose 
2. Probe nitrocellulose filter with antibody 
3. Probe antibody with peroxidase -conjugated 2nd antibody 
Chloronaphthol stained filter 
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each containing 2 x 105 pfu were screened and five positive plaques 
were identified by serum 13A. These were picked into SM as described 
in Chapter 2 and were then plated for the second round of selection. 
Three of the five positives gave significant amplifications of signal 
when stained but the other two did not. These two populations of 
'phage were abandoned at this stage as false positives. The remaining 
three were picked and rescreened twice more before a single plaque from 
each of the three plates was picked into SM. These three clones were 
called A2.1, D1.1 and D2.1. 
The insert cDNA of bacteriophage X DNA was isolated by LGT 
agarose electrophoresis after digestion of the vector with the 
restriction enzyme Eco RI. These inserts were then cloned into the Eco 
RI site of Bluescribe, a pUC based vector. 
The sizes of the inserts were estimated by gel electrophoresis; 
A2.1 was estimated to be approximately 1.7kb and D1.1 and D2.1 were 
both estimated to be about 2.0kb in length. 
The isolated cDNAs cloned into the plasmid vectors should all 
contain information coding for the antigenic site(s) recognised by 
serum 13A. Since the 95kDa band was by far, the major reacting species 
on the Western blots, it was likely that at least one of the clones 
coded for this polypeptide. To test whether the three clones shared 
the same DNA sequences, or contained dissimilar ones (indicating 
that 
they represented different antigenic determinants, either from 
the same 
or different proteins), cross hybridisation was carried 
out. There may 
be more than one antigenic site within the protein 
as autoantibodies 
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found in the serum of autoimmune patients are polyclonal and therefore 
recognise different epitopes of the same protein. The results of the 
cross hybridisation are shown in Figure 4.2. 
X. DNA of each clone was digested with Eco RI and the samples run 
on an agarose gel. The DNA was then Southern blotted onto Hybond -N as 
described in Chapter 2 and probed with the isolated inserts cut from 
the plasmid vectors. This ensures that any signal is due to the 
binding of the inserts, not the vectors. Panel A shows XA2.1, D1.1 and 
D2.1 probed with the insert from pDl.l. A positive signal is observed 
with A2.1, but at about 23kb. This is due to the incomplete digestion 
of XA2.1, so the insert has not been released from the vector. It 
therefore does not run at its estimated position (approximately 1.7kb) 
within the gel. Positive signals are observed also for D1.1 and D2.1; 
D1.1 is acting as a positive control for the reaction and a signal is 
expected, but the presence of signal at the position of D2.1 insert 
shows that the DNA of the probe and the sample is the same. Panel B 
shows the three digests probed with insert cut from pD2.1 and gives the 
same results. This time the positive control is pD2.1 onto XD2.1 and 
the digestion of XA2.1 was again incomplete. The labelled filters were 
washed at O.lx SSC, 0.1% SDS, a stringency at which only very similar 
sequences of DNA remain bound to each other. Therefore it can be 
concluded that the three inserts A2.1, D1.1 and D2.1 all contain the 
same sequence of DNA, albeit of different lengths. 
To discover whether these sequences were part of a known protein 
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Figure 4.2 Autoradiograph of the isolated X clones hybridised with the 
inserts subcloned into plasmids. 
Panel A shows Eco RI restriction digested XA2.1, D1.1 and D2.1 
probed with the insert from pDl.l. 
Panel B shows the same three digests probed with the insert from 
pD2.1. 




1.91 - al 
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or motifs of a group of proteins with a particular function, they were 
sequenced. 
4.2.2 The Sequencing of Clones A2.1, D1.1 and D2.1 
The sequencing method used was as described in Chapter 2. The 
first clone to be sequenced was D1.1 as it was one of the two longest 
isolated. The Sequenase forward primer was used and the sequence read 
from the gel was used to search the Genbank /EMBL database at Daresbury. 
A perfect match was found as shown in Figure 4.3. The sequence of D1.1 
is shown on the top numbered 1 to 242 and it matched nucleotides 1556 
to 1797 of the human DNA topoisomerase I gene. The other two clones 
were sequenced in the same way using the forward primer and then all 
three were sequenced with a reverse primer (prepared by D. Chambers in 
the Unit) to disclose the sequence of the other end of the clones. All 
these sequences also matched up with the DNA topoisomerase I gene, and 
the positions of each clone are shown in Figure 4.4. As predicted by 
the cross -hybridisation experiment the clones do indeed contain 
basically the same sequence of DNA towards the 3' end of the gene. 
4.3 Discussion 
The discovery that the antigen recognised by #13(H) and 13A was 
DNA topoisomerase was not, in retrospect, surprising. These two sera 
were samples taken from two scleroderma patients and DNA 
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Figure 4.3 Sequence read from the forward primed pD1.1 matched to 




























































































































































































































































































































































































































































































































































Figure 4.4 To show the positions of clones A2.1, D1.1 and D2.1 within 
the human DNA topoisomerase gene. 
A2.1 spans nucleotides 1416 to 3156, D1.1, nucleotides 1556 to 
3645 and D2.1, nucleotides 1523 to 3617. 
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topoisomerase I is a marker antigen for this disease, as discussed in 
Chapter 1. It was originally called Scl -70 as the molecular weight of 
it was estimated at 70kDa (Douvas et al., 1979). It was subsequently 
revised to approximately 100kDa (Shero et al., 1986; Guldner et al., 
1986). The molecular weight estimate of 95kDa for the positive band in 
the initial Western blot screening was sufficiently close to the 
molecular weight of DNA topoisomerase I for the likelihood that the 
antigen was indeed DNA topoisomerase I to be recognised. The 
immunofluorescent staining pattern was also consistent. The 
immunoblotting data shown in Figure 3.24 is especially suggestive. 
The protein identified by 13A (labelled #17 in this figure) was shown 
with breakdown products present. It is well documented that the 100kDa 
protein can be spontaneously degraded if protease inhibitors were not 
present during the extraction procedure. PMSF was included in the 
buffers in the procedure I used (as described in Chapter 2), but had 
obviously not been effective in that particular preparation. The 
initial immunoblot using #13(H) did not show the antibody binding to 
any breakdown products. Although the 95kDa polypeptide did not turn 
out to be a novel antigen, the results obtained prove the validity of 
the cloning approach for the identification of autoimmune antigens. 
The nucleolar and diffuse granular staining in whole cells 
(Douvas et al., 1979) and the apparent localisation of staining with 
metaphase chromosomes shown in Chapter 3 correlates well with the 
documented intracellular distribution of DNA topoisomerase I (Muller 
et al., 1985). This demonstrates the use of indirect 
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immunofluorescence as a tool for the intracellular localisation of 
autoimmune antigens, but as discussed in Chapter 3.3 it is not of great 
assistance alone in a blind study. 
The actual sizes of the inserts can be calculated as we now know 
where within the DNA topoisomerase I gene they start and finish. A2.1 
was estimated to be approximately 1.7kb and is actually 1,695óp. D1.1 
was estimated at 2.0kb and is actually 2,089óp and D2.1 also estimated 
at 2.0kb is actually 2,094óp. The estimations of size of the three 
clones were in fact quite close. 
All three clones were located towards the 3' end of the gene. 
When the library was prepared the first cDNA strand was transcribed 
from the mRNA from an oligo -dT primer bound to the poly -A tail of the 
mature RNA using reverse transcriptase which produces complementary DNA 
from 5' to 3'. This means that the beginning of the first cDNA strand 
is in fact the end of the mRNA. The reverse transcriptase rarely 
produces a full length sequence and the complementary RNA is removed by 
digestion. The second DNA strand is produced by a DNA polymerase 
resulting in a double stranded copy of the 3' end of the mRNA. The 
length of the cDNA and how far it extends into the coding region from 
the 3' end depends on how much of the mRNA was transcribed by the 
reverse transcriptase. The 3' end points of the three clones are also 
different. This is due to the 5' to 3' exonuclease activity of the DNA 
polymerase I used to produce the second strand. This exonuclease 
removes non -base -paired nucleotides from the 5' end of double stranded 
molecules of DNA. If the polymerase did not end at the very terminus 
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of the molecule, the unmatched bases would be removed, as in clones 
A2.1 and D2.1. 
Approximately 1 x 106 pfus were screened (five plates each 
containing 2 x 105 pfu) and three positive clones were isolated from 
these. The library used was in fact an amplified library so all 
sequences transcribed into DNA from the mRNA by reverse transcriptase 
should be multiplied, but some ? clones will amplify better than 
others, due to their size, constituent nucleotides etc.. 
Other studies have shown that DNA 
topoisomerase I is a single copy gene located on chromosome 20 q12 -13.2 
and gives rise to an mRNA of 4,000 nucleotides (Juan et al., 1988). 
D'Arpa et al. (1988) found that the length of the mRNA was 4,100 
nucleotides, but their published sequence is 3,645 nucleotides in 
length. There is a discrepancy of approximately 500 nucleotides 
between the two. Although the length of the mRNA is only estimated the 
difference is too great to be explained by experimental error. However 
on closer examination of the published sequence it is observed that the 
3' end terminates in a natural Eco RI site instead of the cDNA 
equivalent of the poly -A tail of a mature mRNA. This "tail" may be 150 
to 200 bp in length which accounts for some of the missing nucleotides 
but it is quite possible that there is a portion of sequence in the 
order of 200 nucleotides missing from the 3' end of the sequence. One 
of my clones, D1.1, also ends at that natural Eco RI site. 
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When a library is constructed the transcribed lengths of cDNA 
have linkers ligated to their ends which have the restiction site 
required for insertion into the vector within them. The cDNAs are then 
digested with the enzyme in question (Eco RI in this case) and ligated 
into the vector. However the cDNA itself may contain that particular 
restriction site. It is, therefore, first modified with Eco RI 
methylase to prevent cleavage. As the sequence of DNA topoisomerase I 
ends at a natural Eco RI site an explanation for this may be that the 
methylase modification step was either not included or was 
inefficiently carried out in the libraries used. An alternative 
solution is that the library was successfully methylated and my clone, 
D1.1, terminating with the restriction site, originally contained the 
missing sequence. However when it was digested to liberate the insert 
for sub -cloning, two fragments were produced; one of approximately 
2.0kb and another of 200bp or so. This tiny frayment would be lost on 
a 1% agarose gel. In order to sequence the end of this gene, the 
digest of the original clone would have to be run under conditions in 
which the small fragment could be visualised and cloned individually. 
It too could then be sequenced. The deduction of the remaining few 
hundred base pairs of the sequence of DNA topoisomerase I has not yet 
been done. 
Two sera out of a batch of thirteen from scleroderma patients 
possessed autoantibodies to this protein, yet DNA topoisomerase I is 
the diagnostic marker for this disease. Although the number of sera 
studied in this instance was too small to be of real statistical value, 
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it can be used to estimate the proportion of patients in this batch who 
have autoantibodies to the antigen present in their sera. 2/13 sera 
with the autoantibodies gives us a figure of approximately 16%. 
Guldner et al. (1986) have reported that out of approximately 80 
scleroderma sera studied, 20% of them possessed these autoantibodies, 
so considering the number of sera studied in this project, my 
calculated proportion is quite a reasonable estimate. Shero et al. 
(1986) concluded that sera containing autoantibodies to DNA 
topoisomerase I (or Scl -70, as they called it) seemed to be taken from 
patients with the more severe, diffuse states of the disease. The 
number of sera containing autoantibodies against DNA topoisomerase I 
will vary according to the number of patients with the more severe 
condition with serum samples in the batch provided for analysis. This 
explains why 11 of the sera I analysed did not contain autoantibodies 
to DNA topoisomerase I. Perhaps the term "diagnostic antigen" should 
be qualified in this case to refer only to the severe states of the 
disease. 
These results demonstrate that the presence of a diagnostic 
antigen can aid the diagnosis of an autoimmune condition as previously 
shown by the immunoblotting of serum #7(ML). (This patient was 
diagnosed with scleroderma, but the discovery of autoantibodies to 
CENP -A resulted in revision of the original diagnosis to CREST.) 
However, the lack of a particular autoantibody does not necessarily 
mean that the patient does not have the disease for which its 
reactivity is a marker. These diseases are progressive in their 
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development, so all the autoantibodies which characterise the disease 
are not necessarily present at initial diagnosis. 
It is not known why autoantibodies are produced to nuclear 
antigens in any of the known autoimmune diseases, and so the production 
of antibodies to DNA topoisomerase I in 20% of scleroderma patients 
alone is just as much of a mystery. If cellular components become 
exposed to the immune system by some mechanism of the disease 
autoantibodies will be produced. Autoimmunity can be thought to be the 
breakdown of tolerance, or the presentation of previously sequestered 
antigens, possibly due to the inefficient degradation of cellular 
debris. 
DNA topoisomerase I is a highly active and abundant enzyme which 
is involved in relaxing positive and negative supercoils by nicking and 
reclosing single strands of DNA (Fink, 1989). However it is not 
crucial for the survival of the cell as discovered by mutation 
experiments in Saccharomyces cerevisiae (Brill and Sternglanz, I9fl@). 
Supercoils can be relaxed by DNA topoisomerase II (an enzyme which cuts 
and rejoins double strands of DNA) but the process takes much longer. 
Wallis et al. have isolated a third structural gene in yeast which 
codes for another type I topoisomerase (Wallis et al., 1989) which may 
also assist with the relaxation of supercoiled DNA in the absence of 
DNA topoisomerase I. 
Therefore this abundant enzyme may stimulate the production of 
autoantibodies against it. However it is far from the only abundant 
protein within the nucleus, and it is not exclusively selected for 
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presentation to the immune system, so this does not explain why this 
protein in particular is the antigenic target of autoantibodies in a 
proportion of sera from patients with scleroderma. The phenomenon of 
auto -reactions whether they are disease specific or not, are not well 
understood. As discussed in Chapter 1 it is not known whether they are 
a cause or an effect of the disease. Even though our knowledge of 
autoimmune diseases and their aetiology is improved with every antigen 
discovered, there is still a long way to go before we can begin to 
understand their full complexity and find a cure. 
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5 THE CLONING OF THE PUTATIVE HUMAN ENHANCER OF SPLIT GENE 
5.1 Introduction 
Sera #14(R) and 14A have been shown to recognise a nuclear 
antigen by indirect immunofluorescence, and a protein of 38kDa on 
Western blots of nuclear proteins. Chapter 4, describing the cloning 
of DNA topoisomerase I, has shown how effective the screening of an 
expression library can be for identifying autoantigens, so 14A, which 
reacts more strongly, was selected to screen the normal human testis 
expression library used previously. 
5.2 Results 
5.2.1 The Isolation of a Single Positive Clone Using Serum 14A 
As in Chapter 4, five plates each with 2 x 105 pfu were screened 
with the serum. On two occasions serum 14A did not identify any 
plaques on the primary round of screening. At the third attempt, 
having plated some 3 million bacteriophage, two positive plaques were 
identified. They were picked and rescreened but only one gave the 
expected amplification of signal. This clone was picked and rescreened 
as before; the other was discarded as a false positive. From the 
positive bacteriophage population isolated in the primary round of 
screening, a single positive plaque was picked into SM after four 
rounds of purification. (In retrospect it would have been safer to 
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have picked more than one plaque, in order to check that a pure 
population was present on the final plate, by cross hybridisation of 
the isolated bacteriophage.) Preparations of bacteriophage were made 
and then the insert was cut out of the vector using the restriction 
enzyme Eco RI and isolated by running on an agarose gel. The insert, 
with an estimated size of 1.9kb was subcloned into the Eco RI site of 
the phagemid vector, Bluescribe. I called this positive clone V1.1. 
As with the DNA topoisomerase clones the insert was sequenced in 
an attempt to identify the protein antigen of serum 14A. 
5.2.2 The Sequencing of Clone V1.1 
V1.1 was sequenced using the dideoxy nucleotide method with the 
forward primer from the Sequenase kit as described in Chapter 2. The 
sequence read from the gel was used to search the Genbank /EMBL database 
at Daresbury. No similar sequence was found. The clone was then 
sequenced in the same manner from the reverse oligo- primer (prepared by 
D. Chambers) and this sequence was also run through the database. This 
time a matching sequence was found and the alignment of the two is 
shown in Figure 5.1. The sequence of V1.1 is shown along the top 
numbered 4 to 166 and is matched with nucleotides 2171 to 2333 of the 
Drosophila gene, Enhancer of Split (E(spl)). This gene is involved in 
the development of the central nervous system in the fly. 
The central nervous system in Drosophila is derived from a 
population of cells known as the neurogenic region, after invagination 
of the syncytial blastoderm to produce the mesoderm. Precursor cells 
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Figure 5.1 The sequence of reverse primed pV1.1 matched to nucleotides 
































































































































































































































delaminate from this layer and these cells, known as neuroblasts, go on 
to form the nervous system, whilst the remaining cells develop into the 
epidermis of the fly (Poulson, 1950). The determination of cell fate 
from this single population of cells has been shown to be due to 
cellular interactions (Technau and Campos -Ortega, 1986) and under 
genetic control, by studying mutant phenotypes defined by the 
neurogenic genes (Poulson, 1937; Lehmann et al., 1983). The mutant 
neurogenic phenotype (consisting of hypertrophy of the nervous system 
and absence of epidermis) is the result of a loss of function of any 
one of the six zygotic gene loci; Notch, big brain, mastermind, Delta, 
neuralized, and Enhancer of split. 
Notch (Wharton et al., 1985) and Delta (Vassin et al., 1987) have 
been shown to code for transmembrane proteins supporting the theory 
that cellular interactions between the neurogenic genes takes place at 
the product level. 
The Drosophila melanogaster E(spl) is a multi -gene complex 
consisting of 11 transcripts, ml to mil. m9 was cloned by Hartley et 
al (1988) and it is this E(spl) transcript to which V1.1 shows 
homology. I was given a full length cDNA, NB5, a construct, BXB25, 
which rescues otherwise lethal mutations at the locus, and a mouse 
serum antibody, IC2, raised to a fusion protein of E(spl), by D. Hartley. 
In order to show the relationship between the human gene and the 
Drosophila E(spl) gene, V1.1 was cross hybridised to NB5 and BXB25. 
Figure 5.2 shows the results of these experiments. NB5 was digested 
with Eco RI giving rise to four bands, plus two from partial digestion 
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Figure 5.2 The left hand panels show the autoradiographs of V1.1 
hybridised to NB5 and pVl.l (as a positive control), when both are 
digested with Eco RI. The right hand panels show the ethidium bromide 
stained gels before Southern blotting. 








of the cDNA as shown by the ethidium bromide stained agarose gel. V1.1 
cross hybridises with three of those bands, one a partial digest band 
at -4.3kb, and bands at -2kb and -1.3kb. The band at -1.3kb correlates 
closely with an expected band of 1216 bases from NB5, as there are Eco 
R1 restriction sites at bases 2117 and 3333. The band at -2.3kb is 
Bluescript plasmid and the hybridisation is caused by labelled plasmid 
contaminating the insert probe, V1.1. The partially digested band at 
4.3kb may represent the insert alone and is therefore recognised by 
the probe as it contains the region from bases 2171 to 3021, which is 
extremely homologous to the human probe. 
V1.1 was also shown to hybridise to the construct BXB25. Figure 
5.3 shows V1.1 hybridised to itself as a positive control and also to a 
band of -1.3kb produced by the restriction digestion of BXB25 with Eco 
Rl. (The upper band at -3kb in the pVl.1 lane which also shows 
hybridisation to the insert is due to plasmid contaminating the 
labelled probe.) The hybridisation to this construct shows that the 
V1.1 bears homology to the region of the gene which is required for the 
normal neurogenic development of D. melanogaster. 
Figure 5.4 shows the results of cross hybridising the 1.3kb band 
of NB5 to pVl.1 and total NB5 (as a positive control), digested with 
Eco RI as previously, and then washed with differing concentrations of 
SSC. As the concentration of SSC is reduced the level of hybridisation 
signal with the 1.9kb band of pVl.1 is reduced also, until at O.lx SSC 
the level of hybridisation has almost disappeared. This shows that 
although the two sequences are extremely homologous, they are not 
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Figure 5.3 The left hand panels show the autoradiographs of V1.1 
hybridised to BXB25 and pV1.1 (as a positive control), when both are 
digested with Eco RI. The right hand panels show the ethidium bromide 








Figure 5.4 shows autoradiographs of pVl.1 and NB5 digested with Eco RI 
hybridised with the 1.3kb band of NB5. Each panel has been washed with 
a different concentration of SSC. The concentration of SDS in the wash 
is maintained at 0.1%. Panel ETBR shows the ethidium bromide stained 
gel before Southern blotting. 
t 
N 
-Pn C. GJ 
CO N CO 
I I I 
159 
identical, as washing with O.lx SSC has reduced the amount of DNA 
hybridised. If they were identical the level of signal would not be 
affected by washing more stringently. Hybridisation to the two upper 
bands of NB5 by the 1.3kb fragment is due to contamination of the probe 
with remnants of these pieces of DNA. These experiments showed that 
V1.1 is related to the Drosophila E(spl) gene. 
The human clone pV1.1 was further characterised by completing the 
sequencing of the open reading frame by using double stranded nested 
deletions of the clone (as described in Chapter 2) and 18 -mer oligo- 
primers prepared by D. Chambers. Figure 5.5 shows the position of the 
deletion clones, the primers used and the designated 5' and 3' ends of 
the clone. Figure 5.6 shows the comparison of the open reading frames 
of the Drosophila gene and V1.1. The two sequences have the 
termination codon, TAA, in the same position and after this point show 
no homology to each other. However, within the reading frame, the 
sequences show -76.5% identity. 
In the longest open reading frame, the human clone encodes a 
peptide which shows -88% identity with the Drosophila E(spl) protein as 
shown in Figure 5.7. However this open reading frame is out of frame 
with lac Z and so should not produce a fusion protein containing E(spl) 
sequences. If the longest open reading frame is not capable of 
producing a protein, the question arises as to whether the insert is 
transcribed. The simplest test was to determine the orientation of the 
insert within the Xgt11 expression library. Therefore XV1.1 was mapped 
using restriction enzymes. 
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Figure 5.5 To show the forward and reverse primed sequences of pVl.l, 
the position of deletion clones and the position of the oligo- primers 

















































Figure 5.6 To show the entire open reading frame of V1.1 matched to 
nucleotides 2171 to 3021 of Drosophila E(sp1). 
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4 gtgccgtgaccatcagcaaccccagcaggcacgtctacacaggtggcaag 53 
IIII 11 111111 II 1111 I I IIII IIIII II 111111 
2171 GTGCGGTAACCATCTCTAATCCCACAAAGfACGTGTACACGGGC,GGCAAG 2220 
54 ggctgcgtgaagatctgggacatcagccagccaggcagcaagagccccat 103 IIIIIIII III 1 IIIIIIIII II II IIII 11111 II I 
2221 GGCTGCGTCAAGGTATGGGACATCTCGCAACCGGGCAACAAGAATCCAGT 2270 
104 ctcccagct gga ctgcct gaa cagggaca atta cat gcg ctcctgcaagc 153 
111111111 II III I I IIIII 11111 11111 1111 
2271 TAGCCAGCTGGATTGTCTGCAGCGCGACAACTACATCCGCTCGGrAAAGC 2320 
154 t gca cc ct gat ggg cgca cg ct ca t cgt gggcggcgagggcagca cgct c 203 
Ill II II II II 11111 11111111111 1111 II II 
2321 TGCTGCCCGACGGCCGTACGCTGATCGTGGGCGGTGAGGCGTCCAACCTG 2370 
204 accatctgggacctggcctcgcccacgccccgcatcaaggccgagctgac 253 
1111111111 111111 II 11111 11111 11111 II II II 
2371 TCCATCTGGGATCTGGCCAGTCCGACGCCTCGCATAAAGGCGGAACTAAC 2420 
259 gtcctcggctcccgcctgttatgccctggccattagccctgacgccaaag 303 
II IIII IIIIIIII II II IIIIIIIIIIIIIIIIII I II 1 
2421 ATCGGCGGCGCCCGCCTGCTACGCTCTGGCCATTAGCCCTGACTCGAAGG 2470 
309 tctgcttctcctgctgcagcgatgggaacattgctgtctgggacctgcac 353 
I I1111III 11111111111 II II II 11111 IIIIIIIIIIII 
2471 TGTGCTTCTCGTGCTGCAGCGACG(',CAATATCGCTGTGTGGGACCTGCAC 2520 
354 aaccagaccctggtcaggcagttccagggccacacagatggggccagctg 403 
III III 111111 1 11111111111111 II II II 11 II 
2521 AACGAGATCCTGGTGCGCCAGTTCCAGGGCCATACCGACGGCGCTTCATG 2570 
404 catagacatctcccatgatggcaccaaactgtggacagggggcctggaca 453 
111 111111 I 111111 III 11111111 II III 1 1111 
2571 CATCGACATCAGTCCGGATGGCTCCAGGCTGTGGACGGGCGGCTTAGACA 2620 
454 acacggtgcgctcctgggacctgcgggagggccgacagctacagcagcat 503 
1111111111111111111 11111 11111 II 11111 II 11111 
2621 ACACGGTGC(CTCÇTGGGATCTGCGCGAGGGTCGCCAGCTGCAACAGCAC 2670 
509 gacttcacttcccagatcttctcgctgggctactgccccactggggagtg 553 
1111111 II II II 11111111 11111111 11111 II il II 
2671 GACTTCAGCTCTCAAATATTCTCGCTCGGCTACTGTCCCACAGGCGACTG 2720 
559 gctggctgtgggcatggagagcagcaacgtggaggtgctgcaccacacca 603 
111111111111 1111111 1 I IIIIIIIIIIIIIII 1 1 
2721 GCTG('CTGTGGGTATGGAGAACTCGCATGTGGAGGTGCTG('-ACGCATCGA 2770 
609 agcctcacaagtaccagctgcacctgcacgagagctgcgtgctctccctc 653 
111 1111111 II 11111 11111111111111111 II II 11 
2771 AACCGGACAAGTATCAACTGCATCTGCACGAGAGCTGCGTTCTGTCGCTG 2820 
654 aagttcgcctactgcggcaagtggttcgtgagcactgggaaagataacct 703 
II III IIIIIIIII IIIIIIII III II IIIII IIIII 
2821 CGCTTTGCCGCCTGCGGCAAATGGTTCGITTCCACCG'CAAAGACAACCT 2870 
709 tctcaacgcctggaggacgccttatggagccagcatatcccagtctaaag 753 
II 11111 III I II 11111 11 1111111111 111111 II 1 
2871 GCTTAACGCATGGCGAACACCTTACGGTGCCAGCATATTCCAGTCGAAGG 2920 
759 aatcctcgtctgtcttgagttgtgacatttcagcggatgacaaatacatt 803 
II 1 11 II 11 I II II 11111 III 1 II 111111111111 
2921 AAACATCATCCGTACTTAGCTGCGACATATCAACTGACGACAAATACATT 2970 
809 gtaacaggctctggtgacaagaaggccacagtttatgaggtcatctacta 853 
II II II II II II IIIIIIII II II II II II II II 11 
2971 GTGACGGGTTCGGGCGATAAGAAGGCTACTGTCTACGAAVI°1'ATTTATTA 3020 
854 a 859 
1 
3021 A 3021 
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Figure 5.7 To show the peptide encoded by V1.1 matched to the protein 
product of Drosophila E(spl). 
165 
1 AVTISNPSRHVYTGGKGCVKIWDISQPGSKSPISQLDCLNRDNYMRSCKL 50 
1111111.:-111111111I:1111111-1-I:1IIIII.IIII:1i.11 
438 AVTISNPTKYVYTGGKGCVKVWDISQPGNKNPVSQLDCLQRDNYIRSVKL 487 
51 HPDGRTLIVGGEGSTLTIWDLASPTPRIKAELTSSAPACYALAISPDAKV 100 
1111111III1:1.I-IIIIIIIIIIIIIII11.111111111111-11 
488 LPDGRTLIVGGEASNLSIWDLASPTPRIKAELTSAAPACYALAISPDSKV 537 
101 CFSCCSDGNIAVWDLHNQTLVRQFQGHTDGASCIDISHDGTKLWTGGLDN 150 
11111111111111111:-111111111111111111.11-:IIIIIIII 
538 CFSCCSDGNIAVWDLHNEILVRQFQGHTDGASCIDISPDGSRLWTGGLDN 587 
151 TVRSWDLREGRQLQQHDFTSQIFSLGYCPTGEWLAVGMESSNVEVLHHTK 200 
111111111111111111.111111111111:1111111.1:11111 .I 
588 TVRSWDLREGRQLQQHDFSSQIFSLGYCPTGDWLAVGMENSHVEVLHASK 637 
201 PHKYQLHLHESCVLSLKFAYCGKWFVSTGKDNLLNAWRTPYGASISQSKE 250 
I.IIII111.1111111:11 1111111111111111111111111 111 
638 PDKYQLHLHESCVLSLRFAACGKWFVSTGKDNLLNAWRTPYGASIFQSKE 687 
251 SSSVLSCDISADDKYIVTGSGDKKATVYEVIY 282 
.I111111II.II11111111111II1III11 
688 TSSVLSCDISTDDKYIVTGSGDKKATVYEVIY 719 
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5.2.3 The Mapping of Clone V1.1 Within the X Bacteriophage Vector 
The "MAPSort" programme of the UWGCG software at Daresbury 
analyses any given sequence for restriction enzyme sites. Informative 
sites were identified for V1.1 in this manner in order to map the 
orientation of the clone within the ?gtll expression vector. V1.1 has 
a PstI site 317bp from the predicted 5' Eco RI site. XV1.1 was cut 
with PstI alone and with PstI and enzymes flanking the Eco RI cloning 
site within the bacteriphage vector; in this case KpnI and Sacl. 
(These enzymes have no restriction sites within V1.1.) Figure 5.8 
shows a map of the kgtll expression vector, indicating the restriction 
sites of the flanking enzymes chosen and the position of the lac Z 
gene. The restriction digested kV1.1 was analysed by Southern 
blotting. 
The oligo primer #554 (used to complete the sequencing of DNA 
within the reading frame of the clone) begins 129 bases from the 5' end 
of V1.1 and was used to probe for restriction fragments at the 5' side 
of the PstI site. The Eco RI cloning site is 1040bp from the flanking 
KpnI site and 1060bp from SacI,and the PstI site is 317bp from the Eco 
RI site at the 5' end of the clone. If the KpnI restriction site is 5' 
to the PstI site, a double digest of XV1.1 with PstI and KpnI will 
yield a fragment of 1357óp, which will hybridise with the labelled 
oligomer, #554. However, if the Sacl site is 5' to the PstI site, a 
double digest with PstI and Sad will produce a fragment of 1397bp 
which will also hybridise with #554. Figure 5.9 shows the results of 
this experiment. 
167 
Figure 5.8 Map of the 7gt11 expression vector, indicating some 














































Pst I - 
1.9 - 
Pst I /Kpn I - 1.5 - 
1.3 - 
Figure 5.9 Autoradiograph of ?V1.1 digested with PstI, PstI and KpnI, 
and PstI and Sacl, probed with the oligo- primer #554 is shown in the 
right hand panel. The ethidium stained gel before Southern blotting is 
shown in the left hand panel. 
S. 
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V1.1 digested with PstI alone shows a band of -2.3kb which 
hybridises with labelled #554. The length of this fragment is the 
distance from the internal PstI site to the nearest external PstI site 
at the 5' end of the clone. In the Kpnl /PstI digest a band of -1.5kb 
is clearly visible. This is approximately the predicted distance for 
KpnI to be at the 5' end of the clone. The larger band of -2.2kb in 
the SacI /PstI digested DNA is not consistent with the Sacl site being 
5' of the PstI site. It is due to the fragment produced by the 
internal PstI site and a Sacl site beyond KpnI at the 5' end of the 
clone. 
The Xgtll expression vector produces protein encoded by the 
inserted piece of DNA as a fusion with j3 -gal. The above results show 
that the 5' end of the human clone is not in the correct orientation to 
produce a fusion protein. This means that the protein produced by the 
X. vector is a portion of 0-gal fused to a peptide encoded by the 
complement of the 3' end of the clone and not the human protein 
equivalent to the Drosophila E(spl) m9 gene. 
The potential protein encoded by the complement of the 3' 
untranslated end of V1.1 has an open reading frame of only 93 bases 
before a stop codon is reached as shown in Figure 5.10. Therefore, the 
induced A.gtll vector should produce a portion of the 0-gal protein 
fused to 31 amino acids encoded by the complement of the 3' end of 
V1.1. There are four possible reasons for the apparent recognition of 
this clone by serum 14A. First, this short peptide alone may be 
related to the real epitope of the antibody. Second, the peptide 
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Figure 5.10 The sequence of forward primed V1.1 and the translated 
peptide, Protein X. 
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1 gg gtitat.ic ag 
51 abcalggclaccl tt 
c ogga 
gglcc 
tg ciccalgaciccgl tgtIggalggcla cacgcatticc 
aa cctggttglcc attticcalcac) tctltáalgact 
101 tttctcctct ttcttcaatt ggttaccctc cctgtctcct cttcccaggt 
151 gagagcatct gtttatttaa aaaaaaaaaa aaaaaaagcc accacgagtg 
201 attacaaata cagcaggcga aatacacact cagagtttcc ggtgggaagg 
251 ggcctagc 
1 GGYQSGCPDP CGGTRIPAGT LRPTWLPFPH S* 
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coupled with ß -gal could have created a false epitope causing the serum 
antibody to bind to what appears to be its true binding site. Thirdly, 
the clone picked may have been a negative clone on the quarternary 
plate which had not been purified out in the previous three rounds of 
screening. Lastly, it may be that a weak bacterial promoter (or some 
sequence of DNA behaving as such) present as part of the inserted piece 
of DNA, was transcribing the human E(spl) protein in frame and that the 
antibody was recognising that protein. 
In order to distinguish some of these possibilities, the 
Drosophila antibody, IC2, was applied to Western blots of total nuclear 
extract, to see if it recognised the 38kDa protein identified by sera 
#14(R) and 14A. It did not. It was also applied to whole cells, and 
the staining pattern compared to that of 14A. 14A gave bright granular 
staining of PARIT cell nuclei prepared in KCM, with a brighter, denser 
level of staining around the periphery of the nuclei. PARIT nuclei 
prepared in PBS showed coarser granular staining. These results are 
shown in Figure 5.11. IC2, when applied to PARIT cells prepared in 
KCM, gave bright granular staining of the nuclei with a very dense 
bright level of staining of the periphery. It also showed granular 
staining of PARIT cell nuclei prepared in PBS. In both cases, IC2 
showed additional cytoplasmic staining. These results are shown in 
Figure 5.12. Staining patterns given by the normal serum, JL, are 
shown in Chapter 3. The nuclear staining patterns of 14A and IC2 are 
strikingly similar. The antibodies were also applied to mouse cells, 
to see if the staining pattern observed with 102 was due to a 
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Figure 5.11 Whole PARIT cells stained with serum 14A, as the first 
antibody and fluorescein conjugated rabbit anti -human IgG y as the 
second antibody. 
(a) and (b) show cells prepared in KCM stained with 14A and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with 14A and 
counterstained with DAPI to localise the nucleus. 
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Figure 5.12 Whole PARIT cells stained with IO2, as the first antibody 
and fluorescein conjugated rabbit anti -mouse IgG as the second 
antibody. 
(a) and (b) show cells prepared in KCM stained with IC2 and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with IC2 and 
counterstained with DAPI to localise the nucleus. 
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conserved antigen(s). 14A showed coarse granular staining of the L 
cells when prepared in KCM and PBS, with a little cytoplasmic staining 
of those in PBS, as shown in Figure 5.13. IC2 showed a uniform level 
of staining throughout the nuclei with brighter patches in both types 
of preparation, as shown in Figure 5.14. It showed no cytoplasmic 
staining in either preparation. The two antibodies show quite similar 
staining in mouse cells also, although not the same as the patterns 
observed in PARIT cells. It seemed possible, therefore by this assay, 
that the autoimmune serum 14A was recognising the human and mouse 
E(spl) homologue. 
In order to determine what protein product the serum antibody was 
recognising in the screen, fusion proteins of human E(spl), in and out 
of frame, and of the 31 amino acids from the 3' end of V1.1 and 
referred to as Protein X, were produced. 
5.2.4 Fusion Proteins of V1.1 
Fusion proteins can be produced using bacteriophage in a 
lysogenic growth phase. E. coli Y1089 cells were infected with the 
bacteriophage ?V1.1, and cultured, with the bacteriophage multiplying 
within their hosts as an integral part of the host genome. The 
bacteriophage was then induced to begin transcribing the ß -gal fusion 
protein. After a suitable time interval the cells were lysed and the 
liberated proteins isolated. The induced product should be clearly 
visible on SDS -PAGE, at a molecular weight a little higher than ß -gal 
(as the inserted piece of DNA produces a fusion protein). However this 
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Figure 5.13 Whole mouse L cells stained with serum 14A, as the first 
antibody and fluorescein conjugated rabbit anti -human IgG y as the 
second antibody. 
(a) and (b) show cells prepared in KCM stained with 14A and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with 14A and 
counterstained with DAPI to localise the nucleus. 
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Figure 5.14 Whole mouse L cells stained with IO2, as the first 
antibody and fluorescein conjugated rabbit anti -mouse IgG as the second 
antibody. 
(a) and (b) show cells prepared in KCM stained with IC2 and 
counterstained with DAPI to localise the nucleus, 
(c) and (d) show cells prepared in PBS stained with IC2 and 
counterstained with DAPI to localise the nucleus. 
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was not the case: there was no new protein band visible at the correct 
molecular weight, after induction. There was also no non -fusion ß -gal 
product visible in the vector -only control extract. There are three 
possible explanations for these results. Firstly, the lysogenic 
bacteriophage may have been failing to produce any fusion protein at 
all upon induction with IPTG. Secondly, the fusion protein may have 
been produced but subsequently degraded by the host cell, before the 
cells were lysed and protein extracts run on the gel, or lastly, as 
there is only one copy of the gene within each host cell, the protein 
may have been at too low a level to detect. Fusion proteins were 
produced upon induction when cultured in Y1090 cells, in order for the 
library to have been screened, but the lytic growth cycle allows 
amplification of the bacteriophage, and therefore the number of copies 
of the Lac Z gene, and the quantity of protein required was very small. 
Although there appeared to be no fusion proteins present, I Western 
blotted the gels and probed them with the antibody 14A. There was no 
reaction of the antibody with protein bands of the correct molecular 
weight, just non -specific staining due to second antibody activity. I 
made several attempts to produce fusion proteins by this method without 
success, and eventually used a different strategy. 
The insert, V1.1, was cloned into another fusion protein 
production vector, pGEX -3X, by R. Hill. pGEX -3X was used to produce 
the human E(spl) in frame, as a fusion with glutathione S- transferase, 
by cloning the V1.1 insert into a Bam HI /Smal site. The fusion protein 
construct was transformed into E. coli strain BL21 DE3 which is lon- 
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and is deficient of some cellular proteases. D. Hartley kindly 
provided a gift of a D. melanogaster fusion protein construct which 
contains the -1.2kb Eco RI fragment in pGEX -1N. This vector will 
produce the C- terminal half of the Drosophila protein in frame fused to 
glutathione S- transferase in the host cell XL -1 blue. The fusion 
proteins were produced by induction of the vectors with IPTG, denatured 
and size separated by SDS -PAGE. The gels were then Western blotted 
onto nitrocellulose and the filters probed with the serum 14A, plus a 
polyclonal mouse serum, IC2, (precipitated with ammonium sulphate) to 
the Drosophila fusion protein. 
Figure 5.15 shows the protein produced by the induction of the 
fusion vectors in E. coli strains BL21 DE3 and XL -1 blue, run on SDS- 
PAGE and stained with Coomassie Blue. Figure 5.16 shows the results of 
the antibody probing of these protein extracts. 
Panel A shows the Western blot probed with the Drosophila 
antibody IC2. IC2 stains a band at -20kDa in the extract of pGEX 
vector only after induction for one hour. This is glutathione S- 
transferase alone. Bands at -55 kDa in the extracts of fusions of in 
frame human Enhancer of split and of Drosophila, after one and two 
hours of induction, are also stained with IC2. As IC2 is a polyclonal 
mouse serum raised against the fusion protein in pGEX, the antibodies 
present are against E(spl) and glutathione S- transferase fusion 
protein. This explains why binding to the glutathione S- transferase 
alone is observed. However, the staining of the -55kDa proteins in the 
induced fusion protein vector lanes may also be due to anti -glutathione 
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Figure 5.15 Total protein extracts of fusion vectors pGEX -1N and 3X in 
E.coli strains BL21 DE3 and XL -1 blue, before and after induction with 
IPTG. Lane 1 shows the total protein extract of vector, pGEX -3X, 
before induction, lane 2 shows it after induction. Lane 3 shows total 
protein extract of Em9 plus the fusion protein vector, pGEX -3X, before 
induction, lanes 4 and 5 show total protein extracts after i and 2 
hours of induction. Lane 6 shows total protein extracts of D. 
melanogaster NB5 plus the fusion protein vector pGEX -1N, before 
induction, lanes 7 and 8 show total protein extracts after 1 and 2 
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Figure 5.16 Western blots of duplicate gel to the one shown in Figure 
5.15, probed with the first antibodies IO2 and 14A. IC2 is localised 
with peroxidase conjugated rabbit anti -mouse IgG and 14A is localised 
with peroxidase conjugated rabbit anti -human IgG y. 
Panel A shows the Western blot probed with IC2. Lane 1 shows the total 
protein extract of vector, pGEX -3X, before induction, lane 2 shows it 
after induction. Lane 3 shows total protein extract of V1.1 in the 
fusion protein vector, pGEX -3X, before induction, lanes 4 and 5 show 
total protein extracts after 1 and 2 hours of induction. Lane 6 shows 
total protein extract of D. melanogaster NB5 in the fusion protein 
vector, pGEX -1N, before induction, lanes 7 and 8 show total protein 
extracts after 1 and 2 hours of induction. 
Panel B shows an identical Western blot probed with 14A. The lanes are 
loaded as above. 
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S- transferase activity, and not to antibody specificity for the fusion 
proteins encoded by V1.1 and the Eco RI fragment of the Drosophila 
clone. However the binding of IC2 does prove that the peptides 
recognised are indeed fusion proteins, and therefore the induction was 
successful. 
Panel B shows the staining pattern observed with 14A as the first 
antibody. There is no binding to any of the induced products at all, 
just background staining probably due to second antibody activity or 
non -specific binding due to the effects of applying a human serum onto 
extracts of E. coli cells. Therefore, it can be concluded that serum 
14A does not bind to the product of the open reading frame of the 
sequence of human E(spl) or the Drosophila fusion protein. 
Human E(spl) out of frame and the 31 amino acid peptide from the 
3' end (further referred to as Protein X) were cloned in pGEMEX -1 and 
produced as fusions with 260 amino acids of the T7 gene 10 leader 
peptide. However, no induction could be seen on the stained 
polyacrylamide gel when the extracts were run out and size separated. 
This may be due to problems with the vector, as the induction 
conditions were known to be successful, as pGEX -3X and 1N proved. 
Without the fusion proteins of the 31 amino acids of Protein X or the 
out of frame human E(spl), the possibility cannot be excluded that 
either of these fused with ß -gal in the X vector is the true antigen. 
It is unlikely that either are of biological significance and leaves 
the possibilities that the antibody recognised the original X clone 
artefactually, or that V1.1 was a spurious clone on the quarternary 
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plate which had not been purified out in the rounds of screening. 
However, the human Enhancer of split gene has been isolated. The 38kDa 
protein recognised by sera #14(R) and 14A on Western blots is still to 
be identified and cloned. 
As this clone, V1.1, is part of a previously unidentified gene in 
humans, it was necessary to determine that the gene was present within 
the normal human genome. This was done by cross hybridising V1.1 to 
digested human genomic DNA. Figure 5.17 shows the results of this 
experiment. Human kidney DNA was digested with Eco RI, Bam HI and Hind 
III, and all three digests show bands of hybridisation with V1.1 
showing that this gene is a component of the normal human genome. 
Thus it would appear that 14A has fortuitously allowed the 
isolation of a human gene, homologous to the Drosophila E(spl) gene, 
which had not been previously identified. The gene will now be 
referred to as Em9. However, further studies in human are difficult, 
therefore mouse clones of Em9 were identified. 
5.2.5 The Identification of the Mouse Equivalent of Em9 
A mouse 8.5 day embryonic Xgt10 cDNA library was screened with 
the human clone V1.1 by Robert Hill and Christine Sime. Several 
positive clones were identified and these were prepared on a large 
scale in the X vector and the inserts were subcloned into the Eco RI 
site of the phagemid vector, Bluescript. Three of these clones were 
thought to represent the entire gene; Esp4.1, Esp3.1 and Esp2.3. Figure 
5.18 shows the positions of these clones within the Drosophila gene. 
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Figure 5.17 The right hand panel shows the autoradiograph of human 
genomic kidney DNA digested with Eco RI, Bam HI and Hind III, 
hybridised with V1.1. The left hand panel shows the ethidium bromide 












Figure 5.18 To show the positions of mouse clones Esp4.1, Esp3.1 and 
Esp2.3 within the Drosophila E(spl) gene. 
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V1.1 was purified from an adult human testis cDNA expression 
library. In retrospect, as previously mentioned, it would have been 
useful to have picked more than one positive clone from the final 
plate. This would have allowed cross hybridisation to check that all 
clones on the plate were the same. However, at the time, four rounds 
of selection were considered sufficient to eliminate contaminating 
negative clones. 
When it was shown that the clone was out of frame and present in 
the Xgt11 vector in the wrong orientation, the question arose as to how 
the clone was identified. The production of fusion proteins allowed 
clarification; whether the clone was found by happy accident, or that 
the serum antibodies of MCTD patients #14(R) and 14A were specific for 
the putative product of the partial Em9 clone. 14A did not bind to 
E(spl) in frame, showing that a weak bacterial promoter transcribing 
the gene was not present. The possibilities remaining are those of 
there being a false epitope created by the fusion of Protein X to ß -gal 
or that Protein X alone is an antigen. The remaining possibility is 
that V1.1 was picked by mistake. This means that the clone is 
unrelated to the 38kDa antigen and explains why the Drosophila antibody 
did not bind to the 38kDa antigen on Western blots of PARIT nuclear 
extracts. Problems of repeating the positive signal from the purified 
clone infected into Y1090 cells, which were dismissed as trivial 
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problems with library screening (experienced by others in the Unit at 
that time), are also explained by this hypothesis. 
The results of cross hybridisation of the Drosophila clone, NB5, 
and the construct, BXB25, to V1.1, and the sequence comparisons prove 
that V1.1 is indeed a partial clone of the human homologue to the 
E(spl) gene. I attempted to isolate further cDNA clones of Em9 from 
the human testis library, plus an adult human liver library and an 
adult lung library, using V1.1 as a probe. However after screening 
another 3 million or so plaques from each library, none hybridised with 
V1.1. The absence of clones in the other two libraries is perhaps an 
indication that the Em9 gene is not expressed in these tissues. 
Unfortunately a full length cDNA of Em9 has yet to be isolated. 
Possibly it would be easier to find in a human foetal library, if the 
gene is expressed developmentally in humans as it is in Drosophila. 
The hybridisation of V1.1 to human genomic kidney DNA shows that 
the gene is present in the human genome. In order to determine an 
expression pattern in both adult and foetal tissues, I ran several 
Northern blots with RNA given to me by Paula Monaghan and Kathy 
Pritchard -Jones, and probed them with V1.1. There was no hybridisation 
at any detectable level with adult or foetal samples. In adult 
tissues, the gene may not be expressed at all so this result was 
expected, but no expression in foetal material was surprising. However 
it may be that the expression of this gene occurs at a stage when human 
foetal samples are not available, or that Em9 is expressed within a 
short time span, or /and at a low level, so it is difficult to detect. 
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In situ hybridisation is a much more sensitive technique and foetal 
expression may be detected by this method. As human samples are 
extremely difficult to come by, and mouse clones of the gene have been 
identified, this approach was tried using mouse samples and will be 
discussed in Appendix I. 
The mouse antibody, IC2, to a fusion protein of the 3' half of 
the Drosophila gene gave very similar staining patterns to that of 14A. 
As it is now known that V1.1 is in no way related to 14A, the similar 
staining must be viewed with extreme caution. As discussed in Chapter 
3, indirect immunofluorescence gives many ill defined staining 
patterns, which are difficult to correlate with particular antigens 
unless these are to distinct regions such as kinetochore recognition by 
#7(ML). #14(R) and 14A show staining that probably relates to the 
38kDa antigen and to U1 -RNP also. The fact that staining of 14A 
appears similar to the staining of IC2 is most likely to be an 
artefact. The apparent staining of the nuclear membrane by 14A in 
cells prepared in KCM may be the effect of soluble antigens leaching 
out of the cell being caught on the membrane, thus giving a false 
antigenic localisation. This staining pattern is not observed in the 
staining with 14A of cells prepared in PBS. However cells prepared in 
both types of buffer show staining at the nuclear membrane with IC2. 
Is this the true cellular position of the Em9 protein? IC2 stains the 
nuclei of embyronic Drosophila cells (D. Hartley, pers. comm.). RNA 
from adult tissues probed with V1.1 has not shown expression of Em9. 
In order to be confident that this staining pattern was real, RNA from 
191 
PARIT cells would have to be isolated and probed with V1.1 to check for 
the expression of Em9. Without this additional information, the 
staining pattern cannot be taken as a true positive result. 
V1.1 was used as a probe to search for other mammalian gene 
equivalents. An 8.5 day mouse embryonic cDNA library contained several 
mouse clones which were subsequently isolated. As the gene is 
developmentally expressed in Drosophila, the presence of these clones 
within a library made from developing mouse is not surprising. The 
absence of clones in adult libraries indicates that the mouse homologue 
of E(spl), may well be performing a developmental role. The relative 
abundance of clones compared with the single clone found in the adult 
human library indicates that the gene is being expressed at a much 
higher level in the mouse embryo. If the mouse gene is developmental 
in function, it should follow, therefore, that the human gene is also 
performing a developmental role. However the human library that 
contained V1.1 was a normal adult cDNA expression library, made from 
RNA derived from a testis biopsy. Therefore the gene must have been 
transcribed in the testis for the RNA to have been present, but the 
tissue was essentially adult and not from a developing embryo as with 
the mouse library. However the testis is not a typical somatic tissue, 
as the process of spermatogenesis takes place within it. It is 
documented that normally inactive genes may be transcribed at low 
levels in the testis due to spermatogenesis (Willison and Ashworth, 
1987), which may account for the presence of a developmentally 
expressed gene in an adult cDNA library. 
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The discovery of a mouse equivalent opens many avenues for the 
further study of this gene, which would be much more difficult to 





6 GENERAL DISCUSSION 
6.1 Summary of Results 
The use of autoimmune patients' sera containing anti -nuclear 
antibodies as probes for nuclear substructure has been well documented 
and is discussed in the Introduction. The aim of this project was to 
use autoimmune sera to aid the identification of novel nuclear antigens 
and, if possible, to characterise them further. 
Two techniques were used for the initial analysis of patient sera 
provided. These were immunocytochemistry and Western blotting, as 
discussed in Chapter 3. Immunocytochemistry alone allowed the 
identification of a patient with CREST syndrome, a subclass of 
scleroderma (progressive systemic sclerosis). It has been shown that a 
high proportion of CREST patients possess serum autoantibodies which 
recognise the centromeres of metaphase chromosomes (Spowart et al., 
1985; Moroi et al., 1980). This gives rise to a very distinctive 
immunofluorescence pattern. which was detected using this patient's 
serum. The immunocytochemistry was confirmed by Western blotting, 
which allowed the reacting antigen to be identified as the 19kDa 
polypeptide which has been called CENP -A (Earnshaw et al., 1986). The 
patient in question had not been previously classified as CREST, and 
therefore the detection of anti -centromere antibodies in her serum was 
of help to the clinicians in managing her condition. 
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Two SLE patients were similarly identified by their sera. The 
autoantibodies showed characteristic intense staining of the whole 
nucleus and of metaphase chromosomes by indirect immunofluorescence, 
indicating an affinity for DNA and /or histone, as previously described 
(Tan, 1982). When the sera were applied to proteins which had been 
size separated and Western blotted, #23(BB) stained histone H1 very 
clearly, whilst #24(NF) did not appear to recognise a protein antigen 
at all. It can therefore be concluded that serum #23(BB) had 
autoantibodies which stained histone H1 and possibly DNA also. Serum 
#24(NF) probably contains autoantibodies which bind to only DNA. 
The staining patterns produced by autoantibodies in the sera of 
patients with SLE and CREST are very distinctive, whereas the patterns 
produced by other types of autoantibody related to other diseases tend 
to be less well defined. Serum #13(H), from a scleroderma patient, was 
shown to stain nucleoli of whole cells with background granular 
staining and appeared to be localised to the chromosomes in metaphase 
spreads. The Western blots with this serum showed autoantibodies 
present bound to an antigen of 95kDa. The molecular weight of the 
antigen did not appear to correspond that of any known antigen, so the 
antigen did appear to be novel. However, with hindsight, this 
assumption was incorrect. Serum #14(R) showed granular staining of 
whole nuclei also. On Western blots the serum antibodies bound to two 
bands, one of 70kDa and the other of 38kDa. The 70kDa band 
corresponded to the size documented for one of the antigenic proteins 
associated with snRNP (Mimori et al., 1984; Habets et al., 1985). When 
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the patient from whom the serum sample had been taken was revealed to 
be suffering from MCTD, this correlation with nRNP was further 
strengthened, as U1 RNP is frequently associated with this condition 
(Mattioli and Reichlin, 1973). The band of 38kDa did not appear to 
correspond with any known nuclear antigen. 
It therefore seemed that the combination of these two techniques 
had allowed the identification of two novel nuclear antigens, one of 
95kDa and the other of 38kDa, which was the initial aim of the project. 
The next goal was to further characterise and hopefully identify these 
antigens. In order to facilitate this, further serum samples from more 
patients suffering from the same diseases were obtained to see if the 
antigens were disease related. The 95kDa antigen was found to be 
recognised by autoantibodies from one more serum sample, while the 
38kDa antigen was identified by two further samples. In both cases a 
serum with autoantibodies at a greater titre or with higher affinity 
for the antigen in question was discovered. These sera appeared to 
show the same staining patterns by immunocytochemistry and it was these 
sera, called 13A and 14A, which were used in the next stages of the 
project, the screening of a Agt11 expression library. 
A human testis expression library was used for the purposes of 
this project as I was not looking for tissue specific genes, but 
ubiquitously expressed genes coding for nuclear proteins possibly of a 
structural nature. 13A was used to screen the library first, and three 
positive clones were isolated. These were found to cross hybridise 
with each other and upon sequencing, they were found to encode human 
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DNA topoisomerase I. This is not a novel protein, and is in fact the 
diagnostic antigen (Scl -70) for scleroderma, the disease suffered by 
the patients from whom the serum samples were taken. The identity of 
the antigen had not been realised earlier, despite the staining of the 
95kDa band on Western blots and the pattern of staining shown in whole 
cells and metaphase spreads which, with hindsight, show characteristic 
staining for Scl -70. However, the recloning of this gene proved quite 
conclusively that this approach for the isolation and identification of 
novel nuclear antigens is a feasible one and, in theory should allow 
the characterisation of truly novel proteins. 
Towards this end, the same library was screened with serum 14A, 
but this time only one positive clone was identified after some 3 
million plaques had been plated. This clone, V1.1, was sequenced also 
and was found to show homology to the m9 transcript of a Drosophila 
melanogaster multi -gene complex called Enhancer of split (E(spl)). 
This gene is involved in the development of the nervous system of the 
fly as briefly discussed in Chapter 5. The question then arose as to 
how human autoimmune disease was related to a gene showing homology 
with a fruit fly neural development gene. It has since been shown that 
serum 14A does not recognise the protein encoded by V1.1 when expressed 
as a fusion product, and that the clone was in fact contained in the X. 
vector in the opposite orientation to the direction of transcription. 
There was a short open reading frame in the direction of transcription 
for 31 amino acids, but these alone are highly unlikely to be of any 
biological importance. In conclusion, the clone isolated from the 
198 
library is most likely to be a spurious negative clone remaining on the 
quarternary plate, and was picked by mistake instead of a true positive 
plaque. The method, having been successful in the cloning of DNA 
topoisomerase I, is therefore not flawless. The 38kDa protein stained 
by #14(R) and 14A on Western blots is yet to be identified. 
However, serendipity has allowed the isolation of the human 
homologue of the Drosophila E(spl) gene. The human clone, V1.1, has 
been shown to cross hybridise with the Drosophila cDNA, NB5, and with a 
construct, BXB25, which rescues otherwise lethal mutations. It has 
also been shown to hybridise to human genomic DNA, proving that the 
gene is present within the human genome. The remainder of the reading 
frame of V1.1 has been sequenced and shows -76.5% identity at the 
nucleic acid level and -88% similarity at the amino acid level to 
Drosophila E(sp1). A full length clone of the gene could not be 
detected in the testis library or two other libraries screened with 
V1.1. 
Human genes are difficult to study due to the lack of human 
material available and the ethical problems of experimentation upon a 
human system, therefore V1.1 was used as a probe to screen an 8.5 day 
mouse embryonic library, with the intention of isolating a mouse 
homologue of the gene which would be very much easier to study. Three 
clones were isolated. It is thought that these clones contain the full 
length sequence of the mouse gene within them. The degree of homology 
of the mouse clones, Esp4.1, Esp3.1 and Esp2.3, to the Drosophila gene 
is similar to that shown with the human sequence. The isolation of 
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mouse clones opens many more avenues for the further study of this 
gene. 
6.2 Future Work 
6.2.1 Autoimmunity 
There is much work to be done in the field of autoimmunity 
generally. During the course of this project a 38kDa antigen was 
identified on Western blots by #14(R) and 14A. This has yet to be 
further characterised. The strategy I employed during the course of 
this project would seem to be a suitable way forward. This will 
hopefully allow the true identity of the antigen to be determined. 
Although the aim of the project was to identify novel nuclear antigens 
associated with autoimmune disease, the true identity of this antigen 
was not pursued in this particular case, as the gene isolated by 
accident, the previously unidentified human Enhancer of split,is an 
interesting gene in its own right. 
However further antigens important both in nuclear structure and 
autoimmune diseases may also be detected and identified in this manner. 
In order to fully understand the problems which face us in the study of 
autoimmune disease, we require as much basic information and background 
knowledge about the antigens and autoantibodies involved, as possible. 
This method therefore, may be providing a way forward in the study of 
autoimmunity. 
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6.2.2 Mammalian Enhancer of split 
The three mouse clones of E(spl) have yet to be fully sequenced. 
Some preliminary work indicates that the mouse gene may well be shorter 
than that in Drosophila. Forward and reverse primed sequences of all 
of the clones have been compared to the Drosophila sequence. The 5' 
end of Esp2.3 has been matched to a stretch of nucleotides beginning at 
base 2259. The 3' ends of Esp 3.1 and 4.1 have also been matched to 
stretches of nucleotides ending with bases 2354 and 2840 respectively. 
The 3' end of Esp2.3 does not show any homology to the Drosophila 
sequence, presumably because it is untranslated as was observed with 
the 3' end of V1.1. The 5' ends of Esp3.1 and 4.1 also do not show any 
homology. The 5' end of Esp4.1 does not contain an open reading frame 
within the few hundred bases that have been sequenced, so this may be 
5' untranslated, but the forward primed sequence of Esp3.1 does contain 
an open reading frame. This stretch of the sequence does not show any 
homology to the Drosophila gene so it is quite probable that the level 
of homology at the 5' end of the gene is lost. The mouse gene is 
thought to be shorter as the length of the clones has been used to 
estimate the possible length of the gene. The Drosophila protein 
begins at nucleotide 862 and finishes at nucleotide 3021 giving a 
protein of some 720 amino acids. However Esp4.1 only extends to 
approximately base 1200, and has no open reading frame at its 5' end. 
This means that with -340 fewer bases at the 5' end, the protein will 
be over 100 amino acids smaller. This calculation is made with the 
assumption that the mouse gene will end at the same point as the 
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Drosophila gene as seen with the human clone. (The position of the 
mouse clones within the Drosophila gene is shown in Figure 5.18.) 
A polymorphism in the mouse gene has been identified (data not 
shown) and this will be used to map the gene to a particular chromosome 
in the mouse. There are several known neurological mutations in the 
mouse and it may be that this gene will map to the same area as one of 
these mutations. 
As already mentioned, the E(spl) gene in Drosophila is in fact a 
multi -gene complex and we have been supplied with full length cDNAs of 
two of the other transcripts, m5 and m8. Work is underway at the 
present time in order to try and identify mouse equivalents for these 
two genes also. It is not known whether the localisation of the 11 or 
more genes making up the E(spl) complex in the same area of the same 
chromosome is fortuitous or whether there is some fundamental reason 
behind it. If the mouse has equivalent genes corresponding to these 
other transcripts and they too are localised within the same area of a 
particular chromosome, it will argue for the latter. 
The Drosophila protein has been localised to the nuclei of cells 
within the embryo. Preliminary work done with the Drosophila antibody, 
IC2, showed staining within the nucleus and around the nuclear membrane 
of cells from a human lymphoblastoid cell line. However it is not 
known whether the cells were expressing the protein, so these results 
are in no way confirmed. They may well be artefactual, so further work 
is required in order to determine the cellular localisation of the m9 
protein (and the m5 and m8 proteins if they exist in mammals). 
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The Drosophila gene might code for a protein involved in signal 
transduction. The outcome of the signal is that some cells from a 
single population are restricted to an epidermal lineage whilst others 
delaminate and follow a neural pathway. It is not possible to say that 
the gene will have the same function in mouse as in Drosophila merely 
because they are homologous, as the development of the nervous system 
in a fruit fly is vastly different to that of a mouse, 
In the mouse the precursor of the CNS, the neural tube, is 
derived from the primitive ectoderm of the developing embryo (Snow, 
1977) due to the delamination of cells from the epithelium to form a 
mesodermal layer. This process forms the primitive streak and at the 
anterior end of this structure a swelling known as Hensen's node forms. 
Primitive ectoderm cells are laid down along the midline of the 
mesodermal cells forming the notochord, whilst the overlying ectoderm 
is induced to form a neural plate which folds forming the hollow neural 
tube. The neural tube dissociates from the ectoderm of the embryo and 
chains of ectodermal cells align with it in chains. These chains are 
known as the neural crests and these cells are the precursors of the 
peripheral parts of the sensory nervous system, the dorsal root ganglia 
of the spinal nerves and sensory ganglia of the brain amongst other 
structures. 
In Drosophila, the nervous system develops from the ventral 
ectoderm which is a population of cells which lie either side of cells 
which will form the mesoderm. These flanking cells are known as the 
ventral ectoderm. From this population of cells the neuroblasts 
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segregate and move towards the inside of the embryo. The remaining 
cells form the ectoderm. The control of this delamination is due to 
the neurogenic genes as discussed in Chapter 5. 
The differences in the development of the CNS in mouse and 
Drosophila are obvious, however in both systems, a delamination process 
is fundamental. In the mouse it gives rise to the neural tube from 
which the nervous system forms, whilst in Drosophila it gives rise to 
neuroblasts which then divide to give neurons of the ventral cord. The 
similarity of these processes in this respect may well indicate that 
the two genes are performing essentially the same function in two very 
different systems. In fact, the degree of similarity in the two genes 
may well be indicating that this is the case. 
Much of the work to determine the effects of Drosophila genes is 
done by complementation. The gene of interest often has mutants 
existing in the fly. A construct containing all or part of the gene 
can be introduced and the resulting phenotypes recorded. In this way, 
the function of the gene can be studied and the essential parts of that 
gene determined. This approach was used to determine the function of 
the m9 transcript of the E(spl) complex. We want to attempt the same 
type of experiment. We aim to build a construct which contains the 
mouse gene instead of the Drosophila one and to introduce this into 
Drosophila embryos homozygous for the mutant gene. This will enable us 
to determine whether the mouse protein is indeed capable of performing 
the same function as that of Drosophila. 
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A human fusion protein has been produced, as discussed in Chapter 
5, and I am in the process of purifying enough of this protein to 
inject rabbits in order to produce polyclonal serum antibodies. Mice 
may also be injected in order to produce monoclonal antibodies. 
In situ work in order to determine the pattern of expression in 
mouse embryos has been undertaken. 9 and 11 day embryos have been 
studied, but the initial impressions are that the gene is expressed 
more or less everywhere in the 9 day embryo with some differences in 
the density of staining in the 11 day embryo. More sections and more 
ages of embryos will have to be studied before a definite expression 
pattern can be determined. Some of the preliminary results are shown 
in Appendix I. The way forward with Em9 depends very much on the 
outcome of the experiments discussed here, those underway and those not 
yet begun. The prospects are undeniably exciting and the work may shed 






Three clones of Em9 were isolated from a Xgt10 mouse 8.5 day 
embryonic cDNA library as previously described. The isolation of 
these clones is advantageous, as material is more readily available 
when studying mouse as opposed to human. We know that Em9 was 
expressed in the 8.5 day embryo as a cDNA library is prepared from 
RNA isolated from the tissue of interest. In situ hybridisation was 
the method chosen to detect the pattern of this expression. 
Of the three clones Esp4.1 was the longest and therefore was 
selected to be used to make the RNA probe required for the in situ 
technique. As the clones were detected in the mouse 8.5 day 
embryonic library, mice at 9 days of development were used. Younger 
mice may not be expressing the gene and are also difficult to handle 
experimentally. 11 day mice were also used to see if the expression 
of this gene was extended beyond 8.5/9 days, and, whether the 
pattern of expression was restricted by organogenesis. 
Materials and Methods 
In Situ Hybridisation 
The method used during the course of this project was that 
modified by Duncan Davidson and Elizabeth Graham in this unit from 
Wilkinson et al., 1987. 
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Preparation of Embryos 
C57BL /6 (inbred) and Swiss (outbred) mice were used. Females 
of each strain were placed in a cage with a single male and were 
examined for the presence of a sperm plug. Positive females were 
separated from the males. The day following the presence of a sperm 
plug was considered "day zero ". On designated days, females were 
sacrificed by cervical dislocation and the foetuses removed into ice 
cold PBS. The foetuses were then staged according to morphological 
criteria and transferred into ice cold paraformaldehyde (PFA) pH 7.2 
and left to fix at 4 °C o /n. PFA is a weak cross linking fixative 
which, while preserving the tissue, permits access of the probe. 
Wax Processing of Staged Embryos 
The fixed embyos wre rinsed in PBS for 30 mins and then 
transferred into 0.85% NaC1 for 30 mins at 4 °C. The embryos were 
dehydrated in the following steps and all washes were carried out at 
RT. They were washed twice for 15 mins each in 1:1 0.85% 
NaCl:ethanol, 15 mins in 70% ethanol, 30 mins in 70% ethanol, 30 -60 
mins in 85% ethanol, 1 hr in 95% ethanol and finally for 3x ihr in 
100% ethanol. The embryos were then incubated in a clearing 
solution "Histoclear" for 30 mins twice and then again o /n. The 
following morning the embyos were incubated for 3x 60 mins at 60 °C 
in molten wax. Glass blocks were used to embed the embryos after 
careful orientation. The wax was then allowed to solidify under 
water at 4 °C. The blocks can now be stored at RT indefinitely. 
208 
Wax Sectioning of the Embedded Embryos 
Histology slides were pretreated to prevent the sections from 
washing off during processing. They were washed in 10% HC1 in 70% 
ethanol for lOsecs and then rinsed in distilled water. They were 
then washed in 95% ethanol for lOsecs and dried in the oven at 150 °C 
for 5mins. Cooled slides were dipped into 2% TESPA in acetone for 
lOsecs, then rinsed for 2x lOsecs in 100% acetone, once in distilled 
water and baked at 42 °C until dry. 
During the prehybridisation of the sections, coverslips were 
prepared, having been previously soaked in 100% ethanol o /n. They 
were dipped in 100% ethanol, then silane for 20secs and air dried. 
They were then rinsed again in 100% ethanol, air dried and cut to 
size. 
Ribbons of sections 6µm thick, were cut on a microtome and 
then groups of three were lowered onto a floating bath of sterile 
distilled water at 55 °C to stretch and remove any creases. The 
sections were then carefully oriented and removed onto the 
pretreated slides. The sections were sealed onto slides at 60 °C 
o /n, desiccated and stored at RT. 
pretreatment of the Sections on Slides 
The sections were desiccated o/n and then treated for 2x 
10mins in xylene to remove the wax. They were then rehydrated 
through an ethanol series for 2mins each, beginning with 100% 
ethanol. They were then passed through 0.85% NaC1 and PBS for 5mins 
each. The sections were then treated in 4% PFA in PBS (pH 7.4) for 
20mins to further fix the sections to the slides before washing for 
2x 5mins in PBS. The slides were drained and treated with 20µg /ml 
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proteinase K in 50mM Tris, 5mM EDTA pH 7.2 for 7.5mins before 
washing for 5mins in PBS. The proteinase K treatment facilitates 
the access of the probe to the mRNA. The slides were again treated 
with 4% PFA in PBS for 5mins and then briefly washed in sterile 
distilled water for lOsecs. The sections were then acetylated by 
washing for 30secs in O.1M triethanolamine (TEA) pH 8 before 
incubating in TEA plus 6241l acetic anhydride for 2x 10mins each. 
The acetylation step blocks basic groups, which would otherwise 
contribute to the background by nonspecific binding of the nucleic 
acid probe. The sections were then washed in PBS and 0.85% NaC1 for 
5mins each before dehydrating through an ethanol series for 2mins 
each, ending with 100% ethanol and then air drying. 
Radiolabelling of Probes For In Situ Hybridisation 
The mouse clone, Esp4.1 was subcloned out of the X vector, in 
which it was isolated from the library, into Bluescript. In this 
vector the insert was situated between opposing T7 and T3 promotors, 
from which it can be transcribed. The probe to be used has first to 
be linearised in order that a sense strand can be transcribed from 
one promoter and an anti -sense strand transcribed from the other. 
This was achieved by restriction endonuclease digestion with NotI 
after which the DNA was phenol /chloroform extracted, precipitated, 
washed and dried under vacuum before being resuspended in TE. 
The labelling transcription reaction involves the addition of 
6111 of labelling buffer, 1111 of each of 10mM rCTP, 10mM rATP, 10mM 
rGTP, 1M DTT, 3111 of water, 12111 of 35S rUTP ( >1mCi /100u1), 14g of 
prepared DNA in 5111 of TE, 1.2111 of RNase block and 0.8111 T7 /T3 
polymerase. This was incubated at 37 °C for 25mins. A further 0.8111 
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of polymerase was added and the incubation continued for another 
25mins. The labelling efficiency was checked by comparing TCA 
precipitated and non -precipitated samples in 10m1 of Aquasol, using 
a scintillation counter. 241 of carrier yeast RNA (10mg /m1) was 
added and the labelling mix was then incubated with lgl of DNase I 
at 37 °C for lOmins in order to digest the template DNA. 241 of 0.1M 
EDTA and 67.541 of TE plus 50mM DTT were then added to stop the 
reaction and the probe was phenol extracted twice and then 
phenol /chloroform extracted once before precipitation o/n at -20 °C 
with 1/10 vol 3M sodium acetate and 3vols cold ethanol. The probe 
was pelleted and washed twice in 80% ethanol, 50mM DTT in TE and 
once in 100% ethanol. It was then dried and resuspended in l00µ1 
DEPC water. In order to reduce the size of the probe to -150 bases, 
to facilitate penetration into the tissue during hybridisation, the 
probe was digested under mild alkaline conditions: 90µ1 of sodium 
bicarbonate and 541 of 1M DTT were added and this was incubated at 
60 °C for ihr. The probe was then precipitated with 1 /10 vol 6M 
ammonium acetate pH 5.2 and 3vols cold ethanol with lgl yeast RNA as 
a carrier o/n at -20 °C. The probe was pelleted and washed as above 
plus a further wash in BO% ethanol in TE. The pellet was dried 
again, dissolved in approximately 5Oµ1 of TE, 50mM DTT and incubated 
on ice for 20mins. 141 of this was counted as before and the probe 
dissolved in TE:hybridisation mix, 50mM DTT (1:9) so that the final 
concentration was 1.2 x 105 dpm /ml. 
Hybridisation Mix for In Situs 
50% formamide, 10% dextran sulphate, lx Denhardt's solution, 
20mM Tris pH 8, 0.3M NaCl, 5mM EDTA, 10mM sodium phosphate, 0.5µg /m1 
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yeast RNA. This can be stored at -70 °C. 50mM DTT is added 
immediately before use. 
Hybridisation 
The probe was added to the hybridisation mix and heated to 
80 °C for 2mins to denature it. The probe was then cooled on ice and 
then - 5µ1 was pipetted onto each row of sections. The sections and 
probe are then covered with the prepared coverslips and the slides 
were put into a slide box with a tissue soaked in 50% formamide, 5x 
SSC. The box is sealed into a plastic bag and submerged in a 
waterbath at 55 °C o /n. 
After hybridisation the slides are washed for 15 - 30mins in 
5x SSC, 10mM DTT at 55 °C to remove the coverslips, then for 20mins 
in 50% formamide, 2x SSC, 0.1M DTT at 65 °C. They are then washed 3x 
in 0.5M NaCl, 10mM Tris, 5mM EDTA at pH 7.5 at 37 °C for 10mins each 
before treatment with RNase A (40µg /ml) in NTE buffer pH 7.5 at 37 °C 
for 30mins. The RNase A removes single strand, nonspecifically 
bound RNA probe and this reduces the background labelling. The 
slides were then washed for 15mins in NTE buffer alone at 37 °C then 
in 50% formamide, 2x SSC, 0.1M DTT for 20mins at 65 °C. The 
remainder of the washes were at RT. The slides were washed 3x in 2x 
SSC for 10mins each and then 3x in 0.1x SSC again for 10mins each. 
The slides are then incubated for lmin each in 30 %, 50 %, 70% and 90% 
ethanol, each made up in 0.3M ammonium acetate. The slides are 
finally washed in 100% ethanol for 2x 5mins before air drying prior 
to autoradiography. 
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Autoradiography of Slides 
This was carried out under safe light conditions, using an 
S902 light pointed towards the wall. Ilford K5 emulsion at 40 °C was 
mixed 1:1 with water at the same temperature. The slides were 
dipped twice into this and then left to drain. They were then 
loaded into the light tight slide box containing silica gel and left 
to dry for a minimum of 3hrs. The box was then wrapped in foil and 
put in the cold room to expose for 6 weeks. 
Development and Fixation of In Situ Hybridised Sections 
All solutions are stored at 4 °C, but warmed to RT before use. 
The slides at RT were incubated in developer D19 for 4mins and then 
rinsed in distilled water. They were fixed in 1:3 Kodafix:distilled 
water for 4mins before washing for 2x 10mins in distilled water. 
The sections were stained in methyl green for a few secs before 
rinsing once more in distilled water and drying in air o /n. The 
slides were mounted in DPX mountant the following day. 
Photography of In Situ Hybridised Sections 
In situ hybridised sections were photographed by Duncan 
Davidson on a Wild Photomakroscop M400 with a Wild Leitz MPS46 
photoautomat on colour Kodak Ektar 25 film. High power photographs 
were taken by Norman Davidson on a Leitz Orthoplan microscope, with 
the same type of film. 
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Results and Discussion 
In an 11 day mouse embryo a high level of staining is apparent 
in Figure 1 in the dark field photograph (B), and it appears that 
the probe has hybridised to all parts of the embryo. this raises 
the question of whether the grains are present due to specific 
hybridisation or whether they are representing a non -specific high 
level of background. 
Figure 2 shows a section through a blood vessel from the same 
section in both light and dark field. The arrow (on the dark field 
photograph) indicates the position of the red blood cells within the 
vessel and the figure quite clearly shows the high level of staining 
of the vessel walls but a much reduced amount in the area of the red 
blood cells. The cell density is comparable, so this effect is not 
due to differing concentrations of cells. This clearly indicates 
that the grains are not due to to nonspecific binding, but to the 
specific labelling of the probe. 
The evidence shown here indicates that there is a high level 
of expression of Em9 throughout the mouse embryo at 11 days. A 
similar observation in the embryo of Drosophila has also been noted 
(D. Hartley, pers. comm.). However on closer examination of the 
sections differences in the level of expression in some areas were 
observed. 
Figure 3 shows a posterior section of the neural tube of an 11 
day mouse. In both light and dark field, the neural tube shows a 
slightly higher level of expression than the flanking tissues, with 
a denser region lying within. The inner edge also appears to show 
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Figure 1 shows a longitudinal section through an 11 day C57BL /6 
mouse embryo. 
neural tube aorta neural tube 
heart 
myotomes 
hind limb bud 
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Figure 2 shows a section through a blood vessel of an 11 day C57BL /6 
embryo. 
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Figure 3 shows a section through the posterior end of the neural 
tube of an 11 day C57BL /6 mouse embryo. 
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an elevated level of expression when compared to that in the rest of 
the neural tube. 
Figure 4 shows a section through the fore brain and Rathke's 
pouch in an 11 day embryo. Again the level of staining in the fore 
brain appears to be elevated when compared to that of the 
surrounding tissues. In the dark field photograph the neck of 
Rathke's pouch seems to be showing a higher level of staining than 
the rest of the structure as indicated by the lower arrow. Also the 
floor plate of the brain seems to show a reduced level of expression 
when compared to the rest of the brain (as indicated by the upper 
arrow). The reduced level of expression in the floor plate is shown 
more clearly in a section through the hind brain in Figure 5 in both 
light and dark field. The heart was also observed to show a 
reduction in the level of expression (data not shown). 
In the 9 day embryos studied, a general high level of 
expression was observed. Sections through these regions in 9 day 
embryos showed no reduction in the level of expression in the heart 
and floor plate, or any increase in the level in the neck of 
Rathke's pouch and within the posterior of the neural tube. This 
may be because the expression pattern is more uniform at 9 days and 
that the pattern changes and is restricted by 11 days. The tissues 
which show the reduced level of expression do not seem to have 
anything in common with each other in terms of their derivation or 
eventual function in the mouse. More sections at different stages 
of development in the mouse will have to be studied, before a 
complete picture of the embryonic expression of Em9 can be produced. 
The evidence here shows that the gene is indeed expressed in 
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Figure 4 shows a section through the fore brain and Rathke's pouch 
of an 11 day C57BL /6 mouse embryo. 
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Figure 5 shows a section through the hind brain of an 11 day C57BL /6 
mouse embryo. 
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the developing mouse embryo as expected from its isolation from a 
cDNA library. The more or less uniform pattern of this expression 
is unexpected, as the gene has a very specific role to play in a 
specific region in the Drosophila embryo. It may be that the 
spatial arrangement of the mRNA is particularly specific but that 
translational control restricts the functional protein. It is also 
possible that the control of the specific delamination of 
neuroblasts within the neurogenic ectoderm requires the interaction 
of a further gene in order to define the area in which this function 
occurs. If this is the case, the gene may not yet have been 
identified. Further work in this area will hopefully allow a better 
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